Document Name: role of Cetiol 868/0Ctyl Stearate in Anti Ozone Cream3
Document link: https://www.google.com.pg/patents/US20050142080



US20050142080A1 - Cosmetic or dermatological light protection formulation with a benzoxazole derivative 
        - Google Patents










































US20050142080A1 - Cosmetic or dermatological light protection formulation with a benzoxazole derivative 
        - Google Patents
Cosmetic or dermatological light protection formulation with a benzoxazole derivative 
       

Download PDF
Info

Publication number
US20050142080A1



US20050142080A1
US10/871,819
US87181904A
US2005142080A1
US 20050142080 A1
US20050142080 A1
US 20050142080A1
 
 
 
US 87181904 A
US87181904 A
US 87181904A
US 2005142080 A1
US2005142080 A1
US 2005142080A1
Authority
US
United States
Prior art keywords
preparation
group
oil component
cosmetic
bis
Prior art date
2001-12-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned


Application number
US10/871,819
Inventor
Anja Goppel
Jens Schulz
Heike Lerg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

    Beiersdorf AG
  
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
2001-12-20
Filing date
2004-06-18
Publication date
2005-06-30


Priority claimed from DE10162841.2
external-priority


2001-12-20
Priority claimed from DE2001162841
external-priority
patent/DE10162841A1/en


2004-06-18
Application filed by Beiersdorf AG
filed
Critical
Beiersdorf AG


2004-06-18
Priority to US10/871,819
priority
Critical
patent/US20050142080A1/en


2005-03-07
Assigned to BEIERSDORF AG
reassignment
BEIERSDORF AG
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors: GOPPEL ANJA, LERG, HEIKE, SCHULZ, JENS


2005-06-30
Publication of US20050142080A1
publication
Critical
patent/US20050142080A1/en


Status
Abandoned
legal-status
Critical
Current

Links



USPTO



USPTO PatentCenter



USPTO Assignment



Espacenet



Global Dossier



Discuss




239000002537
cosmetic
Substances




0.000
title
claims
abstract
description
112


BCMCBBGGLRIHSE-UHFFFAOYSA-N
Benzoxazole
Chemical class


C1=CC=C2OC=NC2=C1
BCMCBBGGLRIHSE-UHFFFAOYSA-N
0.000
title
claims
abstract
description
44


230000004224
protection
Effects




0.000
title
claims
description
62


239000000203
mixture
Substances




0.000
title
description
108


238000009472
formulation
Methods




0.000
title
description
18


238000002360
preparation method
Methods




0.000
claims
abstract
description
196


210000003491
Skin
Anatomy




0.000
claims
abstract
description
86


230000001965
increased
Effects




0.000
claims
abstract
description
18


230000002633
protecting
Effects




0.000
claims
abstract
description
12


230000032683
aging
Effects




0.000
claims
abstract
description
10


-1
flavone glycoside
Chemical class




0.000
claims
description
134


239000000126
substance
Substances




0.000
claims
description
130


239000004904
UV filter
Substances




0.000
claims
description
56


150000001875
compounds
Chemical class




0.000
claims
description
40


239000002253
acid
Substances




0.000
claims
description
34


229940114374
BUTYLENE GLYCOL DICAPRYLATE
Drugs




0.000
claims
description
28


JYJAMZPYEGWUDM-UHFFFAOYSA-N
4-octanoyloxybutyl octanoate
Chemical compound


CCCCCCCC(=O)OCCCCOC(=O)CCCCCCC
JYJAMZPYEGWUDM-UHFFFAOYSA-N
0.000
claims
description
26


DLAHAXOYRFRPFQ-UHFFFAOYSA-N
dodecyl benzoate
Chemical compound


CCCCCCCCCCCCOC(=O)C1=CC=CC=C1
DLAHAXOYRFRPFQ-UHFFFAOYSA-N
0.000
claims
description
24


150000002632
lipids
Chemical class




0.000
claims
description
24


239000007788
liquid
Substances




0.000
claims
description
24


229940031765
DIETHYLHEXYL 2,6-NAPHTHALATE
Drugs




0.000
claims
description
22


OTTBIMWIPWJULZ-UHFFFAOYSA-N
bis(2-ethylhexyl) naphthalene-1,6-dicarboxylate
Chemical compound


CCCCC(CC)COC(=O)C1=CC=CC2=CC(C(=O)OCC(CC)CCCC)=CC=C21
OTTBIMWIPWJULZ-UHFFFAOYSA-N
0.000
claims
description
22


239000004480
active ingredient
Substances




0.000
claims
description
20


SRVSYCCHRDXMMS-UHFFFAOYSA-N
dodecan-5-yl 2-hydroxybenzoate
Chemical compound


CCCCCCCC(CCCC)OC(=O)C1=CC=CC=C1O
SRVSYCCHRDXMMS-UHFFFAOYSA-N
0.000
claims
description
18


150000003712
vitamin E derivatives
Chemical class




0.000
claims
description
16


125000001841
imino group
Chemical group


[H]N=*

0.000
claims
description
14


NZZIMKJIVMHWJC-UHFFFAOYSA-N
Dibenzoylmethane
Chemical class


C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1
NZZIMKJIVMHWJC-UHFFFAOYSA-N
0.000
claims
description
12


229940046009
Vitamin E
Drugs




0.000
claims
description
12


229930003427
Vitamin E
Natural products




0.000
claims
description
12


235000019165
vitamin E
Nutrition




0.000
claims
description
12


239000011709
vitamin E
Substances




0.000
claims
description
12


AGBQKNBQESQNJD-SSDOTTSWSA-N
Lipoic acid
Chemical compound


OC(=O)CCCC[C@@H]1CCSS1
AGBQKNBQESQNJD-SSDOTTSWSA-N
0.000
claims
description
10


229930003944
flavones
Natural products




0.000
claims
description
10


235000011949
flavones
Nutrition




0.000
claims
description
10


125000001997
phenyl group
Chemical group


[H]C1=C([H])C([H])=C(*)C([H])=C1[H]

0.000
claims
description
10


239000005871
repellent
Substances




0.000
claims
description
10


230000002940
repellent
Effects




0.000
claims
description
10


239000000758
substrate
Substances




0.000
claims
description
10


239000003086
colorant
Substances




0.000
claims
description
8


239000001023
inorganic pigment
Substances




0.000
claims
description
8


SBLKVIQSIHEQOF-OWOJBTEDSA-N
(E)-octadec-9-enedioic acid
Chemical compound


OC(=O)CCCCCCC\C=C\CCCCCCCC(O)=O
SBLKVIQSIHEQOF-OWOJBTEDSA-N
0.000
claims
description
6


235000019136
lipoic acid
Nutrition




0.000
claims
description
6


229960002663
thioctic acid
Drugs




0.000
claims
description
6


150000003918
triazines
Chemical class




0.000
claims
description
6


229940120503
Dihydroxyacetone
Drugs




0.000
claims
description
4


RXKJFZQQPQGTFL-UHFFFAOYSA-N
Dihydroxyacetone
Chemical compound


OCC(=O)CO
RXKJFZQQPQGTFL-UHFFFAOYSA-N
0.000
claims
description
4


DSSYKIVIOFKYAU-UHFFFAOYSA-N
Camphor
Chemical class


C1CC2(C)C(=O)CC1C2(C)C
DSSYKIVIOFKYAU-UHFFFAOYSA-N
0.000
claims
4


WPYMKLBDIGXBTP-UHFFFAOYSA-M
benzoate
Chemical compound


[O-]C(=O)C1=CC=CC=C1
WPYMKLBDIGXBTP-UHFFFAOYSA-M
0.000
claims
4


125000004051
hexyl group
Chemical group


[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])*

0.000
claims
4


XBDQKXXYIPTUBI-UHFFFAOYSA-M
propionate
Chemical compound


CCC([O-])=O
XBDQKXXYIPTUBI-UHFFFAOYSA-M
0.000
claims
2


GWEVSGVZZGPLCZ-UHFFFAOYSA-N
titanium dioxide
Inorganic materials


O=[Ti]=O
GWEVSGVZZGPLCZ-UHFFFAOYSA-N
0.000
description
122


239000003995
emulsifying agent
Substances




0.000
description
72


239000000049
pigment
Substances




0.000
description
68


PEDCQBHIVMGVHV-UHFFFAOYSA-N
glycerine
Chemical compound


OCC(O)CO
PEDCQBHIVMGVHV-UHFFFAOYSA-N
0.000
description
60


239000003921
oil
Substances




0.000
description
60


235000019198
oils
Nutrition




0.000
description
60


229920000435
poly(dimethylsiloxane)
Polymers




0.000
description
58


235000013870
dimethyl polysiloxane
Nutrition




0.000
description
54


LFQSCWFLJHTTHZ-UHFFFAOYSA-N
ethanol
Chemical compound


CCO
LFQSCWFLJHTTHZ-UHFFFAOYSA-N
0.000
description
54


XLYOFNOQVPJJNP-UHFFFAOYSA-N
water
Substances


O
XLYOFNOQVPJJNP-UHFFFAOYSA-N
0.000
description
52


239000012071
phase
Substances




0.000
description
50


239000004205
dimethyl polysiloxane
Substances




0.000
description
48


239000000839
emulsion
Substances




0.000
description
48


CXQXSVUQTKDNFP-UHFFFAOYSA-N
C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C
Chemical compound


C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C
CXQXSVUQTKDNFP-UHFFFAOYSA-N
0.000
description
41


229940008099
dimethicone
Drugs




0.000
description
40


239000002245
particle
Substances




0.000
description
40


XLOMVQKBTHCTTD-UHFFFAOYSA-N
zinc monoxide
Chemical compound


[Zn]=O
XLOMVQKBTHCTTD-UHFFFAOYSA-N
0.000
description
40


235000010215
titanium dioxide
Nutrition




0.000
description
38


239000004408
titanium dioxide
Substances




0.000
description
36


229920001577
copolymer
Polymers




0.000
description
34


239000000975
dye
Substances




0.000
description
34


YBGZDTIWKVFICR-JLHYYAGUSA-N
Octyl methoxycinnamate
Chemical compound


CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1
YBGZDTIWKVFICR-JLHYYAGUSA-N
0.000
description
32


239000000499
gel
Substances




0.000
description
32


239000007787
solid
Substances




0.000
description
32


QIQXTHQIDYTFRH-UHFFFAOYSA-N
Stearic acid
Chemical compound


CCCCCCCCCCCCCCCCCC(O)=O
QIQXTHQIDYTFRH-UHFFFAOYSA-N
0.000
description
30


229920001296
polysiloxane
Polymers




0.000
description
28


VYPSYNLAJGMNEJ-UHFFFAOYSA-N
silicium dioxide
Chemical compound


O=[Si]=O
VYPSYNLAJGMNEJ-UHFFFAOYSA-N
0.000
description
28


239000003963
antioxidant agent
Substances




0.000
description
26


235000006708
antioxidants
Nutrition




0.000
description
26


230000000694
effects
Effects




0.000
description
26


229920001971
elastomer
Polymers




0.000
description
26


239000000806
elastomer
Substances




0.000
description
26


229960001679
octinoxate
Drugs




0.000
description
26


229920000036
polyvinylpyrrolidone
Polymers




0.000
description
26


JEIPFZHSYJVQDO-UHFFFAOYSA-N
iron(III) oxide
Inorganic materials


O=[Fe]O[Fe]=O
JEIPFZHSYJVQDO-UHFFFAOYSA-N
0.000
description
24


239000001267
polyvinylpyrrolidone
Substances




0.000
description
24


235000013855
polyvinylpyrrolidone
Nutrition




0.000
description
24


JGUMTYWKIBJSTN-UHFFFAOYSA-N
2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate
Chemical compound


C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1
JGUMTYWKIBJSTN-UHFFFAOYSA-N
0.000
description
22


FMJSMJQBSVNSBF-UHFFFAOYSA-N
Octocrylene
Chemical compound


C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1
FMJSMJQBSVNSBF-UHFFFAOYSA-N
0.000
description
22


XAGFODPZIPBFFR-UHFFFAOYSA-N
aluminum
Chemical compound


[Al]
XAGFODPZIPBFFR-UHFFFAOYSA-N
0.000
description
22


230000000111
anti-oxidant
Effects




0.000
description
22


229960000601
octocrylene
Drugs




0.000
description
22


239000002304
perfume
Substances




0.000
description
22


125000005373
siloxane group
Chemical group


[SiH2](O*)*

0.000
description
22


239000000243
solution
Substances




0.000
description
22


235000014692
zinc oxide
Nutrition




0.000
description
22


229940085262
Cetyl dimethicone
Drugs




0.000
description
20


LXCFILQKKLGQFO-UHFFFAOYSA-N
Methylparaben
Chemical compound


COC(=O)C1=CC=C(O)C=C1
LXCFILQKKLGQFO-UHFFFAOYSA-N
0.000
description
20


DHMQDGOQFOQNFH-UHFFFAOYSA-N
glycine
Chemical compound


NCC(O)=O
DHMQDGOQFOQNFH-UHFFFAOYSA-N
0.000
description
20


239000004530
micro-emulsion
Substances




0.000
description
20


239000000516
sunscreening agent
Substances




0.000
description
20


239000011787
zinc oxide
Substances




0.000
description
20


229940100460
PEG-100 Stearate
Drugs




0.000
description
18


QCDWFXQBSFUVSP-UHFFFAOYSA-N
Phenoxyethanol
Chemical compound


OCCOC1=CC=CC=C1
QCDWFXQBSFUVSP-UHFFFAOYSA-N
0.000
description
18


229960005323
Phenoxyethanol
Drugs




0.000
description
18


229940086555
cyclomethicone
Drugs




0.000
description
18


229920001888
polyacrylic acid
Polymers




0.000
description
18


229920002545
silicone oil
Polymers




0.000
description
18


239000011780
sodium chloride
Substances




0.000
description
18


BVKZGUZCCUSVTD-UHFFFAOYSA-L
Carbonate dianion
Chemical compound


[O-]C([O-])=O
BVKZGUZCCUSVTD-UHFFFAOYSA-L
0.000
description
16


WSSJONWNBBTCMG-UHFFFAOYSA-N
Homosalate
Chemical compound


C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O
WSSJONWNBBTCMG-UHFFFAOYSA-N
0.000
description
16


VBICKXHEKHSIBG-UHFFFAOYSA-N
rac-1-monostearoylglycerol
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO
VBICKXHEKHSIBG-UHFFFAOYSA-N
0.000
description
16


230000000475
sunscreen
Effects




0.000
description
16


UVCJGUGAGLDPAA-UHFFFAOYSA-N
2-phenyl-3H-benzimidazole-5-sulfonic acid
Chemical class


N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1
UVCJGUGAGLDPAA-UHFFFAOYSA-N
0.000
description
14


RFVNOJDQRGSOEL-UHFFFAOYSA-N
Glycol stearate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCCO
RFVNOJDQRGSOEL-UHFFFAOYSA-N
0.000
description
14


FMRHJJZUHUTGKE-UHFFFAOYSA-N
Octyl salicylate
Chemical compound


CCCCC(CC)COC(=O)C1=CC=CC=C1O
FMRHJJZUHUTGKE-UHFFFAOYSA-N
0.000
description
14


229940048845
POLYGLYCERYL-3 DIISOSTEARATE
Drugs




0.000
description
14


235000021355
Stearic acid
Nutrition




0.000
description
14


238000010521
absorption reaction
Methods




0.000
description
14


NIXOWILDQLNWCW-UHFFFAOYSA-N
acrylic acid
Chemical compound


OC(=O)C=C
NIXOWILDQLNWCW-UHFFFAOYSA-N
0.000
description
14


PNEYBMLMFCGWSK-UHFFFAOYSA-N
al2o3
Chemical compound


[O-2].[O-2].[O-2].[Al+3].[Al+3]
PNEYBMLMFCGWSK-UHFFFAOYSA-N
0.000
description
14


239000004359
castor oil
Substances




0.000
description
14


235000019438
castor oil
Nutrition




0.000
description
14


229940075529
glyceryl stearate
Drugs




0.000
description
14


239000010445
mica
Substances




0.000
description
14


229910052618
mica group
Inorganic materials




0.000
description
14


230000002335
preservative
Effects




0.000
description
14


239000003755
preservative agent
Substances




0.000
description
14


239000011734
sodium
Substances




0.000
description
14


229910052708
sodium
Inorganic materials




0.000
description
14


QIQXTHQIDYTFRH-UHFFFAOYSA-M
stearate
Chemical compound


CCCCCCCCCCCCCCCCCC([O-])=O
QIQXTHQIDYTFRH-UHFFFAOYSA-M
0.000
description
14


239000008117
stearic acid
Substances




0.000
description
14


CWLGEPSKQDNHIO-JOBJLJCHSA-N
(E)-N-[(E)-benzylideneamino]-1-phenylmethanimine
Chemical compound


C=1C=CC=CC=1/C=N/N=C/C1=CC=CC=C1
CWLGEPSKQDNHIO-JOBJLJCHSA-N
0.000
description
12


WBYWAXJHAXSJNI-VOTSOKGWSA-M
.beta-Phenylacrylic acid
Natural products


[O-]C(=O)\C=C\C1=CC=CC=C1
WBYWAXJHAXSJNI-VOTSOKGWSA-M
0.000
description
12


NKJOXAZJBOMXID-UHFFFAOYSA-N
1-octoxyoctane
Chemical compound


CCCCCCCCOCCCCCCCC
NKJOXAZJBOMXID-UHFFFAOYSA-N
0.000
description
12


LEACJMVNYZDSKR-UHFFFAOYSA-N
2-octyldodecan-1-ol
Chemical compound


CCCCCCCCCCC(CO)CCCCCCCC
LEACJMVNYZDSKR-UHFFFAOYSA-N
0.000
description
12


BXWNKGSJHAJOGX-UHFFFAOYSA-N
Cetyl alcohol
Chemical compound


CCCCCCCCCCCCCCCCO
BXWNKGSJHAJOGX-UHFFFAOYSA-N
0.000
description
12


WSDISUOETYTPRL-UHFFFAOYSA-N
DMDM hydantoin
Chemical compound


CC1(C)N(CO)C(=O)N(CO)C1=O
WSDISUOETYTPRL-UHFFFAOYSA-N
0.000
description
12


229940032067
PEG-20 Stearate
Drugs




0.000
description
12


229920002701
Polyoxyl 40 Stearate
Polymers




0.000
description
12


125000004432
carbon atoms
Chemical group


C*

0.000
description
12


229940073669
ceteareth 20
Drugs




0.000
description
12


229960000541
cetyl alcohol
Drugs




0.000
description
12


239000011248
coating agent
Substances




0.000
description
12


238000000576
coating method
Methods




0.000
description
12


230000000875
corresponding
Effects




0.000
description
12


235000014113
dietary fatty acids
Nutrition




0.000
description
12


150000002148
esters
Chemical class




0.000
description
12


239000000194
fatty acid
Substances




0.000
description
12


239000006260
foam
Substances




0.000
description
12


238000005470
impregnation
Methods




0.000
description
12


229960002216
methylparaben
Drugs




0.000
description
12


239000002480
mineral oil
Substances




0.000
description
12


229910052760
oxygen
Inorganic materials




0.000
description
12


229920000642
polymer
Polymers




0.000
description
12


KWYUFKZDYYNOTN-UHFFFAOYSA-M
potassium hydroxide
Chemical compound


[OH-].[K+]
KWYUFKZDYYNOTN-UHFFFAOYSA-M
0.000
description
12


DNIAPMSPPWPWGF-UHFFFAOYSA-N
propylene glycol
Chemical compound


CC(O)CO
DNIAPMSPPWPWGF-UHFFFAOYSA-N
0.000
description
12


150000003839
salts
Chemical class




0.000
description
12


229910052710
silicon
Inorganic materials




0.000
description
12


239000010703
silicon
Substances




0.000
description
12


239000000377
silicon dioxide
Substances




0.000
description
12


KEAYESYHFKHZAL-UHFFFAOYSA-N
sodium
Chemical compound


[Na]
KEAYESYHFKHZAL-UHFFFAOYSA-N
0.000
description
12


HEMHJVSKTPXQMS-UHFFFAOYSA-M
sodium hydroxide
Chemical compound


[OH-].[Na+]
HEMHJVSKTPXQMS-UHFFFAOYSA-M
0.000
description
12


OULAJFUGPPVRBK-UHFFFAOYSA-N
tetratriacontan-1-ol
Chemical compound


CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO
OULAJFUGPPVRBK-UHFFFAOYSA-N
0.000
description
12


239000001993
wax
Substances




0.000
description
12


TYYHDKOVFSVWON-UHFFFAOYSA-N
2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione
Chemical compound


C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1
TYYHDKOVFSVWON-UHFFFAOYSA-N
0.000
description
10


UBNYRXMKIIGMKK-RMKNXTFCSA-N
Amiloxate
Chemical compound


COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1
UBNYRXMKIIGMKK-RMKNXTFCSA-N
0.000
description
10


QZKRHPLGUJDVAR-UHFFFAOYSA-K
EDTA trisodium salt
Chemical compound


[Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O
QZKRHPLGUJDVAR-UHFFFAOYSA-K
0.000
description
10


239000004471
Glycine
Substances




0.000
description
10


240000007842
Glycine max
Species




0.000
description
10


235000010469
Glycine max
Nutrition




0.000
description
10


229960004881
Homosalate
Drugs




0.000
description
10


VZRKEAFHFMSHCD-UHFFFAOYSA-N
IR3535
Chemical compound


CCCCN(C(C)=O)CCC(=O)OCC
VZRKEAFHFMSHCD-UHFFFAOYSA-N
0.000
description
10


239000004166
Lanolin
Substances




0.000
description
10


TUNFSRHWOTWDNC-UHFFFAOYSA-N
Myristic acid
Chemical compound


CCCCCCCCCCCCCC(O)=O
TUNFSRHWOTWDNC-UHFFFAOYSA-N
0.000
description
10


229940049964
Oleate
Drugs




0.000
description
10


DXGLGDHPHMLXJC-UHFFFAOYSA-N
Oxybenzone
Chemical compound


OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1
DXGLGDHPHMLXJC-UHFFFAOYSA-N
0.000
description
10


230000006750
UV protection
Effects




0.000
description
10


229960005193
avobenzone
Drugs




0.000
description
10


229960000655
ensulizole
Drugs




0.000
description
10


238000005187
foaming
Methods




0.000
description
10


239000007789
gas
Substances




0.000
description
10


150000004706
metal oxides
Chemical class




0.000
description
10


235000010270
methyl p-hydroxybenzoate
Nutrition




0.000
description
10


239000004292
methyl p-hydroxybenzoate
Substances




0.000
description
10


235000010446
mineral oil
Nutrition




0.000
description
10


LSNNMFCWUKXFEE-UHFFFAOYSA-N
sulfonic acid
Chemical compound


OS(O)=O
LSNNMFCWUKXFEE-UHFFFAOYSA-N
0.000
description
10


239000007762
w/o emulsion
Substances




0.000
description
10


239000000230
xanthan gum
Substances




0.000
description
10


229920001285
xanthan gum
Polymers




0.000
description
10


235000010493
xanthan gum
Nutrition




0.000
description
10


229940082509
xanthan gum
Drugs




0.000
description
10


MCPKSFINULVDNX-UHFFFAOYSA-N
2-(benzotriazol-2-yl)-4-methylphenol
Chemical compound


CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1
MCPKSFINULVDNX-UHFFFAOYSA-N
0.000
description
8


FGGSPCRNKDZEKY-UHFFFAOYSA-N
3-hexoxypentane-1,2,3-triol
Chemical compound


CCCCCCOC(O)(CC)C(O)CO
FGGSPCRNKDZEKY-UHFFFAOYSA-N
0.000
description
8


ANJLMAHUPYCFQY-UHFFFAOYSA-N
4-phenyl-1H-benzimidazole-2-sulfonic acid
Chemical compound


C=12NC(S(=O)(=O)O)=NC2=CC=CC=1C1=CC=CC=C1
ANJLMAHUPYCFQY-UHFFFAOYSA-N
0.000
description
8


VLPFTAMPNXLGLX-UHFFFAOYSA-N
Axona
Chemical compound


CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC
VLPFTAMPNXLGLX-UHFFFAOYSA-N
0.000
description
8


GLQBXSIPUULYOG-UHFFFAOYSA-M
Bismuth oxychloride
Chemical compound


Cl[Bi]=O
GLQBXSIPUULYOG-UHFFFAOYSA-M
0.000
description
8


241000640882
Condea
Species




0.000
description
8


ZAKOWWREFLAJOT-CEFNRUSXSA-N
D-Î±-tocopherylacetate
Chemical compound


CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C
ZAKOWWREFLAJOT-CEFNRUSXSA-N
0.000
description
8


HUVYTMDMDZRHBN-UHFFFAOYSA-N
Drometrizole trisiloxane
Chemical compound


C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O
HUVYTMDMDZRHBN-UHFFFAOYSA-N
0.000
description
8


229940068171
ETHYL HEXYL SALICYLATE
Drugs




0.000
description
8


229940074052
GLYCERYL ISOSTEARATE
Drugs




0.000
description
8


229920000126
Latex
Polymers




0.000
description
8


239000004907
Macro-emulsion
Substances




0.000
description
8


239000004909
Moisturizer
Substances




0.000
description
8


229940031709
PEG-30-dipolyhydroxystearate
Drugs




0.000
description
8


229940057910
Shea butter
Drugs




0.000
description
8


GLDOVTGHNKAZLK-UHFFFAOYSA-N
Stearyl alcohol
Chemical compound


CCCCCCCCCCCCCCCCCCO
GLDOVTGHNKAZLK-UHFFFAOYSA-N
0.000
description
8


235000018936
Vitellaria paradoxa
Nutrition




0.000
description
8


241001135917
Vitellaria paradoxa
Species




0.000
description
8


239000000654
additive
Substances




0.000
description
8


229910052782
aluminium
Inorganic materials




0.000
description
8


235000010210
aluminium
Nutrition




0.000
description
8


229940073609
bismuth oxychloride
Drugs




0.000
description
8


PUPZLCDOIYMWBV-UHFFFAOYSA-N
butylene glycol
Chemical compound


CC(O)CCO
PUPZLCDOIYMWBV-UHFFFAOYSA-N
0.000
description
8


OKTJSMMVPCPJKN-UHFFFAOYSA-N
carbon
Chemical compound


[C]
OKTJSMMVPCPJKN-UHFFFAOYSA-N
0.000
description
8


230000001684
chronic
Effects




0.000
description
8


239000007957
coemulsifier
Substances




0.000
description
8


238000004040
coloring
Methods




0.000
description
8


239000000470
constituent
Substances




0.000
description
8


125000004122
cyclic group
Chemical group




0.000
description
8


RTZKZFJDLAIYFH-UHFFFAOYSA-N
diethyl ether
Chemical group


CCOCC
RTZKZFJDLAIYFH-UHFFFAOYSA-N
0.000
description
8


QXNVGIXVLWOKEQ-UHFFFAOYSA-N
disodium
Chemical compound


[Na][Na]
QXNVGIXVLWOKEQ-UHFFFAOYSA-N
0.000
description
8


GLCJMPWWQKKJQZ-UHFFFAOYSA-L
disodium;2-[4-(4,6-disulfonato-1H-benzimidazol-2-yl)phenyl]-1H-benzimidazole-4,6-disulfonate;hydron
Chemical compound


[Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O
GLCJMPWWQKKJQZ-UHFFFAOYSA-L
0.000
description
8


150000004665
fatty acids
Chemical class




0.000
description
8


239000001257
hydrogen
Substances




0.000
description
8


229910052739
hydrogen
Inorganic materials




0.000
description
8


XEEYBQQBJWHFJM-UHFFFAOYSA-N
iron
Chemical compound


[Fe]
XEEYBQQBJWHFJM-UHFFFAOYSA-N
0.000
description
8


235000019388
lanolin
Nutrition




0.000
description
8


239000004816
latex
Substances




0.000
description
8


229910044991
metal oxide
Inorganic materials




0.000
description
8


230000001333
moisturizer
Effects




0.000
description
8


239000007764
o/w emulsion
Substances




0.000
description
8


ZQPPMHVWECSIRJ-KTKRTIGZSA-M
oleate
Chemical compound


CCCCCCCC\C=C/CCCCCCCC([O-])=O
ZQPPMHVWECSIRJ-KTKRTIGZSA-M
0.000
description
8


BARWIPMJPCRCTP-CLFAGFIQSA-N
oleyl oleate
Chemical compound


CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC
BARWIPMJPCRCTP-CLFAGFIQSA-N
0.000
description
8


239000012188
paraffin wax
Substances




0.000
description
8


239000000843
powder
Substances




0.000
description
8


FAPWRFPIFSIZLT-UHFFFAOYSA-M
sodium chloride
Chemical compound


[Na+].[Cl-]
FAPWRFPIFSIZLT-UHFFFAOYSA-M
0.000
description
8


QAOWNCQODCNURD-UHFFFAOYSA-L
sulfate
Chemical compound


[O-]S([O-])(=O)=O
QAOWNCQODCNURD-UHFFFAOYSA-L
0.000
description
8


LADGBHLMCUINGV-UHFFFAOYSA-N
tricaprin
Chemical compound


CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC
LADGBHLMCUINGV-UHFFFAOYSA-N
0.000
description
8


ZQTYRTSKQFQYPQ-UHFFFAOYSA-N
trisiloxane
Chemical compound


[SiH3]O[SiH2]O[SiH3]
ZQTYRTSKQFQYPQ-UHFFFAOYSA-N
0.000
description
8


150000003722
vitamin derivatives
Chemical class




0.000
description
8


OIQXFRANQVWXJF-QBFSEMIESA-N
(2Z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one
Chemical class


CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1
OIQXFRANQVWXJF-QBFSEMIESA-N
0.000
description
6


MEJYDZQQVZJMPP-ULAWRXDQSA-N
(3S,3aR,6R,6aR)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan
Chemical compound


CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21
MEJYDZQQVZJMPP-ULAWRXDQSA-N
0.000
description
6


ZMFDXQTVCRGRNM-YXTPZADFSA-N
(Z)-but-2-ene;(E)-but-2-ene
Chemical group


C\C=C\C.C\C=C/C
ZMFDXQTVCRGRNM-YXTPZADFSA-N
0.000
description
6


JLPULHDHAOZNQI-ZTIMHPMXSA-N
1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine
Chemical compound


CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC
JLPULHDHAOZNQI-ZTIMHPMXSA-N
0.000
description
6


YJISHJVIRFPGGN-UHFFFAOYSA-N
5-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol
Chemical compound


O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1
YJISHJVIRFPGGN-UHFFFAOYSA-N
0.000
description
6


AKUPYGILGNUOIG-UHFFFAOYSA-N
5-methoxy-4-phenyltriazine
Chemical compound


COC1=CN=NN=C1C1=CC=CC=C1
AKUPYGILGNUOIG-UHFFFAOYSA-N
0.000
description
6


WNROFYMDJYEPJX-UHFFFAOYSA-K
Aluminium hydroxide
Chemical compound


[OH-].[OH-].[OH-].[Al+3]
WNROFYMDJYEPJX-UHFFFAOYSA-K
0.000
description
6


229910052582
BN
Inorganic materials




0.000
description
6


229960001631
Carbomer
Drugs




0.000
description
6


QDOXWKRWXJOMAK-UHFFFAOYSA-N
Chromium(III) oxide
Chemical compound


O=[Cr]O[Cr]=O
QDOXWKRWXJOMAK-UHFFFAOYSA-N
0.000
description
6


MMOXZBCLCQITDF-UHFFFAOYSA-N
DEET
Chemical compound


CCN(CC)C(=O)C1=CC=CC(C)=C1
MMOXZBCLCQITDF-UHFFFAOYSA-N
0.000
description
6


210000004209
Hair
Anatomy




0.000
description
6


SZVJSHCCFOBDDC-UHFFFAOYSA-N
Iron(II,III) oxide
Chemical compound


O=[Fe]O[Fe]O[Fe]=O
SZVJSHCCFOBDDC-UHFFFAOYSA-N
0.000
description
6


229940067606
Lecithin
Drugs




0.000
description
6


206010062080
Pigmentation disease
Diseases




0.000
description
6


239000004698
Polyethylene (PE)
Substances




0.000
description
6


ABTZKZVAJTXGNN-UHFFFAOYSA-N
Stearyl heptanoate
Chemical compound


CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC
ABTZKZVAJTXGNN-UHFFFAOYSA-N
0.000
description
6


229940072029
Trilaureth-4 Phosphate
Drugs




0.000
description
6


NBIIXXVUZAFLBC-UHFFFAOYSA-K
[O-]P([O-])([O-])=O
Chemical compound


[O-]P([O-])([O-])=O
NBIIXXVUZAFLBC-UHFFFAOYSA-K
0.000
description
6


229940048053
acrylate
Drugs




0.000
description
6


125000005250
alkyl acrylate group
Chemical group




0.000
description
6


125000000217
alkyl group
Chemical group




0.000
description
6


235000013871
bee wax
Nutrition




0.000
description
6


239000012166
beeswax
Substances




0.000
description
6


230000015572
biosynthetic process
Effects




0.000
description
6


159000000007
calcium salts
Chemical class




0.000
description
6


229930016911
cinnamic acid
Natural products




0.000
description
6


235000013985
cinnamic acid
Nutrition




0.000
description
6


239000006071
cream
Substances




0.000
description
6


125000003438
dodecyl group
Chemical group


[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])*

0.000
description
6


KCXVZYZYPLLWCC-UHFFFAOYSA-N
edta
Chemical compound


OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O
KCXVZYZYPLLWCC-UHFFFAOYSA-N
0.000
description
6


150000002191
fatty alcohols
Chemical class




0.000
description
6


230000002349
favourable
Effects




0.000
description
6


239000000945
filler
Substances




0.000
description
6


238000005755
formation reaction
Methods




0.000
description
6


150000004676
glycans
Polymers




0.000
description
6


ZUVCYFMOHFTGDM-UHFFFAOYSA-L
hexadecyl phosphate
Chemical compound


CCCCCCCCCCCCCCCCOP([O-])([O-])=O
ZUVCYFMOHFTGDM-UHFFFAOYSA-L
0.000
description
6


230000002209
hydrophobic
Effects




0.000
description
6


229910000460
iron oxide
Inorganic materials




0.000
description
6


235000013980
iron oxide
Nutrition




0.000
description
6


229940113096
isoceteth 20
Drugs




0.000
description
6


239000000787
lecithin
Substances




0.000
description
6


235000010445
lecithin
Nutrition




0.000
description
6


230000000670
limiting
Effects




0.000
description
6


CSNNHWWHGAXBCP-UHFFFAOYSA-L
mgso4
Chemical compound


[Mg+2].[O-][S+2]([O-])([O-])[O-]
CSNNHWWHGAXBCP-UHFFFAOYSA-L
0.000
description
6


229960001173
oxybenzone
Drugs




0.000
description
6


239000010452
phosphate
Substances




0.000
description
6


230000019612
pigmentation
Effects




0.000
description
6


229920000058
polyacrylate
Polymers




0.000
description
6


229920000573
polyethylene
Polymers




0.000
description
6


229920001282
polysaccharide
Polymers




0.000
description
6


239000005017
polysaccharide
Substances




0.000
description
6


150000004804
polysaccharides
Polymers




0.000
description
6


230000001603
reducing
Effects




0.000
description
6


XUIMIQQOPSSXEZ-UHFFFAOYSA-N
silicon
Chemical group


[Si]
XUIMIQQOPSSXEZ-UHFFFAOYSA-N
0.000
description
6


QGLITUFXHVRMGV-UHFFFAOYSA-M
sodium;tetratriacontyl sulfate
Chemical compound


[Na+].CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCOS([O-])(=O)=O
QGLITUFXHVRMGV-UHFFFAOYSA-M
0.000
description
6


239000007921
spray
Substances




0.000
description
6


239000003381
stabilizer
Substances




0.000
description
6


235000013311
vegetables
Nutrition




0.000
description
6


230000037303
wrinkles
Effects




0.000
description
6


FDATWRLUYRHCJE-UHFFFAOYSA-N
CCCCCCOC(=O)C1=C(C(=O)C2=CC=C(N(CC)CC)C=C2O)C=CC=C1
Chemical compound


CCCCCCOC(=O)C1=C(C(=O)C2=CC=C(N(CC)CC)C=C2O)C=CC=C1
FDATWRLUYRHCJE-UHFFFAOYSA-N
0.000
description
5


MAOBFOXLCJIFLV-UHFFFAOYSA-N
(2-aminophenyl)-phenylmethanone
Chemical compound


NC1=CC=CC=C1C(=O)C1=CC=CC=C1
MAOBFOXLCJIFLV-UHFFFAOYSA-N
0.000
description
4


HJIAMFHSAAEUKR-UHFFFAOYSA-N
(2-hydroxyphenyl)-phenylmethanone
Chemical class


OC1=CC=CC=C1C(=O)C1=CC=CC=C1
HJIAMFHSAAEUKR-UHFFFAOYSA-N
0.000
description
4


IQXJCCZJOIKIAD-UHFFFAOYSA-N
1-(2-methoxyethoxy)hexadecane
Chemical compound


CCCCCCCCCCCCCCCCOCCOC
IQXJCCZJOIKIAD-UHFFFAOYSA-N
0.000
description
4


DURPTKYDGMDSBL-UHFFFAOYSA-N
1-butoxybutane
Chemical compound


CCCCOCCCC
DURPTKYDGMDSBL-UHFFFAOYSA-N
0.000
description
4


YVLPJIGOMTXXLP-UUKUAVTLSA-N
15,15'-cis-Phytoene
Natural products


C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C
YVLPJIGOMTXXLP-UUKUAVTLSA-N
0.000
description
4


XDOFQFKRPWOURC-UHFFFAOYSA-M
16-methylheptadecanoate
Chemical compound


CC(C)CCCCCCCCCCCCCCC([O-])=O
XDOFQFKRPWOURC-UHFFFAOYSA-M
0.000
description
4


VUKAUDKDFVSVFT-UHFFFAOYSA-N
2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol
Chemical compound


COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O
VUKAUDKDFVSVFT-UHFFFAOYSA-N
0.000
description
4


NKEQOUMMGPBKMM-UHFFFAOYSA-N
2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O
NKEQOUMMGPBKMM-UHFFFAOYSA-N
0.000
description
4


ICIDSZQHPUZUHC-UHFFFAOYSA-N
2-octadecoxyethanol
Chemical compound


CCCCCCCCCCCCCCCCCCOCCO
ICIDSZQHPUZUHC-UHFFFAOYSA-N
0.000
description
4


YQEMORVAKMFKLG-UHFFFAOYSA-N
2-stearoylglycerol
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO
YQEMORVAKMFKLG-UHFFFAOYSA-N
0.000
description
4


YJIXVMRMRLFWEE-UHFFFAOYSA-N
28-hydroxyoctacosyl 2-hydroxyoctadecanoate
Chemical compound


CCCCCCCCCCCCCCCCC(O)C(=O)OCCCCCCCCCCCCCCCCCCCCCCCCCCCCO
YJIXVMRMRLFWEE-UHFFFAOYSA-N
0.000
description
4


NJLKZOZYTRRDBO-UHFFFAOYSA-N
3-iodopropyl N-butylcarbamate
Chemical class


CCCCNC(=O)OCCCI
NJLKZOZYTRRDBO-UHFFFAOYSA-N
0.000
description
4


KKJKXQYVUVWWJP-UHFFFAOYSA-N
4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid
Chemical compound


CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C(S(O)(=O)=O)C=C1
KKJKXQYVUVWWJP-UHFFFAOYSA-N
0.000
description
4


KGKQNDQDVZQTAG-UHFFFAOYSA-N
8-methylnonyl 2,2-dimethylpropanoate
Chemical compound


CC(C)CCCCCCCOC(=O)C(C)(C)C
KGKQNDQDVZQTAG-UHFFFAOYSA-N
0.000
description
4


XVAMCHGMPYWHNL-UHFFFAOYSA-N
Bemotrizinol
Chemical compound


OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1
XVAMCHGMPYWHNL-UHFFFAOYSA-N
0.000
description
4


WPYMKLBDIGXBTP-UHFFFAOYSA-N
Benzoic acid
Chemical compound


OC(=O)C1=CC=CC=C1
WPYMKLBDIGXBTP-UHFFFAOYSA-N
0.000
description
4


FQUNFJULCYSSOP-UHFFFAOYSA-N
Bisoctrizole
Chemical compound


N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O
FQUNFJULCYSSOP-UHFFFAOYSA-N
0.000
description
4


241000195940
Bryophyta
Species




0.000
description
4


PDNLXUROKBBMBE-BYOHNYAZSA-N
CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O
Chemical compound


CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O
PDNLXUROKBBMBE-BYOHNYAZSA-N
0.000
description
4


229940056318
Ceteth-20
Drugs




0.000
description
4


ACTIUHUUMQJHFO-UPTCCGCDSA-N
Coenzyme Q10
Chemical compound


COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O
ACTIUHUUMQJHFO-UPTCCGCDSA-N
0.000
description
4


229940102552
DISTEARDIMONIUM HECTORITE
Drugs




0.000
description
4


XMSXQFUHVRWGNA-UHFFFAOYSA-N
Decamethylcyclopentasiloxane
Chemical compound


C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1
XMSXQFUHVRWGNA-UHFFFAOYSA-N
0.000
description
4


XTJFFFGAUHQWII-UHFFFAOYSA-N
Dibutyl adipate
Chemical compound


CCCCOC(=O)CCCCC(=O)OCCCC
XTJFFFGAUHQWII-UHFFFAOYSA-N
0.000
description
4


MTHSVFCYNBDYFN-UHFFFAOYSA-N
Diethylene glycol
Chemical compound


OCCOCCO
MTHSVFCYNBDYFN-UHFFFAOYSA-N
0.000
description
4


NIQCNGHVCWTJSM-UHFFFAOYSA-N
Dimethyl phthalate
Chemical compound


COC(=O)C1=CC=CC=C1C(=O)OC
NIQCNGHVCWTJSM-UHFFFAOYSA-N
0.000
description
4


206010015150
Erythema
Diseases




0.000
description
4


GHXZTYHSJHQHIJ-UHFFFAOYSA-N
Exidine
Chemical compound


C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1
GHXZTYHSJHQHIJ-UHFFFAOYSA-N
0.000
description
4


229940074046
GLYCERYL LAURATE
Drugs




0.000
description
4


229940100608
GLYCOL DISTEARATE
Drugs




0.000
description
4


229920000926
Galactomannan
Polymers




0.000
description
4


FPVVYTCTZKCSOJ-UHFFFAOYSA-N
Glycol distearate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC
FPVVYTCTZKCSOJ-UHFFFAOYSA-N
0.000
description
4


UYTPUPDQBNUYGX-UHFFFAOYSA-N
Guanine
Chemical compound


O=C1NC(N)=NC2=C1N=CN2
UYTPUPDQBNUYGX-UHFFFAOYSA-N
0.000
description
4


OVSQVDMCBVZWGM-IDRAQACASA-N
Hirsutrin
Natural products


O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O
OVSQVDMCBVZWGM-IDRAQACASA-N
0.000
description
4


WYVVKGNFXHOCQV-UHFFFAOYSA-N
Iodopropynyl butylcarbamate
Chemical compound


CCCCNC(=O)OCC#CI
WYVVKGNFXHOCQV-UHFFFAOYSA-N
0.000
description
4


AXISYYRBXTVTFY-UHFFFAOYSA-N
Isopropyl myristate
Chemical compound


CCCCCCCCCCCCCC(=O)OC(C)C
AXISYYRBXTVTFY-UHFFFAOYSA-N
0.000
description
4


229940001447
Lactate
Drugs




0.000
description
4


229940039717
Lanolin
Drugs




0.000
description
4


POULHZVOKOAJMA-UHFFFAOYSA-N
Lauric acid
Chemical compound


CCCCCCCCCCCC(O)=O
POULHZVOKOAJMA-UHFFFAOYSA-N
0.000
description
4


210000000088
Lip
Anatomy




0.000
description
4


229940044591
METHYL GLUCOSE DIOLEATE
Drugs




0.000
description
4


229940078812
MYRISTYL MYRISTATE
Drugs




0.000
description
4


235000018330
Macadamia integrifolia
Nutrition




0.000
description
4


240000000912
Macadamia tetraphylla
Species




0.000
description
4


235000003800
Macadamia tetraphylla
Nutrition




0.000
description
4


TWRXJAOTZQYOKJ-UHFFFAOYSA-L
MgCl2
Chemical compound


[Mg+2].[Cl-].[Cl-]
TWRXJAOTZQYOKJ-UHFFFAOYSA-L
0.000
description
4


229920000881
Modified starch
Polymers




0.000
description
4


ARIWANIATODDMH-UHFFFAOYSA-N
Monolaurin
Chemical compound


CCCCCCCCCCCC(=O)OCC(O)CO
ARIWANIATODDMH-UHFFFAOYSA-N
0.000
description
4


PZNSFCLAULLKQX-UHFFFAOYSA-N
N#B
Chemical compound


N#B
PZNSFCLAULLKQX-UHFFFAOYSA-N
0.000
description
4


229960003921
Octisalate
Drugs




0.000
description
4


229940057874
PHENYL TRIMETHICONE
Drugs




0.000
description
4


229940100518
POLYGLYCERYL-4 ISOSTEARATE
Drugs




0.000
description
4


229940099511
POLYSORBATE 65
Drugs




0.000
description
4


IPCSVZSSVZVIGE-UHFFFAOYSA-N
Palmitic acid
Chemical compound


CCCCCCCCCCCCCCCC(O)=O
IPCSVZSSVZVIGE-UHFFFAOYSA-N
0.000
description
4


240000008426
Persea americana
Species




0.000
description
4


235000011236
Persea americana var americana
Nutrition




0.000
description
4


229960000502
Poloxamer
Drugs




0.000
description
4


229920002642
Polysorbate 65
Polymers




0.000
description
4


QELSKZZBTMNZEB-UHFFFAOYSA-N
Propylparaben
Chemical group


CCCOC(=O)C1=CC=C(O)C=C1
QELSKZZBTMNZEB-UHFFFAOYSA-N
0.000
description
4


229960003351
Prussian blue
Drugs




0.000
description
4


DNMNDNSFJMUUFM-UHFFFAOYSA-N
Prussian blue
Chemical compound


[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N
DNMNDNSFJMUUFM-UHFFFAOYSA-N
0.000
description
4


240000000528
Ricinus communis
Species




0.000
description
4


235000004443
Ricinus communis
Nutrition




0.000
description
4


229940057429
SORBITAN ISOSTEARATE
Drugs




0.000
description
4


YGSDEFSMJLZEOE-UHFFFAOYSA-N
Salicylic acid
Chemical compound


OC(=O)C1=CC=CC=C1O
YGSDEFSMJLZEOE-UHFFFAOYSA-N
0.000
description
4


229940083037
Simethicone
Drugs




0.000
description
4


244000044822
Simmondsia californica
Species




0.000
description
4


235000004433
Simmondsia californica
Nutrition




0.000
description
4


AQMNWCRSESPIJM-UHFFFAOYSA-M
Sodium metaphosphate
Chemical compound


[Na+].[O-]P(=O)=O
AQMNWCRSESPIJM-UHFFFAOYSA-M
0.000
description
4


NWGKJDSIEKMTRX-MDZDMXLPSA-N
Sorbitan oleate
Chemical compound


CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)C1OCC(O)C1O
NWGKJDSIEKMTRX-MDZDMXLPSA-N
0.000
description
4


229950004959
Sorbitan oleate
Drugs




0.000
description
4


229950011392
Sorbitan stearate
Drugs




0.000
description
4


YYGNTYWPHWGJRM-RUSDCZJESA-N
Squalene
Natural products


C(=C\CC/C(=C\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\C)/C)/C
YYGNTYWPHWGJRM-RUSDCZJESA-N
0.000
description
4


229920002472
Starch
Polymers




0.000
description
4


229940032147
Starch
Drugs




0.000
description
4


QAOWNCQODCNURD-UHFFFAOYSA-N
Sulfuric acid
Chemical compound


OS(O)(=O)=O
QAOWNCQODCNURD-UHFFFAOYSA-N
0.000
description
4


XOAAWQZATWQOTB-UHFFFAOYSA-N
Taurine
Chemical compound


NCCS(O)(=O)=O
XOAAWQZATWQOTB-UHFFFAOYSA-N
0.000
description
4


229940099259
Vaseline
Drugs




0.000
description
4


229940045997
Vitamin A
Drugs




0.000
description
4


FPIPGXGPPPQFEQ-BOOMUCAASA-N
Vitamin A
Natural products


OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C
FPIPGXGPPPQFEQ-BOOMUCAASA-N
0.000
description
4


FGUZFFWTBWJBIL-XWVZOOPGSA-N
[(1R)-1-[(2S,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate
Chemical compound


CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O
FGUZFFWTBWJBIL-XWVZOOPGSA-N
0.000
description
4


HEAHZSUCFKFERC-LRVMPXQBSA-N
[(2E)-2-[[4-[(Z)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid
Chemical compound


CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C
HEAHZSUCFKFERC-LRVMPXQBSA-N
0.000
description
4


HVUMOYIDDBPOLL-IIZJTUPISA-N
[2-[(2R,3S,4R)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@@H](O)[C@@H]1O
HVUMOYIDDBPOLL-IIZJTUPISA-N
0.000
description
4


NIXOWILDQLNWCW-UHFFFAOYSA-M
acrylate
Chemical compound


[O-]C(=O)C=C
NIXOWILDQLNWCW-UHFFFAOYSA-M
0.000
description
4


150000001252
acrylic acid derivatives
Chemical class




0.000
description
4


239000000443
aerosol
Substances




0.000
description
4


150000001298
alcohols
Chemical class




0.000
description
4


125000001931
aliphatic group
Chemical group




0.000
description
4


FPIPGXGPPPQFEQ-OVSJKPMPSA-N
all-trans-retinol
Chemical compound


OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
FPIPGXGPPPQFEQ-OVSJKPMPSA-N
0.000
description
4


229960001452
alpha-Tocopherol Acetate
Drugs




0.000
description
4


230000001153
anti-wrinkle
Effects




0.000
description
4


230000003078
antioxidant
Effects




0.000
description
4


WXQWKYFPCLREEY-UHFFFAOYSA-O
azanium;ethanol
Chemical class


[NH4+].CCO.CCO.CCO
WXQWKYFPCLREEY-UHFFFAOYSA-O
0.000
description
4


UHHXUPJJDHEMGX-UHFFFAOYSA-K
azanium;manganese(3+);phosphonato phosphate
Chemical compound


[NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O
UHHXUPJJDHEMGX-UHFFFAOYSA-K
0.000
description
4


FQLQNUZHYYPPBT-UHFFFAOYSA-O
azanium;potassium
Chemical compound


[NH4+].[K+]
FQLQNUZHYYPPBT-UHFFFAOYSA-O
0.000
description
4


150000008366
benzophenones
Chemical class




0.000
description
4


150000001565
benzotriazoles
Chemical class




0.000
description
4


YBJHBAHKTGYVGT-ZKWXMUAHSA-N
biotin
Chemical compound


N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21
YBJHBAHKTGYVGT-ZKWXMUAHSA-N
0.000
description
4


229910052799
carbon
Inorganic materials




0.000
description
4


235000012730
carminic acid
Nutrition




0.000
description
4


229940081733
cetearyl alcohol
Drugs




0.000
description
4


229940074979
cetyl palmitate
Drugs




0.000
description
4


235000017471
coenzyme Q10
Nutrition




0.000
description
4


229940110767
coenzyme Q10
Drugs




0.000
description
4


239000008139
complexing agent
Substances




0.000
description
4


WMWXXXSCZVGQAR-UHFFFAOYSA-N
dialuminum;oxygen(2-);hydrate
Chemical compound


O.[O-2].[O-2].[O-2].[Al+3].[Al+3]
WMWXXXSCZVGQAR-UHFFFAOYSA-N
0.000
description
4


239000006185
dispersion
Substances




0.000
description
4


239000001245
distarch phosphate
Substances




0.000
description
4


235000013804
distarch phosphate
Nutrition




0.000
description
4


239000003792
electrolyte
Substances




0.000
description
4


231100000321
erythema
Toxicity




0.000
description
4


150000002170
ethers
Chemical class




0.000
description
4


125000001495
ethyl group
Chemical group


[H]C([H])([H])C([H])([H])*

0.000
description
4


230000003203
everyday
Effects




0.000
description
4


239000004872
foam stabilizing agent
Substances




0.000
description
4


WSFSSNUMVMOOMR-UHFFFAOYSA-N
formaldehyde
Chemical compound


O=C
WSFSSNUMVMOOMR-UHFFFAOYSA-N
0.000
description
4


239000001307
helium
Substances




0.000
description
4


229910052734
helium
Inorganic materials




0.000
description
4


SWQJXJOGLNCZEY-UHFFFAOYSA-N
helium(0)
Chemical compound


[He]
SWQJXJOGLNCZEY-UHFFFAOYSA-N
0.000
description
4


UBHWBODXJBSFLH-UHFFFAOYSA-N
hexadecan-1-ol;octadecan-1-ol
Chemical compound


CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO
UBHWBODXJBSFLH-UHFFFAOYSA-N
0.000
description
4


RAMRROOXFMYSNA-UHFFFAOYSA-N
hexadecyl benzoate
Chemical compound


CCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1
RAMRROOXFMYSNA-UHFFFAOYSA-N
0.000
description
4


CMBYOWLFQAFZCP-UHFFFAOYSA-N
hexyl dodecanoate
Chemical compound


CCCCCCCCCCCC(=O)OCCCCCC
CMBYOWLFQAFZCP-UHFFFAOYSA-N
0.000
description
4


238000000265
homogenisation
Methods




0.000
description
4


229920002674
hyaluronan
Polymers




0.000
description
4


229960003160
hyaluronic acid
Drugs




0.000
description
4


150000002431
hydrogen
Chemical class




0.000
description
4


UFHFLCQGNIYNRP-UHFFFAOYSA-N
hydrogen
Chemical compound


[H][H]
UFHFLCQGNIYNRP-UHFFFAOYSA-N
0.000
description
4


239000001866
hydroxypropyl methyl cellulose
Substances




0.000
description
4


235000010979
hydroxypropyl methyl cellulose
Nutrition




0.000
description
4


229920003088
hydroxypropyl methyl cellulose
Polymers




0.000
description
4


239000000077
insect repellent
Substances




0.000
description
4


229910052742
iron
Inorganic materials




0.000
description
4


VBMVTYDPPZVILR-UHFFFAOYSA-N
iron(2+);oxygen(2-)
Chemical class


[O-2].[Fe+2]
VBMVTYDPPZVILR-UHFFFAOYSA-N
0.000
description
4


230000001788
irregular
Effects




0.000
description
4


229940074928
isopropyl myristate
Drugs




0.000
description
4


239000006210
lotion
Substances




0.000
description
4


239000002932
luster
Substances




0.000
description
4


229910052943
magnesium sulfate
Inorganic materials




0.000
description
4


239000000463
material
Substances




0.000
description
4


238000002844
melting
Methods




0.000
description
4


238000000034
method
Methods




0.000
description
4


125000002496
methyl group
Chemical group


[H]C([H])([H])*

0.000
description
4


235000019426
modified starch
Nutrition




0.000
description
4


235000011929
mousse
Nutrition




0.000
description
4


IJGRMHOSHXDMSA-UHFFFAOYSA-N
nitrogen
Chemical compound


N#N
IJGRMHOSHXDMSA-UHFFFAOYSA-N
0.000
description
4


229910052757
nitrogen
Inorganic materials




0.000
description
4


239000010466
nut oil
Substances




0.000
description
4


OQILCOQZDHPEAZ-UHFFFAOYSA-N
octyl palmitate
Chemical compound


CCCCCCCCCCCCCCCC(=O)OCCCCCCCC
OQILCOQZDHPEAZ-UHFFFAOYSA-N
0.000
description
4


PXDJXZJSCPSGGI-UHFFFAOYSA-N
palmityl palmitate
Chemical compound


CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC
PXDJXZJSCPSGGI-UHFFFAOYSA-N
0.000
description
4


229940032051
peg-8 distearate
Drugs




0.000
description
4


235000019271
petrolatum
Nutrition




0.000
description
4


NBIIXXVUZAFLBC-UHFFFAOYSA-N
phosphoric acid
Chemical compound


OP(O)(O)=O
NBIIXXVUZAFLBC-UHFFFAOYSA-N
0.000
description
4


229920001983
poloxamer
Polymers




0.000
description
4


229920005862
polyol
Polymers




0.000
description
4


150000003077
polyols
Chemical class




0.000
description
4


239000001816
polyoxyethylene sorbitan tristearate
Substances




0.000
description
4


235000010988
polyoxyethylene sorbitan tristearate
Nutrition




0.000
description
4


230000000069
prophylaxis
Effects




0.000
description
4


125000001436
propyl group
Chemical group


[H]C([*])([H])C([H])([H])C([H])([H])[H]

0.000
description
4


229960003415
propylparaben
Drugs




0.000
description
4


238000001953
recrystallisation
Methods




0.000
description
4


229960003471
retinol
Drugs




0.000
description
4


230000001953
sensory
Effects




0.000
description
4


235000012239
silicon dioxide
Nutrition




0.000
description
4


LIVNPJMFVYWSIS-UHFFFAOYSA-N
silicon monoxide
Inorganic materials


[Si-]#[O+]
LIVNPJMFVYWSIS-UHFFFAOYSA-N
0.000
description
4


235000019983
sodium metaphosphate
Nutrition




0.000
description
4


MAKUBRYLFHZREJ-JWBQXVCJSA-M
sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate
Chemical compound


[Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O
MAKUBRYLFHZREJ-JWBQXVCJSA-M
0.000
description
4


239000002904
solvent
Substances




0.000
description
4


239000008107
starch
Substances




0.000
description
4


235000019698
starch
Nutrition




0.000
description
4


229940098758
stearyl heptanoate
Drugs




0.000
description
4


PPBRXRYQALVLMV-UHFFFAOYSA-N
styrene
Chemical compound


C=CC1=CC=CC=C1
PPBRXRYQALVLMV-UHFFFAOYSA-N
0.000
description
4


150000003458
sulfonic acid derivatives
Chemical class




0.000
description
4


238000004381
surface treatment
Methods




0.000
description
4


239000002562
thickening agent
Substances




0.000
description
4


229960005196
titanium dioxide
Drugs




0.000
description
4


230000036572
transepidermal water loss
Effects




0.000
description
4


150000003626
triacylglycerols
Chemical class




0.000
description
4


BSUNTQCMCCQSQH-UHFFFAOYSA-N
triazine
Chemical class


C1=CN=NN=C1.C1=CN=NN=C1
BSUNTQCMCCQSQH-UHFFFAOYSA-N
0.000
description
4


125000002889
tridecyl group
Chemical group


[H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]

0.000
description
4


LINXHFKHZLOLEI-UHFFFAOYSA-N
trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane
Chemical compound


C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1
LINXHFKHZLOLEI-UHFFFAOYSA-N
0.000
description
4


229910052721
tungsten
Inorganic materials




0.000
description
4


XSQUKJJJFZCRTK-UHFFFAOYSA-N
urea
Chemical compound


NC(N)=O
XSQUKJJJFZCRTK-UHFFFAOYSA-N
0.000
description
4


235000019155
vitamin A
Nutrition




0.000
description
4


239000011719
vitamin A
Substances




0.000
description
4


150000003754
zirconium
Chemical class




0.000
description
4


QCWXUUIWCKQGHC-UHFFFAOYSA-N
zirconium
Chemical compound


[Zr]
QCWXUUIWCKQGHC-UHFFFAOYSA-N
0.000
description
4


229910052726
zirconium
Inorganic materials




0.000
description
4


UCMIRNVEIXFBKS-UHFFFAOYSA-N
Î²-Alanine
Chemical compound


NCCC(O)=O
UCMIRNVEIXFBKS-UHFFFAOYSA-N
0.000
description
4


CUNWUEBNSZSNRX-RKGWDQTMSA-N
(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol;(Z)-octadec-9-enoic acid
Chemical compound


OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O
CUNWUEBNSZSNRX-RKGWDQTMSA-N
0.000
description
2


NRTKYSGFUISGRQ-UHFFFAOYSA-N
(3-heptanoyloxy-2,2-dimethylpropyl) heptanoate
Chemical compound


CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC
NRTKYSGFUISGRQ-UHFFFAOYSA-N
0.000
description
2


PULNESMFDLBKAZ-SDNWHVSQSA-N
(4E)-3-hydroxy-4-(phenylhydrazinylidene)cyclohexa-2,5-dien-1-one
Chemical compound


OC1=CC(=O)C=C\C1=N/NC1=CC=CC=C1
PULNESMFDLBKAZ-SDNWHVSQSA-N
0.000
description
2


125000003837
(C1-C20) alkyl group
Chemical group




0.000
description
2


VYMFEDXTTBBWFU-ZHACJKMWSA-N
(E)-2-[2-[2-[2-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-6-[4,5-dihydroxy-2-(hydroxymethyl)-6-methyloxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-methoxyoxan-3-yl]oxy-2-oxoethyl]dec-3-enoic acid
Chemical compound


O1C(CO)C(OC)C(O)C(OC(=O)CC(/C=C/CCCCCC)C(O)=O)C1OC1C(O)C(O)C(OC2C(C(O)C(C)OC2CO)O)OC1COC1C(O)C(O)C(OC)C(CO)O1
VYMFEDXTTBBWFU-ZHACJKMWSA-N
0.000
description
2


YDPSQMGOAILWPE-FYWRMAATSA-N
(E)-octadec-2-enedioic acid
Chemical compound


OC(=O)CCCCCCCCCCCCCC\C=C\C(O)=O
YDPSQMGOAILWPE-FYWRMAATSA-N
0.000
description
2


PHIQHXFUZVPYII-ZCFIWIBFSA-N
(R)-carnitine
Chemical compound


C[N+](C)(C)C[C@H](O)CC([O-])=O
PHIQHXFUZVPYII-ZCFIWIBFSA-N
0.000
description
2


SBLKVIQSIHEQOF-UPHRSURJSA-N
(Z)-octadec-9-enedioic acid
Chemical compound


OC(=O)CCCCCCC\C=C/CCCCCCCC(O)=O
SBLKVIQSIHEQOF-UPHRSURJSA-N
0.000
description
2


IMAYJYGCQCZYID-UHFFFAOYSA-N
1,3,5,7,9,11-hexaoxa-2,4,6,8,10,12-hexasilacyclododecane
Chemical compound


O1[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]1
IMAYJYGCQCZYID-UHFFFAOYSA-N
0.000
description
2


JIHQDMXYYFUGFV-UHFFFAOYSA-N
1,3,5-Triazine
Chemical class


C1=NC=NC=N1
JIHQDMXYYFUGFV-UHFFFAOYSA-N
0.000
description
2


ARXJGSRGQADJSQ-UHFFFAOYSA-N
1-methoxypropan-2-ol
Chemical group


COCC(C)O
ARXJGSRGQADJSQ-UHFFFAOYSA-N
0.000
description
2


OVYMWJFNQQOJBU-UHFFFAOYSA-N
1-octanoyloxypropan-2-yl octanoate
Chemical compound


CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC
OVYMWJFNQQOJBU-UHFFFAOYSA-N
0.000
description
2


RZRNAYUHWVFMIP-KTKRTIGZSA-N
1-oleoylglycerol
Chemical compound


CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO
RZRNAYUHWVFMIP-KTKRTIGZSA-N
0.000
description
2


HTDJPCNNEPUOOQ-UHFFFAOYSA-N
2,2,4,4,6,6-hexamethyl-1,3,5,2,4,6-trioxatrisilinane
Chemical compound


C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1
HTDJPCNNEPUOOQ-UHFFFAOYSA-N
0.000
description
2


IMHQFVGHBDXALM-UHFFFAOYSA-M
2,2-diethylhexanoate
Chemical compound


CCCCC(CC)(CC)C([O-])=O
IMHQFVGHBDXALM-UHFFFAOYSA-M
0.000
description
2


PQHYOGIRXOKOEJ-UHFFFAOYSA-N
2-(1,2-dicarboxyethylamino)butanedioic acid
Chemical compound


OC(=O)CC(C(O)=O)NC(C(O)=O)CC(O)=O
PQHYOGIRXOKOEJ-UHFFFAOYSA-N
0.000
description
2


PQHYOGIRXOKOEJ-UHFFFAOYSA-J
2-(1,2-dicarboxylatoethylamino)butanedioate
Chemical compound


[O-]C(=O)CC(C([O-])=O)NC(C([O-])=O)CC([O-])=O
PQHYOGIRXOKOEJ-UHFFFAOYSA-J
0.000
description
2


SBASXUCJHJRPEV-UHFFFAOYSA-N
2-(2-Methoxyethoxy)ethanol
Chemical group


COCCOCCO
SBASXUCJHJRPEV-UHFFFAOYSA-N
0.000
description
2


BSWRKKZXYUISNO-UHFFFAOYSA-M
2-(2-ethylhexoxy)benzoate
Chemical compound


CCCCC(CC)COC1=CC=CC=C1C([O-])=O
BSWRKKZXYUISNO-UHFFFAOYSA-M
0.000
description
2


LAINPTZBIXYTIZ-UHFFFAOYSA-N
2-(3-hydroxy-2,4,5,7-tetraiodo-6-oxoxanthen-9-yl)benzoic acid
Chemical compound


OC(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C(O)=C(I)C=C21
LAINPTZBIXYTIZ-UHFFFAOYSA-N
0.000
description
2


POAOYUHQDCAZBD-UHFFFAOYSA-N
2-Butoxyethanol
Chemical compound


CCCCOCCO
POAOYUHQDCAZBD-UHFFFAOYSA-N
0.000
description
2


ZNQVEEAIQZEUHB-UHFFFAOYSA-N
2-Ethoxyethanol
Chemical group


CCOCCO
ZNQVEEAIQZEUHB-UHFFFAOYSA-N
0.000
description
2


VKZRWSNIWNFCIQ-UHFFFAOYSA-N
2-[2-(1,2-dicarboxyethylamino)ethylamino]butanedioic acid
Chemical compound


OC(=O)CC(C(O)=O)NCCNC(C(O)=O)CC(O)=O
VKZRWSNIWNFCIQ-UHFFFAOYSA-N
0.000
description
2


SBKDIDITONHJHI-UHFFFAOYSA-N
2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCO
SBKDIDITONHJHI-UHFFFAOYSA-N
0.000
description
2


ZSSVCEUEVMALRD-UHFFFAOYSA-N
2-[4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(octyloxy)phenol
Chemical compound


OC1=CC(OCCCCCCCC)=CC=C1C1=NC(C=2C(=CC(C)=CC=2)C)=NC(C=2C(=CC(C)=CC=2)C)=N1
ZSSVCEUEVMALRD-UHFFFAOYSA-N
0.000
description
2


KXTAOXNYQGASTA-UHFFFAOYSA-N
2-benzylidenepropanedioic acid
Chemical compound


OC(=O)C(C(O)=O)=CC1=CC=CC=C1
KXTAOXNYQGASTA-UHFFFAOYSA-N
0.000
description
2


XMVBHZBLHNOQON-UHFFFAOYSA-N
2-butyl-1-octanol
Chemical compound


CCCCCCC(CO)CCCC
XMVBHZBLHNOQON-UHFFFAOYSA-N
0.000
description
2


NCIAZCLIFWUDPR-UHFFFAOYSA-N
2-butyl-3,4,5,6-tetramethylphenol
Chemical compound


CCCCC1=C(C)C(C)=C(C)C(C)=C1O
NCIAZCLIFWUDPR-UHFFFAOYSA-N
0.000
description
2


GJYCVCVHRSWLNY-UHFFFAOYSA-N
2-butylphenol
Chemical compound


CCCCC1=CC=CC=C1O
GJYCVCVHRSWLNY-UHFFFAOYSA-N
0.000
description
2


SGOWHAISCQQAPM-UHFFFAOYSA-N
2-dodecoxyethanol;phosphoric acid
Chemical compound


OP(O)(O)=O.CCCCCCCCCCCCOCCO
SGOWHAISCQQAPM-UHFFFAOYSA-N
0.000
description
2


LWLRMRFJCCMNML-UHFFFAOYSA-N
2-ethylhexyl dodecanoate
Chemical compound


CCCCCCCCCCCC(=O)OCC(CC)CCCC
LWLRMRFJCCMNML-UHFFFAOYSA-N
0.000
description
2


SFAAOBGYWOUHLU-UHFFFAOYSA-N
2-ethylhexyl hexadecanoate
Chemical compound


CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC
SFAAOBGYWOUHLU-UHFFFAOYSA-N
0.000
description
2


UREKALWDINQAOW-UHFFFAOYSA-N
2-ethyloctyl naphthalene-1-carboxylate
Chemical compound


C1=CC=C2C(C(=O)OCC(CC)CCCCCC)=CC=CC2=C1
UREKALWDINQAOW-UHFFFAOYSA-N
0.000
description
2


MWKPHOIHTLQZIY-UHFFFAOYSA-N
2-hexyldecyl octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC
MWKPHOIHTLQZIY-UHFFFAOYSA-N
0.000
description
2


CTXGTHVAWRBISV-UHFFFAOYSA-N
2-hydroxyethyl dodecanoate
Chemical compound


CCCCCCCCCCCC(=O)OCCO
CTXGTHVAWRBISV-UHFFFAOYSA-N
0.000
description
2


FKOKUHFZNIUSLW-UHFFFAOYSA-N
2-hydroxypropyl octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCC(C)O
FKOKUHFZNIUSLW-UHFFFAOYSA-N
0.000
description
2


KIHBGTRZFAVZRV-UHFFFAOYSA-M
2-hydroxystearate
Chemical compound


CCCCCCCCCCCCCCCCC(O)C([O-])=O
KIHBGTRZFAVZRV-UHFFFAOYSA-M
0.000
description
2


LEEDMQGKBNGPDN-UHFFFAOYSA-N
2-methylnonadecane
Chemical compound


CCCCCCCCCCCCCCCCCC(C)C
LEEDMQGKBNGPDN-UHFFFAOYSA-N
0.000
description
2


RUDXBXPTJPNTSO-UHFFFAOYSA-N
2-octyldodecyl hexadecanoate
Chemical compound


CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC
RUDXBXPTJPNTSO-UHFFFAOYSA-N
0.000
description
2


DQAKJEWZWDQURW-UHFFFAOYSA-N
2-oxopyrrolidine-1-carboxylic acid
Chemical compound


OC(=O)N1CCCC1=O
DQAKJEWZWDQURW-UHFFFAOYSA-N
0.000
description
2


DWYHDSLIWMUSOO-UHFFFAOYSA-N
2-phenyl-1H-benzimidazole
Chemical compound


C1=CC=CC=C1C1=NC2=CC=CC=C2N1
DWYHDSLIWMUSOO-UHFFFAOYSA-N
0.000
description
2


UIVPNOBLHXUKDX-UHFFFAOYSA-N
3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate
Chemical compound


CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C
UIVPNOBLHXUKDX-UHFFFAOYSA-N
0.000
description
2


JAUFWPNLLLUYNV-UHFFFAOYSA-N
3-(16-methylheptadecoxy)propane-1,2-diol
Chemical compound


CC(C)CCCCCCCCCCCCCCCOCC(O)CO
JAUFWPNLLLUYNV-UHFFFAOYSA-N
0.000
description
2


229940099451
3-iodo-2-propynylbutylcarbamate
Drugs




0.000
description
2


229940000641
4-Aminobenzoic Acid
Drugs




0.000
description
2


ALYNCZNDIQEVRV-UHFFFAOYSA-N
4-Aminobenzoic acid
Chemical compound


NC1=CC=C(C(O)=O)C=C1
ALYNCZNDIQEVRV-UHFFFAOYSA-N
0.000
description
2


HEOCBCNFKCOKBX-SDNWHVSQSA-N
4-Methylbenzylidene camphor
Chemical compound


C1=CC(C)=CC=C1\C=C/1C(=O)C2(C)CCC\1C2(C)C
HEOCBCNFKCOKBX-SDNWHVSQSA-N
0.000
description
2


150000005418
4-aminobenzoic acid derivatives
Chemical class




0.000
description
2


FJLRFPXKMBEERQ-UHFFFAOYSA-N
6-[2,6-bis(2,4-dimethylphenyl)-1H-1,3,5-triazin-4-ylidene]-3-octoxycyclohexa-2,4-dien-1-one
Chemical compound


C1=CC(OCCCCCCCC)=CC(=O)C1=C1N=C(C=2C(=CC(C)=CC=2)C)NC(C=2C(=CC(C)=CC=2)C)=N1
FJLRFPXKMBEERQ-UHFFFAOYSA-N
0.000
description
2


SJIDAAGFCNIAJP-UHFFFAOYSA-N
6-methylheptyl octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C
SJIDAAGFCNIAJP-UHFFFAOYSA-N
0.000
description
2


XZOYHFBNQHPJRQ-UHFFFAOYSA-M
7-methyloctanoate
Chemical compound


CC(C)CCCCCC([O-])=O
XZOYHFBNQHPJRQ-UHFFFAOYSA-M
0.000
description
2


XUVVLJKRLAXOKZ-UHFFFAOYSA-N
7-methyloctyl octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCCCCCCC(C)C
XUVVLJKRLAXOKZ-UHFFFAOYSA-N
0.000
description
2


241000238876
Acari
Species




0.000
description
2


229920000800
Acrylic rubber
Polymers




0.000
description
2


241000251468
Actinopterygii
Species




0.000
description
2


XJKJWTWGDGIQRH-BFIDDRIFSA-N
Alginic acid
Chemical compound


O1[C@@H](C(O)=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](C)[C@@H](O)[C@H]1O
XJKJWTWGDGIQRH-BFIDDRIFSA-N
0.000
description
2


235000019489
Almond oil
Nutrition




0.000
description
2


PZZYQPZGQPZBDN-UHFFFAOYSA-N
Aluminium silicate
Chemical class


O=[Al]O[Si](=O)O[Al]=O
PZZYQPZGQPZBDN-UHFFFAOYSA-N
0.000
description
2


229940063655
Aluminum stearate
Drugs




0.000
description
2


241000239290
Araneae
Species




0.000
description
2


XNEFYCZVKIDDMS-UHFFFAOYSA-N
Avobenzone
Chemical compound


C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1
XNEFYCZVKIDDMS-UHFFFAOYSA-N
0.000
description
2


229940091509
BEHENETH-20
Drugs




0.000
description
2


229940110975
BUTYLOCTYL BENZOATE
Drugs




0.000
description
2


239000005711
Benzoic acid
Substances




0.000
description
2


RWCCWEUUXYIKHB-UHFFFAOYSA-N
Benzophenone
Chemical compound


C=1C=CC=CC=1C(=O)C1=CC=CC=C1
RWCCWEUUXYIKHB-UHFFFAOYSA-N
0.000
description
2


229960002747
Betacarotene
Drugs




0.000
description
2


210000001772
Blood Platelets
Anatomy




0.000
description
2


NLZUEZXRPGMBCV-UHFFFAOYSA-N
Butylhydroxytoluene
Chemical compound


CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1
NLZUEZXRPGMBCV-UHFFFAOYSA-N
0.000
description
2


QFOHBWFCKVYLES-UHFFFAOYSA-N
Butylparaben
Chemical compound


CCCCOC(=O)C1=CC=C(O)C=C1
QFOHBWFCKVYLES-UHFFFAOYSA-N
0.000
description
2


YQPYTSMAZLDSIZ-UHFFFAOYSA-N
C(CCC)C(C(C1=CC=CC=C1)=O)(C(C1=CC=CC=C1)=O)OC.COC=1C(=NN=NC1)C1=CC=CC=C1
Chemical compound


C(CCC)C(C(C1=CC=CC=C1)=O)(C(C1=CC=CC=C1)=O)OC.COC=1C(=NN=NC1)C1=CC=CC=C1
YQPYTSMAZLDSIZ-UHFFFAOYSA-N
0.000
description
2


KJMYJQJKSBIUFB-UHFFFAOYSA-N
C(CCCCCCC)[Si](C)(C)C.[O-2].[O-2].[Ti+4]
Chemical compound


C(CCCCCCC)[Si](C)(C)C.[O-2].[O-2].[Ti+4]
KJMYJQJKSBIUFB-UHFFFAOYSA-N
0.000
description
2


GPELYYBGCGMCKN-UHFFFAOYSA-N
C(CCCCCCCCCCCCCCCCC)(=O)OC(C)C.C(CCCCCCCCCCCCCCCCC)(=O)OC(C)C
Chemical compound


C(CCCCCCCCCCCCCCCCC)(=O)OC(C)C.C(CCCCCCCCCCCCCCCCC)(=O)OC(C)C
GPELYYBGCGMCKN-UHFFFAOYSA-N
0.000
description
2


OCFMAQIVFZVNGM-UHFFFAOYSA-N
C1=CC=C2C(N=NC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(S(O)(=O)=O)C=CC2=C1
Chemical compound


C1=CC=C2C(N=NC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(S(O)(=O)=O)C=CC2=C1
OCFMAQIVFZVNGM-UHFFFAOYSA-N
0.000
description
2


GSDLPJHQLLVRLI-QRSDNYJVSA-N
CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O
Chemical compound


CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O
GSDLPJHQLLVRLI-QRSDNYJVSA-N
0.000
description
2


229940073642
CETEARETH-30
Drugs




0.000
description
2


229940073639
CETEARETH-6
Drugs




0.000
description
2


229940073532
Candelilla Wax
Drugs




0.000
description
2


239000004215
Carbon black (E152)
Substances




0.000
description
2


229960004203
Carnitine
Drugs




0.000
description
2


229940044199
Carnosine
Drugs




0.000
description
2


108010087806
Carnosine
Proteins




0.000
description
2


229960001777
Castor Oil
Drugs




0.000
description
2


240000008886
Ceratonia siliqua
Species




0.000
description
2


235000013912
Ceratonia siliqua
Nutrition




0.000
description
2


229910052684
Cerium
Inorganic materials




0.000
description
2


229920001661
Chitosan
Polymers




0.000
description
2


229940080423
Cochineal
Drugs




0.000
description
2


102000008186
Collagen
Human genes




0.000
description
2


108010035532
Collagen
Proteins




0.000
description
2


240000003412
Copernicia prunifera
Species




0.000
description
2


235000010919
Copernicia prunifera
Nutrition




0.000
description
2


229920002261
Corn starch
Polymers




0.000
description
2


229960003624
Creatine
Drugs




0.000
description
2


235000000638
D-biotin
Nutrition




0.000
description
2


239000011665
D-biotin
Substances




0.000
description
2


GHVNFZFCNZKVNT-UHFFFAOYSA-N
Decanoic acid
Chemical compound


CCCCCCCCCC(O)=O
GHVNFZFCNZKVNT-UHFFFAOYSA-N
0.000
description
2


SOROIESOUPGGFO-UHFFFAOYSA-N
Diazolidinyl urea
Chemical compound


OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O
SOROIESOUPGGFO-UHFFFAOYSA-N
0.000
description
2


MEZZCSHVIGVWFI-UHFFFAOYSA-N
Dioxybenzone
Chemical compound


OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O
MEZZCSHVIGVWFI-UHFFFAOYSA-N
0.000
description
2


241000255925
Diptera
Species




0.000
description
2


NOPFSRXAKWQILS-UHFFFAOYSA-N
Docosanol
Chemical compound


CCCCCCCCCCCCCCCCCCCCCCO
NOPFSRXAKWQILS-UHFFFAOYSA-N
0.000
description
2


102000016942
Elastin
Human genes




0.000
description
2


108010014258
Elastin
Proteins




0.000
description
2


210000002615
Epidermis
Anatomy




0.000
description
2


NUVBSKCKDOMJSU-UHFFFAOYSA-N
Ethylparaben
Chemical group


CCOC(=O)C1=CC=C(O)C=C1
NUVBSKCKDOMJSU-UHFFFAOYSA-N
0.000
description
2


229940089020
Evening primrose oil
Drugs




0.000
description
2


SHZGCJCMOBCMKK-DHVFOXMCSA-N
Fucose
Chemical compound


C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O
SHZGCJCMOBCMKK-DHVFOXMCSA-N
0.000
description
2


PNNNRSAQSRJVSB-SLPGGIOYSA-N
Fucose
Natural products


C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O
PNNNRSAQSRJVSB-SLPGGIOYSA-N
0.000
description
2


229940116338
GLYCERYL RICINOLEATE
Drugs




0.000
description
2


229940049294
GLYCERYL STEARATE SE
Drugs




0.000
description
2


229940049290
HYDROGENATED COCO-GLYCERIDES
Drugs




0.000
description
2


IUJAMGNYPWYUPM-UHFFFAOYSA-N
Hentriacontane
Chemical compound


CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
IUJAMGNYPWYUPM-UHFFFAOYSA-N
0.000
description
2


208000000069
Hyperpigmentation
Diseases




0.000
description
2


208000003367
Hypopigmentation
Diseases




0.000
description
2


206010021118
Hypotonia
Diseases




0.000
description
2


229940078546
ISOEICOSANE
Drugs




0.000
description
2


229940100554
ISONONYL ISONONANOATE
Drugs




0.000
description
2


229940089456
ISOPROPYL STEARATE
Drugs




0.000
description
2


NMUOATVLLQEYHI-UHFFFAOYSA-N
Iminosuccinic acid
Chemical compound


OC(=O)CC(=N)C(O)=O
NMUOATVLLQEYHI-UHFFFAOYSA-N
0.000
description
2


206010061218
Inflammation
Diseases




0.000
description
2


XUGNVMKQXJXZCD-UHFFFAOYSA-N
Isopropyl palmitate
Chemical compound


CCCCCCCCCCCCCCCC(=O)OC(C)C
XUGNVMKQXJXZCD-UHFFFAOYSA-N
0.000
description
2


208000001126
Keratosis
Diseases




0.000
description
2


QAQJMLQRFWZOBN-LAUBAEHRSA-N
L-ascorbyl-6-palmitate
Chemical compound


CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
QAQJMLQRFWZOBN-LAUBAEHRSA-N
0.000
description
2


239000011786
L-ascorbyl-6-palmitate
Substances




0.000
description
2


229940099367
LANOLIN ALCOHOLS
Drugs




0.000
description
2


210000001821
Langerhans Cells
Anatomy




0.000
description
2


229920002884
Laureth 4
Polymers




0.000
description
2


239000005639
Lauric acid
Substances




0.000
description
2


241000208473
Macadamia ternifolia
Species




0.000
description
2


XUMBMVFBXHLACL-UHFFFAOYSA-N
Melanin
Chemical class


O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C
XUMBMVFBXHLACL-UHFFFAOYSA-N
0.000
description
2


MJVGBKJNTFCUJM-UHFFFAOYSA-N
Mexenone
Chemical compound


OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1
MJVGBKJNTFCUJM-UHFFFAOYSA-N
0.000
description
2


210000004080
Milk
Anatomy




0.000
description
2


229940105132
Myristate
Drugs




0.000
description
2


235000021360
Myristic acid
Nutrition




0.000
description
2


241000237536
Mytilus edulis
Species




0.000
description
2


LDVFTISYJLDVGU-UHFFFAOYSA-N
OCC(O)CO.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O
Chemical compound


OCC(O)CO.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O
LDVFTISYJLDVGU-UHFFFAOYSA-N
0.000
description
2


229940120511
OLEYL ERUCATE
Drugs




0.000
description
2


240000007594
Oryza sativa
Species




0.000
description
2


235000007164
Oryza sativa
Nutrition




0.000
description
2


108009000578
Oxidative Stress
Proteins




0.000
description
2


229940016593
PEG-20 GLYCERYL ISOSTEARATE
Drugs




0.000
description
2


229940089510
PEG-4 STEARATE
Drugs




0.000
description
2


LXTZRIBXKVRLOA-UHFFFAOYSA-N
Padimate A
Chemical compound


CCCCCOC(=O)C1=CC=C(N(C)C)C=C1
LXTZRIBXKVRLOA-UHFFFAOYSA-N
0.000
description
2


WYWZRNAHINYAEF-UHFFFAOYSA-N
Padimate O
Chemical compound


CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1
WYWZRNAHINYAEF-UHFFFAOYSA-N
0.000
description
2


235000019482
Palm oil
Nutrition




0.000
description
2


235000021314
Palmitic acid
Nutrition




0.000
description
2


235000019483
Peanut oil
Nutrition




0.000
description
2


229940066842
Petrolatum
Drugs




0.000
description
2


239000004264
Petrolatum
Substances




0.000
description
2


229920002690
Polyoxyl 40 HydrogenatedCastorOil
Polymers




0.000
description
2


229940068977
Polysorbate 20
Drugs




0.000
description
2


229920001213
Polysorbate 20
Polymers




0.000
description
2


229920001214
Polysorbate 60
Polymers




0.000
description
2


208000003251
Pruritus
Diseases




0.000
description
2


229940079889
Pyrrolidonecarboxylic Acid
Drugs




0.000
description
2


235000019484
Rapeseed oil
Nutrition




0.000
description
2


229940100459
STEARETH-20
Drugs




0.000
description
2


229940100458
STEARETH-21
Drugs




0.000
description
2


229910004674
SiO0.5
Inorganic materials




0.000
description
2


229940005581
Sodium Lactate
Drugs




0.000
description
2


GCLGEJMYGQKIIW-UHFFFAOYSA-H
Sodium hexametaphosphate
Chemical compound


[Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1
GCLGEJMYGQKIIW-UHFFFAOYSA-H
0.000
description
2


NGSFWBMYFKHRBD-UHFFFAOYSA-M
Sodium lactate
Chemical compound


[Na+].CC(O)C([O-])=O
NGSFWBMYFKHRBD-UHFFFAOYSA-M
0.000
description
2


206010041303
Solar dermatitis
Diseases




0.000
description
2


JNYAEWCLZODPBN-CTQIIAAMSA-N
Sorbitan
Chemical compound


OCC(O)C1OCC(O)[C@@H]1O
JNYAEWCLZODPBN-CTQIIAAMSA-N
0.000
description
2


229960005078
Sorbitan sesquioleate
Drugs




0.000
description
2


PRAKJMSDJKAYCZ-UHFFFAOYSA-N
Squalane
Chemical compound


CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C
PRAKJMSDJKAYCZ-UHFFFAOYSA-N
0.000
description
2


229940031439
Squalene
Drugs




0.000
description
2


206010042496
Sunburn
Diseases




0.000
description
2


235000019486
Sunflower oil
Nutrition




0.000
description
2


229960003080
Taurine
Drugs




0.000
description
2


208000009056
Telangiectasis
Diseases




0.000
description
2


XOLBLPGZBRYERU-UHFFFAOYSA-N
Tin dioxide
Chemical compound


O=[Sn]=O
XOLBLPGZBRYERU-UHFFFAOYSA-N
0.000
description
2


229960001295
Tocopherol
Drugs




0.000
description
2


229940117972
Triolein
Drugs




0.000
description
2


GSEJCLTVZPLZKY-UHFFFAOYSA-N
Tris
Chemical compound


OCCN(CCO)CCO
GSEJCLTVZPLZKY-UHFFFAOYSA-N
0.000
description
2


239000007983
Tris buffer
Substances




0.000
description
2


229940029983
VITAMINS
Drugs




0.000
description
2


CIWBSHSKHKDKBQ-JLAZNSOCSA-N
Vitamin C
Chemical compound


OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
CIWBSHSKHKDKBQ-JLAZNSOCSA-N
0.000
description
2


229940021016
Vitamin IV solution additives
Drugs




0.000
description
2


229920004482
WACKERÂ®
Polymers




0.000
description
2


BZUVPTAFNJMPEZ-XPWSMXQVSA-N
[(E)-docos-13-enyl] (E)-docos-13-enoate
Chemical compound


CCCCCCCC\C=C\CCCCCCCCCCCCOC(=O)CCCCCCCCCCC\C=C\CCCCCCCC
BZUVPTAFNJMPEZ-XPWSMXQVSA-N
0.000
description
2


SZAMSYKZCSDVBH-CLFAGFIQSA-N
[(Z)-octadec-9-enyl] (Z)-docos-13-enoate
Chemical compound


CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC
SZAMSYKZCSDVBH-CLFAGFIQSA-N
0.000
description
2


0
[1*]C1=CC2=C(C=C1)O/C(C1=CC=C(NC3=NC(N[3*])=NC(NC4=CC=C(C5=NC6=C(C=CC([2*])=C6)O5)C=C4)=N3)C=C1)=N\2
Chemical compound


[1*]C1=CC2=C(C=C1)O/C(C1=CC=C(NC3=NC(N[3*])=NC(NC4=CC=C(C5=NC6=C(C=CC([2*])=C6)O5)C=C4)=N3)C=C1)=N\2

0.000
description
2


XDLGATIAMPGERU-UHFFFAOYSA-N
[2-[[4-[[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanyl]methyl]phenyl]methyl]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid
Chemical compound


CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2CC(C=C1)=CC=C1CC1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C
XDLGATIAMPGERU-UHFFFAOYSA-N
0.000
description
2


HEAHZSUCFKFERC-UHFFFAOYSA-N
[2-[[4-[[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid
Chemical compound


CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C
HEAHZSUCFKFERC-UHFFFAOYSA-N
0.000
description
2


HWGKTCLOBSICTE-UHFFFAOYSA-N
[3-decanoyloxy-2-[[3-decanoyloxy-2,2-bis(decanoyloxymethyl)propoxy]methyl]-2-(decanoyloxymethyl)propyl] decanoate
Chemical compound


CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)(COC(=O)CCCCCCCCC)COCC(COC(=O)CCCCCCCCC)(COC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC
HWGKTCLOBSICTE-UHFFFAOYSA-N
0.000
description
2


JPDHZHZDXCSZAT-UHFFFAOYSA-N
[3-octanoyloxy-2-[[3-octanoyloxy-2,2-bis(octanoyloxymethyl)propoxy]methyl]-2-(octanoyloxymethyl)propyl] octanoate
Chemical compound


CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)(COC(=O)CCCCCCC)COCC(COC(=O)CCCCCCC)(COC(=O)CCCCCCC)COC(=O)CCCCCCC
JPDHZHZDXCSZAT-UHFFFAOYSA-N
0.000
description
2


XIKQZKVNIGCOIS-UHFFFAOYSA-N
[Na].[Na].[Na].[Na].[Na].NCCN
Chemical compound


[Na].[Na].[Na].[Na].[Na].NCCN
XIKQZKVNIGCOIS-UHFFFAOYSA-N
0.000
description
2


LWNWBHRPMJEVOV-UHFFFAOYSA-N
[O--].[O--].[Ti+4].CCCCc1c(C)c(C)c(C)c(C)c1O
Chemical compound


[O--].[O--].[Ti+4].CCCCc1c(C)c(C)c(C)c(C)c1O
LWNWBHRPMJEVOV-UHFFFAOYSA-N
0.000
description
2


NBVZMBLJRHUOJR-UHFFFAOYSA-N
[amino-[4-[6-[4-[amino(azaniumylidene)methyl]phenoxy]hexoxy]phenyl]methylidene]azanium;2-hydroxyethanesulfonate
Chemical compound


OCCS(O)(=O)=O.OCCS(O)(=O)=O.C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1
NBVZMBLJRHUOJR-UHFFFAOYSA-N
0.000
description
2


238000002835
absorbance
Methods




0.000
description
2


238000000862
absorption spectrum
Methods




0.000
description
2


238000007259
addition reaction
Methods




0.000
description
2


230000001476
alcoholic
Effects




0.000
description
2


235000010443
alginic acid
Nutrition




0.000
description
2


239000000783
alginic acid
Substances




0.000
description
2


229920000615
alginic acid
Polymers




0.000
description
2


229960001126
alginic acid
Drugs




0.000
description
2


125000003342
alkenyl group
Chemical group




0.000
description
2


150000004347
all-trans-retinol derivatives
Chemical class




0.000
description
2


239000008168
almond oil
Substances




0.000
description
2


229910021502
aluminium hydroxide
Inorganic materials




0.000
description
2


229910000147
aluminium phosphate
Inorganic materials




0.000
description
2


CEGOLXSVJUTHNZ-UHFFFAOYSA-K
aluminium tristearate
Chemical compound


[Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O
CEGOLXSVJUTHNZ-UHFFFAOYSA-K
0.000
description
2


229960004050
aminobenzoic acid
Drugs




0.000
description
2


125000002490
anilino group
Chemical group


[H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H]

0.000
description
2


230000000844
anti-bacterial
Effects




0.000
description
2


239000007864
aqueous solution
Substances




0.000
description
2


125000003118
aryl group
Chemical group




0.000
description
2


235000010323
ascorbic acid
Nutrition




0.000
description
2


229960005070
ascorbic acid
Drugs




0.000
description
2


239000011668
ascorbic acid
Substances




0.000
description
2


235000010385
ascorbyl palmitate
Nutrition




0.000
description
2


239000012298
atmosphere
Substances




0.000
description
2


235000021302
avocado oil
Nutrition




0.000
description
2


239000008163
avocado oil
Substances




0.000
description
2


239000003899
bactericide agent
Substances




0.000
description
2


229910052788
barium
Inorganic materials




0.000
description
2


159000000009
barium salts
Chemical class




0.000
description
2


TZCXTZWJZNENPQ-UHFFFAOYSA-L
barium sulfate
Inorganic materials


[Ba+2].[O-]S([O-])(=O)=O
TZCXTZWJZNENPQ-UHFFFAOYSA-L
0.000
description
2


DSAJWYNOEDNPEQ-UHFFFAOYSA-N
barium(0)
Chemical compound


[Ba]
DSAJWYNOEDNPEQ-UHFFFAOYSA-N
0.000
description
2


235000010233
benzoic acid
Nutrition




0.000
description
2


229940000635
beta-Alanine
Drugs




0.000
description
2


OENHQHLEOONYIE-VYAWBVGESA-N
beta-Carotene
Natural products


CC=1CCCC(C)(C)C=1\C=C\C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)CCCC1(C)C
OENHQHLEOONYIE-VYAWBVGESA-N
0.000
description
2


235000013734
beta-carotene
Nutrition




0.000
description
2


239000011648
beta-carotene
Substances




0.000
description
2


230000004071
biological effect
Effects




0.000
description
2


229960002685
biotin
Drugs




0.000
description
2


DTVQVQGCVNNOSX-UHFFFAOYSA-N
bis(2-ethylhexyl) 2-[(4-methoxyphenyl)methylidene]propanedioate
Chemical compound


CCCCC(CC)COC(=O)C(C(=O)OCC(CC)CCCC)=CC1=CC=C(OC)C=C1
DTVQVQGCVNNOSX-UHFFFAOYSA-N
0.000
description
2


ULBTUVJTXULMLP-UHFFFAOYSA-N
butyl octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCCCC
ULBTUVJTXULMLP-UHFFFAOYSA-N
0.000
description
2


235000010354
butylated hydroxytoluene
Nutrition




0.000
description
2


229940067596
butylparaben
Drugs




0.000
description
2


239000004204
candelilla wax
Substances




0.000
description
2


235000013868
candelilla wax
Nutrition




0.000
description
2


GHVNFZFCNZKVNT-UHFFFAOYSA-M
caprate
Chemical compound


CCCCCCCCCC([O-])=O
GHVNFZFCNZKVNT-UHFFFAOYSA-M
0.000
description
2


239000004202
carbamide
Substances




0.000
description
2


150000001732
carboxylic acid derivatives
Chemical class




0.000
description
2


201000009030
carcinoma
Diseases




0.000
description
2


239000004106
carminic acid
Substances




0.000
description
2


DGQLVPJVXFOQEV-JNVSTXMASA-N
carminic acid
Chemical compound


OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
DGQLVPJVXFOQEV-JNVSTXMASA-N
0.000
description
2


239000004203
carnauba wax
Substances




0.000
description
2


235000013869
carnauba wax
Nutrition




0.000
description
2


CQOVPNPJLQNMDC-ZETCQYMHSA-N
carnosine zwitterion
Chemical compound


[NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1
CQOVPNPJLQNMDC-ZETCQYMHSA-N
0.000
description
2


150000001746
carotenes
Chemical class




0.000
description
2


235000005473
carotenes
Nutrition




0.000
description
2


239000001913
cellulose
Substances




0.000
description
2


229920002678
cellulose
Polymers




0.000
description
2


229920003086
cellulose ether
Polymers




0.000
description
2


239000012185
ceresin wax
Substances




0.000
description
2


GWXLDORMOJMVQZ-UHFFFAOYSA-N
cerium
Chemical compound


[Ce]
GWXLDORMOJMVQZ-UHFFFAOYSA-N
0.000
description
2


229910000421
cerium(III) oxide
Inorganic materials




0.000
description
2


229940081620
ceteth-2
Drugs




0.000
description
2


238000006243
chemical reaction
Methods




0.000
description
2


238000004581
coalescence
Methods




0.000
description
2


229940071160
cocoate
Drugs




0.000
description
2


239000003240
coconut oil
Substances




0.000
description
2


235000019864
coconut oil
Nutrition




0.000
description
2


229920001436
collagen
Polymers




0.000
description
2


229960005188
collagen
Drugs




0.000
description
2


238000001816
cooling
Methods




0.000
description
2


RYGMFSIKBFXOCR-UHFFFAOYSA-N
copper
Chemical compound


[Cu]
RYGMFSIKBFXOCR-UHFFFAOYSA-N
0.000
description
2


239000008120
corn starch
Substances




0.000
description
2


239000000973
cosmetic coloring agent
Substances




0.000
description
2


238000005336
cracking
Methods




0.000
description
2


239000006046
creatine
Substances




0.000
description
2


CVSVTCORWBXHQV-UHFFFAOYSA-N
creatine zwitterion
Chemical compound


NC(=[NH2+])N(C)CC([O-])=O
CVSVTCORWBXHQV-UHFFFAOYSA-N
0.000
description
2


PWEOPMBMTXREGV-UHFFFAOYSA-N
decanoic acid;octanoic acid;propane-1,2-diol
Chemical compound


CC(O)CO.CCCCCCCC(O)=O.CCCCCCCC(O)=O.CCCCCCCCCC(O)=O.CCCCCCCCCC(O)=O
PWEOPMBMTXREGV-UHFFFAOYSA-N
0.000
description
2


229940069876
decyl olivate
Drugs




0.000
description
2


230000001419
dependent
Effects




0.000
description
2


229920005994
diacetyl cellulose
Polymers




0.000
description
2


229960001083
diazolidinylurea
Drugs




0.000
description
2


229940100539
dibutyl adipate
Drugs




0.000
description
2


229960005215
dichloroacetic acid
Drugs




0.000
description
2


229960001673
diethyltoluamide
Drugs




0.000
description
2


OKQDSOXFNBWWJL-UHFFFAOYSA-N
dihexyl carbonate
Chemical compound


CCCCCCOC(=O)OCCCCCC
OKQDSOXFNBWWJL-UHFFFAOYSA-N
0.000
description
2


229960001826
dimethylphthalate
Drugs




0.000
description
2


150000002009
diols
Chemical class




0.000
description
2


ZGTMUACCHSMWAC-UHFFFAOYSA-L
disodium;2-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate
Chemical compound


[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O
ZGTMUACCHSMWAC-UHFFFAOYSA-L
0.000
description
2


238000009826
distribution
Methods




0.000
description
2


229960000735
docosanol
Drugs




0.000
description
2


ZCZXIOQAGGFXNN-UHFFFAOYSA-N
dodecan-5-yl benzoate
Chemical compound


CCCCCCCC(CCCC)OC(=O)C1=CC=CC=C1
ZCZXIOQAGGFXNN-UHFFFAOYSA-N
0.000
description
2


229960003747
ecamsule
Drugs




0.000
description
2


229920002549
elastin
Polymers




0.000
description
2


230000002708
enhancing
Effects




0.000
description
2


HZAXFHJVJLSVMW-UHFFFAOYSA-N
ethanolamine
Chemical compound


NCCO
HZAXFHJVJLSVMW-UHFFFAOYSA-N
0.000
description
2


238000007046
ethoxylation reaction
Methods




0.000
description
2


229960001617
ethyl hydroxybenzoate
Drugs




0.000
description
2


235000008524
evening primrose extract
Nutrition




0.000
description
2


239000010475
evening primrose oil
Substances




0.000
description
2


239000003925
fat
Substances




0.000
description
2


235000019197
fats
Nutrition




0.000
description
2


239000000835
fiber
Substances




0.000
description
2


235000013312
flour
Nutrition




0.000
description
2


239000012530
fluid
Substances




0.000
description
2


235000013305
food
Nutrition




0.000
description
2


229910001679
gibbsite
Inorganic materials




0.000
description
2


125000003976
glyceryl group
Chemical group


[H]C([*])([H])C(O[H])([H])C(O[H])([H])[H]

0.000
description
2


150000002338
glycosides
Chemical class




0.000
description
2


PCHJSUWPFVWCPO-UHFFFAOYSA-N
gold
Chemical compound


[Au]
PCHJSUWPFVWCPO-UHFFFAOYSA-N
0.000
description
2


229910052737
gold
Inorganic materials




0.000
description
2


239000010931
gold
Substances




0.000
description
2


239000008169
grapeseed oil
Substances




0.000
description
2


229960001915
hexamidine
Drugs




0.000
description
2


229940100463
hexyl laurate
Drugs




0.000
description
2


239000003906
humectant
Substances




0.000
description
2


230000036571
hydration
Effects




0.000
description
2


238000006703
hydration reaction
Methods




0.000
description
2


150000002430
hydrocarbons
Chemical class




0.000
description
2


229920006007
hydrogenated polyisobutylene
Polymers




0.000
description
2


229940072106
hydroxystearate
Drugs




0.000
description
2


230000003810
hyperpigmentation
Effects




0.000
description
2


231100001006
hyperpigmentation
Toxicity




0.000
description
2


230000003425
hypopigmentation
Effects




0.000
description
2


229940080260
iminodisuccinate
Drugs




0.000
description
2


230000004054
inflammatory process
Effects




0.000
description
2


239000004615
ingredient
Substances




0.000
description
2


239000002198
insoluble material
Substances




0.000
description
2


230000003993
interaction
Effects




0.000
description
2


UQSXHKLRYXJYBZ-UHFFFAOYSA-N
iron oxide
Chemical compound


[Fe]=O
UQSXHKLRYXJYBZ-UHFFFAOYSA-N
0.000
description
2


UBUHAZKODAUXCP-UHFFFAOYSA-N
iron(2+);oxygen(2-);hydrate
Chemical compound


O.[O-2].[Fe+2]
UBUHAZKODAUXCP-UHFFFAOYSA-N
0.000
description
2


229910021519
iron(III) oxide-hydroxide
Inorganic materials




0.000
description
2


KFZMGEQAYNKOFK-UHFFFAOYSA-N
iso-propanol
Chemical compound


CC(C)O
KFZMGEQAYNKOFK-UHFFFAOYSA-N
0.000
description
2


150000003816
isoflavonoids
Chemical class




0.000
description
2


229930013032
isoflavonoids
Natural products




0.000
description
2


235000012891
isoflavonoids
Nutrition




0.000
description
2


229940075495
isopropyl palmitate
Drugs




0.000
description
2


229940119170
jojoba wax
Drugs




0.000
description
2


JVTAAEKCZFNVCJ-UHFFFAOYSA-M
lactate
Chemical compound


CC(O)C([O-])=O
JVTAAEKCZFNVCJ-UHFFFAOYSA-M
0.000
description
2


150000003893
lactate salts
Chemical class




0.000
description
2


JVTAAEKCZFNVCJ-UHFFFAOYSA-N
lactic acid
Chemical compound


CC(O)C(O)=O
JVTAAEKCZFNVCJ-UHFFFAOYSA-N
0.000
description
2


239000004310
lactic acid
Substances




0.000
description
2


235000014655
lactic acid
Nutrition




0.000
description
2


229940062711
laureth-9
Drugs




0.000
description
2


RYZCLUQMCYZBJQ-UHFFFAOYSA-H
lead(2+);dicarbonate;dihydroxide
Chemical compound


[OH-].[OH-].[Pb+2].[Pb+2].[Pb+2].[O-]C([O-])=O.[O-]C([O-])=O
RYZCLUQMCYZBJQ-UHFFFAOYSA-H
0.000
description
2


229960001518
levocarnitine
Drugs




0.000
description
2


230000031700
light absorption
Effects




0.000
description
2


239000007791
liquid phase
Substances




0.000
description
2


229910001629
magnesium chloride
Inorganic materials




0.000
description
2


235000019341
magnesium sulphate
Nutrition




0.000
description
2


PWHULOQIROXLJO-UHFFFAOYSA-N
manganese
Chemical compound


[Mn]
PWHULOQIROXLJO-UHFFFAOYSA-N
0.000
description
2


229910052748
manganese
Inorganic materials




0.000
description
2


239000011572
manganese
Substances




0.000
description
2


VASIZKWUTCETSD-UHFFFAOYSA-N
manganese(II) oxide
Inorganic materials


[Mn]=O
VASIZKWUTCETSD-UHFFFAOYSA-N
0.000
description
2


201000001441
melanoma
Diseases




0.000
description
2


229910052751
metal
Inorganic materials




0.000
description
2


239000002184
metal
Substances




0.000
description
2


150000002736
metal compounds
Chemical class




0.000
description
2


150000002739
metals
Chemical class




0.000
description
2


125000005341
metaphosphate group
Chemical group




0.000
description
2


CERQOIWHTDAKMF-UHFFFAOYSA-N
methacrylic acid
Chemical compound


CC(=C)C(O)=O
CERQOIWHTDAKMF-UHFFFAOYSA-N
0.000
description
2


ARYZCSRUUPFYMY-UHFFFAOYSA-N
methoxysilane
Chemical compound


CO[SiH3]
ARYZCSRUUPFYMY-UHFFFAOYSA-N
0.000
description
2


239000004200
microcrystalline wax
Substances




0.000
description
2


235000019808
microcrystalline wax
Nutrition




0.000
description
2


235000013336
milk
Nutrition




0.000
description
2


239000008267
milk
Substances




0.000
description
2


230000004048
modification
Effects




0.000
description
2


238000006011
modification reaction
Methods




0.000
description
2


230000003020
moisturizing
Effects




0.000
description
2


235000020638
mussel
Nutrition




0.000
description
2


TUNFSRHWOTWDNC-UHFFFAOYSA-M
myristate
Chemical compound


CCCCCCCCCCCCCC([O-])=O
TUNFSRHWOTWDNC-UHFFFAOYSA-M
0.000
description
2


239000000978
natural dye
Substances




0.000
description
2


230000001264
neutralization
Effects




0.000
description
2


150000002829
nitrogen
Chemical group




0.000
description
2


229940116918
octadecenedioic acid
Drugs




0.000
description
2


UHGIMQLJWRAPLT-UHFFFAOYSA-L
octadecyl phosphate
Chemical compound


CCCCCCCCCCCCCCCCCCOP([O-])([O-])=O
UHGIMQLJWRAPLT-UHFFFAOYSA-L
0.000
description
2


HMMGMWAXVFQUOA-UHFFFAOYSA-N
octamethylcyclotetrasiloxane
Chemical compound


C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1
HMMGMWAXVFQUOA-UHFFFAOYSA-N
0.000
description
2


AXIUTKTZNZMMSI-UHFFFAOYSA-N
octan-3-yl 2-cyano-3,3-diphenylprop-2-enoate
Chemical compound


C=1C=CC=CC=1C(=C(C#N)C(=O)OC(CC)CCCCC)C1=CC=CC=C1
AXIUTKTZNZMMSI-UHFFFAOYSA-N
0.000
description
2


JLKKIOUJQYHKHA-UHFFFAOYSA-N
octan-3-yl 2-hydroxybenzoate;octan-3-yl 2-methoxy-3-phenylprop-2-enoate
Chemical compound


CCCCCC(CC)OC(=O)C1=CC=CC=C1O.CCCCCC(CC)OC(=O)C(OC)=CC1=CC=CC=C1
JLKKIOUJQYHKHA-UHFFFAOYSA-N
0.000
description
2


WWZKQHOCKIZLMA-UHFFFAOYSA-M
octanoate
Chemical compound


CCCCCCCC([O-])=O
WWZKQHOCKIZLMA-UHFFFAOYSA-M
0.000
description
2


125000002801
octanoyl group
Chemical group


C(CCCCCCC)(=O)*

0.000
description
2


125000002347
octyl group
Chemical group


[H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]

0.000
description
2


229940073665
octyldodecyl myristate
Drugs




0.000
description
2


239000004006
olive oil
Substances




0.000
description
2


235000008390
olive oil
Nutrition




0.000
description
2


230000003287
optical
Effects




0.000
description
2


239000003960
organic solvent
Substances




0.000
description
2


210000000056
organs
Anatomy




0.000
description
2


230000036542
oxidative stress
Effects




0.000
description
2


125000004430
oxygen atoms
Chemical group


O*

0.000
description
2


SOQBVABWOPYFQZ-UHFFFAOYSA-N
oxygen(2-);titanium(4+)
Chemical class


[O-2].[O-2].[Ti+4]
SOQBVABWOPYFQZ-UHFFFAOYSA-N
0.000
description
2


CBENFWSGALASAD-UHFFFAOYSA-N
ozone
Chemical compound


[O-][O+]=O
CBENFWSGALASAD-UHFFFAOYSA-N
0.000
description
2


239000002540
palm oil
Substances




0.000
description
2


150000002942
palmitic acid derivatives
Chemical class




0.000
description
2


235000012658
paprika extract
Nutrition




0.000
description
2


235000019809
paraffin wax
Nutrition




0.000
description
2


235000011837
pasties
Nutrition




0.000
description
2


239000000312
peanut oil
Substances




0.000
description
2


239000008194
pharmaceutical composition
Substances




0.000
description
2


231100000760
phototoxic
Toxicity




0.000
description
2


235000011765
phytoene
Nutrition




0.000
description
2


229920003216
poly(methylphenylsiloxane)
Polymers




0.000
description
2


229920001281
polyalkylene
Polymers




0.000
description
2


229920000098
polyolefin
Polymers




0.000
description
2


239000000256
polyoxyethylene sorbitan monolaurate
Substances




0.000
description
2


235000010486
polyoxyethylene sorbitan monolaurate
Nutrition




0.000
description
2


239000001818
polyoxyethylene sorbitan monostearate
Substances




0.000
description
2


235000010989
polyoxyethylene sorbitan monostearate
Nutrition




0.000
description
2


229920002282
polysilicones-15
Polymers




0.000
description
2


229940113124
polysorbate 60
Drugs




0.000
description
2


229920002635
polyurethane
Polymers




0.000
description
2


239000004814
polyurethane
Substances




0.000
description
2


ZLMJMSJWJFRBEC-UHFFFAOYSA-N
potassium
Chemical compound


[K]
ZLMJMSJWJFRBEC-UHFFFAOYSA-N
0.000
description
2


239000011591
potassium
Substances




0.000
description
2


229910052700
potassium
Inorganic materials




0.000
description
2


BWHMMNNQKKPAPP-UHFFFAOYSA-L
potassium carbonate
Chemical compound


[K+].[K+].[O-]C([O-])=O
BWHMMNNQKKPAPP-UHFFFAOYSA-L
0.000
description
2


RMGVATURDVPNOZ-UHFFFAOYSA-M
potassium;hexadecyl hydrogen phosphate
Chemical compound


[K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O
RMGVATURDVPNOZ-UHFFFAOYSA-M
0.000
description
2


VLYFRFHWUBBLRR-UHFFFAOYSA-L
potassium;sodium;carbonate
Chemical compound


[Na+].[K+].[O-]C([O-])=O
VLYFRFHWUBBLRR-UHFFFAOYSA-L
0.000
description
2


PZQSQRCNMZGWFT-QXMHVHEDSA-N
propan-2-yl (Z)-octadec-9-enoate
Chemical compound


CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C
PZQSQRCNMZGWFT-QXMHVHEDSA-N
0.000
description
2


ZPWFUIUNWDIYCJ-UHFFFAOYSA-N
propan-2-yl octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OC(C)C
ZPWFUIUNWDIYCJ-UHFFFAOYSA-N
0.000
description
2


235000010232
propyl p-hydroxybenzoate
Nutrition




0.000
description
2


239000004405
propyl p-hydroxybenzoate
Substances




0.000
description
2


230000001681
protective
Effects




0.000
description
2


239000002994
raw material
Substances




0.000
description
2


230000002829
reduced
Effects




0.000
description
2


230000000717
retained
Effects




0.000
description
2


235000009566
rice
Nutrition




0.000
description
2


229960004889
salicylic acid
Drugs




0.000
description
2


238000007127
saponification reaction
Methods




0.000
description
2


235000003441
saturated fatty acids
Nutrition




0.000
description
2


150000004671
saturated fatty acids
Chemical class




0.000
description
2


239000000741
silica gel
Substances




0.000
description
2


229910002027
silica gel
Inorganic materials




0.000
description
2


BQCADISMDOOEFD-UHFFFAOYSA-N
silver
Chemical compound


[Ag]
BQCADISMDOOEFD-UHFFFAOYSA-N
0.000
description
2


229910052709
silver
Inorganic materials




0.000
description
2


239000004332
silver
Substances




0.000
description
2


150000003385
sodium
Chemical class




0.000
description
2


235000019982
sodium hexametaphosphate
Nutrition




0.000
description
2


239000001540
sodium lactate
Substances




0.000
description
2


235000011088
sodium lactate
Nutrition




0.000
description
2


LUPNKHXLFSSUGS-UHFFFAOYSA-M
sodium;2,2-dichloroacetate
Chemical compound


[Na+].[O-]C(=O)C(Cl)Cl
LUPNKHXLFSSUGS-UHFFFAOYSA-M
0.000
description
2


239000011343
solid material
Substances




0.000
description
2


239000003549
soybean oil
Substances




0.000
description
2


235000012424
soybean oil
Nutrition




0.000
description
2


238000001228
spectrum
Methods




0.000
description
2


229940032094
squalane
Drugs




0.000
description
2


230000000087
stabilizing
Effects




0.000
description
2


229940114926
stearate
Drugs




0.000
description
2


238000003756
stirring
Methods




0.000
description
2


230000035882
stress
Effects




0.000
description
2


125000001424
substituent group
Chemical group




0.000
description
2


229940086735
succinate
Drugs




0.000
description
2


239000002600
sunflower oil
Substances




0.000
description
2


239000000454
talc
Substances




0.000
description
2


229910052623
talc
Inorganic materials




0.000
description
2


229940095064
tartrate
Drugs




0.000
description
2


239000001577
tetrasodium phosphonato phosphate
Substances




0.000
description
2


239000010496
thistle oil
Substances




0.000
description
2


229910001887
tin oxide
Inorganic materials




0.000
description
2


RTAQQCXQSZGOHL-UHFFFAOYSA-N
titanium
Chemical compound


[Ti]
RTAQQCXQSZGOHL-UHFFFAOYSA-N
0.000
description
2


239000010936
titanium
Substances




0.000
description
2


229910052719
titanium
Inorganic materials




0.000
description
2


235000010384
tocopherol
Nutrition




0.000
description
2


239000011732
tocopherol
Substances




0.000
description
2


229930003799
tocopherols
Natural products




0.000
description
2


125000003944
tolyl group
Chemical group




0.000
description
2


230000000699
topical
Effects




0.000
description
2


GKAVWWCJCPVMNR-UHFFFAOYSA-N
tridecyl octadecanoate
Chemical compound


CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCC
GKAVWWCJCPVMNR-UHFFFAOYSA-N
0.000
description
2


230000001960
triggered
Effects




0.000
description
2


125000005591
trimellitate group
Chemical group




0.000
description
2


PHYFQTYBJUILEZ-IUPFWZBJSA-N
triolein
Chemical compound


CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC
PHYFQTYBJUILEZ-IUPFWZBJSA-N
0.000
description
2


235000013799
ultramarine blue
Nutrition




0.000
description
2


235000021122
unsaturated fatty acids
Nutrition




0.000
description
2


150000004670
unsaturated fatty acids
Chemical class




0.000
description
2


230000002792
vascular
Effects




0.000
description
2


200000000024
vascular cognitive impairment
Diseases




0.000
description
2


XTXRWKRVRITETP-UHFFFAOYSA-N
vinyl acetate
Chemical compound


CC(=O)OC=C
XTXRWKRVRITETP-UHFFFAOYSA-N
0.000
description
2


125000000391
vinyl group
Chemical group


[H]C([*])=C([H])[H]

0.000
description
2


235000013343
vitamin
Nutrition




0.000
description
2


239000011782
vitamin
Substances




0.000
description
2


229930003231
vitamins
Natural products




0.000
description
2


238000005406
washing
Methods




0.000
description
2


239000010497
wheat germ oil
Substances




0.000
description
2


HCHKCACWOHOZIP-UHFFFAOYSA-N
zinc
Chemical compound


[Zn]
HCHKCACWOHOZIP-UHFFFAOYSA-N
0.000
description
2


229910052725
zinc
Inorganic materials




0.000
description
2


239000011701
zinc
Substances




0.000
description
2


RNWHGQJWIACOKP-UHFFFAOYSA-N
zinc;oxygen(2-)
Chemical class


[O-2].[Zn+2]
RNWHGQJWIACOKP-UHFFFAOYSA-N
0.000
description
2


GVJHHUAWPYXKBD-IEOSBIPESA-N
Î±-tocopherol
Chemical compound


OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C
GVJHHUAWPYXKBD-IEOSBIPESA-N
0.000
description
2


OENHQHLEOONYIE-JLTXGRSLSA-N
Î²-Carotene
Chemical compound


CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
OENHQHLEOONYIE-JLTXGRSLSA-N
0.000
description
2


FAAHNQAYWKTLFD-UHFFFAOYSA-N
CCC(C)N1CCCC1=O
Chemical compound


CCC(C)N1CCCC1=O
FAAHNQAYWKTLFD-UHFFFAOYSA-N
0.000
description
1


KIWWJOJIJVFICN-UHFFFAOYSA-N
CCCCC1(CC)CNC12=NC(NC1=CC=C(C3=NC4=C(C=CC(C(C)(C)CC)=C4)O3)C=C1)=NC(NC1=CC=C(/C3=N/C4=C(C=CC(C(C)(C)CC)=C4)O3)C=C1)=N2
Chemical compound


CCCCC1(CC)CNC12=NC(NC1=CC=C(C3=NC4=C(C=CC(C(C)(C)CC)=C4)O3)C=C1)=NC(NC1=CC=C(/C3=N/C4=C(C=CC(C(C)(C)CC)=C4)O3)C=C1)=N2
KIWWJOJIJVFICN-UHFFFAOYSA-N
0.000
description
1



Classifications




A—HUMAN NECESSITIES


A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE


A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES


A61K8/00—Cosmetics or similar toiletry preparations


A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition


A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds


A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds








A—HUMAN NECESSITIES


A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE


A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS


A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings


A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations







Abstract

The invention is a light protection-active cosmetic or dermatological preparation comprising (a) at least one benzoxazole derivative, and (b) at least one oil component having a surface tension (Ï) of less than 37 mN/m (at 25Â° C). The invention is also a method of treating or preventing cosmetic or dermatological changes in the skin, a method of tanning or accelerating tanning of the skin, and a method of protecting the skin against light-induced aging, each comprising applying the cosmetic or dermatological preparation to the skin. The invention is also a method of increasing the solubility of benzoxazole in a preparation comprising adding at least one oil component. The invention also includes a wipe impregnated with the preparation. 




Description

CROSS-REFERENCE TO RELATED APPLICATIONS 
    This is a continuation application of PCT/EP02/14298, filed Dec. 16, 2002, which is incorporated herein by reference in its entirety, and also claims the benefit of German Priority Application No. 101 62 841.2, filed Dec. 20, 2001.
 FIELD OF THE INVENTION 
    The present invention relates to cosmetic and dermatological light protection preparations, in particular it relates to cosmetic and dermatological formulations with increased UV-A protection performance. 
 BACKGROUND OF THE INVENTION 
    The harmful effect of the ultraviolet part of solar radiation on the skin is generally known. Depending on their particular wavelength, the rays have different effects on the skin as an organ: 
     The so-called UV-C radiation with a wavelength between 100 and 280 nm is absorbed by the ozone layer in the Earth's atmosphere and accordingly is not found in the solar spectrum. It is therefore of no physiological importance during sunbathing. 
     The so-called UV-B region is between 290 nm and 320 nm. UV-B rays are essentially responsible for the long-lasting tanning of the skin, but can at the same time cause an erythema, simple sunburn or even burns of greater or lesser severity. Chronic photodamage, photodermatoses and Herpes solaris can also be caused by UV-B radiation. 
     It has for a long time been incorrectly assumed that long-wave UV-A radiation with a wavelength between 320 nm and 400 nm only has a negligible biological effect and that, correspondingly, the UV-B rays are responsible for most photodamage to the human skin. However, in the meantime, numerous studies have studied that UV-A radiation is much more hazardous than UV-B radiation with regard to the triggering of photodynamic, specifically phototoxic reactions and chronic changes in the skin. The harmful influence of UV-B radiation can also be further intensified by UV-A radiation. 
     Thus, it has, inter alia, been found that even UV-A radiation suffices under very normal everyday conditions to harm, within a short time, the collagen and elastin fibers which are of essential importance for the structure and strength of the skin. The consequences are chronic photo-induced changes in the skinâthe skin âagesâ prematurely. The clinical appearance of skin aged by light includes, for example, wrinkles and lines, and also an irregular, furrowed relief. In addition, the parts affected by photo-induced skin aging have irregular pigmentation. The formation of brown spots, keratoses and even carcinomas or malignant melanomas is also possible. Skin aged prematurely by everyday UV exposure is, moreover, characterized by lower activity of the Langerhans cells and slight, chronic inflammation. 
     Approximately 90% of the ultraviolet radiation which reaches the Earth consists of UV-A rays. While UV-B radiation varies widely depending on numerous factors (e.g. time of year and time of day or degree of latitude), UV-A radiation remains relatively constant day to day irrespective of the time of year and time of day or geographical factors. At the same time, the majority of UV-A radiation penetrates into the living epidermis, while approximately 70% of UV-B rays are retained by the horny layer. 
     The relatively recent findings concerning the effect of UV-A rays on the skin have led to increased attention now being devoted to protective measures for this ray range. In practice, no sunscreen product is complete any more without an effective UV-A filter effect, and pure UV-B filter preparations are rare. 
     When applying a sunscreen to the skin, the ultraviolet rays can be weakened through two effects: firstly, by reflection and scattering of the rays at the surface of pulverulent solids (physical light protection) and, secondly, by absorption on chemical substances (chemical light protection). Depending on which wavelength region is absorbed, a distinction is made between UV-B filters (absorption range 280 to 320 nm), UV-A filters (absorption range 320 to 400 nm) and broadband filters (absorption range 290 to about 380 nm). 
     To protect against UV-B radiation, numerous compounds are known, the absorption maximum of which should be around 308 nm as far as possible since this is the highest erythema effectiveness of solar radiation. Typical UV-B filters are, for example, derivatives of 3-benzylidenecamphor, of 4-aminobenzoic acid, of cinnamic acid, of salicylic acid, of benzophenone, and also of 2-phenylbenzimidazole. 
     Some compounds are also known for protecting against UV-A radiation, such as, in particular, dibenzoylmethane derivatives. However, dibenzoylmethane derivatives are generally not photostable, as a result of which cosmetic or dermatological preparations with a content of this substance should also comprise certain UV stabilizers. Further known UV-A filter substances are certain water-soluble, sulfonated UV filter substances, such as, for example, phenylene-1,4-bis(2-benzimidazyl)-3,3â²-5,5â²-tetrasulfonic acid and its salts. 
     Besides the pure UV-A or UV-B filters, there are substances which cover both regions. This group of broadband filters includes, for example, asymmetrically substituted s-triazine compounds, such as, for example, 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (INCI: BisEthylhexyloxyphenol Methoxyphenyl Triazine), certain benzophenones, such as, for example, 2-hydroxy-4-methoxybenzophenone (INCI: Benzophenone 3) or 2,2â²-methylenebis(6-(2H-benzotriazole-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (INCI: Methylene Bis-Benzotriazolyl Tetramethylenebutylphenol). 
     In general, the light absorption behavior of light protection filter substances is very well known and documented, especially as there are positive lists for the use of such substances in most industrialized countries, which impose very strict standards on the documentation. Since, in order to characterize a filter substance, not only is the position of the absorption maximum important, but primarily the absorption range, absorption spectra are recorded for each substance. However, the absorbance values can at best be a guide for the concentration of the substances in the finished formulations since interactions with ingredients of the skin or of the surface of the skin itself may give rise to imponderables. In addition, it is usually difficult to estimate beforehand how uniformly and thickly the filter substance is distributed in and on the horny layer of the skin. 
     To test the UV-A protection performance, use is usually made of the IPD method (IPD=immediate pigment darkening). Similarly to the determination of the sun protection factor, this method gives a value which indicates how much longer the skin protected with the light protection composition can be irradiated with UV-A radiation until the pigmentation which occurs is the same as for the unprotected skin. 
     The use concentration of known light protection filter substances present in the form of a solid, which exhibit a high filter effect in the UV-A region is, however, often limitedâespecially in combination with other substances to be dissolved. This therefore gives rise to certain technical difficulties relating to formulation in achieving relatively high sun protection factors or UV-A protection performance. 
     In order to ensure optimum UV protection, UV filter substances must of course be in dissolved form. Certain UV filter substancesâsuch as benzotriazoles, triazine and benzoxazole derivativesâare characterized per se by good light protection effect. However, their main disadvantage is that they are sparingly soluble in customary oil components. Accordingly, a disadvantage of the prior art is that with these filter substances only comparatively low light protection factors could usually be achieved since their solubility or dispersibility in the formulations is too low, i.e. they cannot be incorporated, or can only be incorporated with difficulty, in a satisfactory manner into such formulations. 
     Even if, in principle, a certain UV protection can be achieved at limited solubility, another problem often arises, that of recrystallization. Sparingly soluble substances in particular recrystallize relatively rapidly, which can be caused by fluctuations in temperature or other influences. Uncontrolled recrystallization of an essential preparation constituent, such as a UV filter, however, has extremely disadvantageous effects on the properties of the given preparation andâlast but not leastâon the desired light protection. 
     Since light protection filter substances are generally expensive and since some light protection filter substances are also difficult to incorporate into cosmetic or dermatological preparations in relatively high concentrations, it was an object of the invention to arrive, in a simple and cost-effective manner, at preparations which, despite having unusually low concentrations of conventional UV-A light protection filter substances, nevertheless achieve an acceptable or even high UV-A protection performance. 
 SUMMARY OF THE INVENTION 
    It was surprising and could not have been foreseen by the person skilled in the art that light-protective cosmetic or dermatological preparations, characterized in that they comprise 
      (a) at least one benzoxazole derivative and   (b) at least one oil component with a surface tension Ï of less than 37 mN/m (at 25Â° C.), 

 would overcome the disadvantages of the prior art. 
   
    The preparations according to the invention are entirely satisfactory preparations in every respect, which are not restricted to a limited choice of raw materials. Accordingly, they are particularly suitable as bases for preparations with diverse application purposes. The preparations according to the invention exhibit very good sensory and cosmetic properties, such as, for example, extensibility on the skin or the ability to be absorbed into the skin, and are further characterized by very good light protection effectiveness, an exceptionally high UV-A protection performance, and by excellent skin compatibility coupled with excellent skincare data.
 DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS 
    In particular, the use of oil components with a surface tension a of less than 37 mN/m (measured using a K10T tensiometer from KrÃ¼ss with a ring against air at 25Â° C.) as solvent, solubility promoter, solubilizer or stabilizer for benzoxazole derivative is in accordance with the invention. 
     In a particularly advantageous embodiment, the present invention accordingly provides the use of oil components with a surface tension Ï of less than 37 mN/m for achieving or increasing the solubility of benzoxazole derivatives in cosmetic or dermatological preparations. 
     In particular, it was surprising that the solubility of benzoxazole derivatives is also increased through the use according to the invention when further compounds which are sparingly soluble per seâsuch as, for example, benzotriazoles or triazine derivativesâare present in the cosmetic or dermatological preparations. 
     For the purposes of the present invention, the cosmetic or dermatological preparations comprise at least one oil phase either on its own or as an oil phase of a disperse two-phase or multiphase system, which can additionally comprise one or more water phases. 
     For the purposes of the present invention, advantageous benzoxazole derivatives are characterized by the following structural formula,  
        

 in which R1, R2 and R3, independently of one another, are chosen from the group of branched or unbranched, saturated or unsaturated alkyl radicals having 1 to 10 carbon atoms. It is particularly advantageous according to the invention to choose the radicals R1 and R2 to be the same, in particular from the group of branched alkyl radicals having 3 to 5 carbon atoms. It is also particularly advantageous for the purposes of the present invention if R3 is an unbranched or branched alkyl radical having 8 carbon atoms, in particular the 2-ethylhexyl radical. 

     A benzoxazole derivative which is particularly preferred according to the invention is 2,4-bis[5-1 (dimethylpropyl)benzoxazole-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine with the CAS No. 288254-16-0, which is characterized by the structural formula  
        

 and is available from 3V Sigma under the trade name UvasorbÂ® K2A. 

     The total amount of one or more benzoxazole derivatives in the finished cosmetic or dermatological preparations is advantageously chosen from the range from 0.01% by weight to 20% by weight, preferably from 0.1 to 10% by weight, in each case based on the total weight of the preparations. 
     Advantageous oil components with a surface tension a of less than 37 mN/m for the purposes of the present invention are given below:  
                   Ï [mN/m]   INCI Trade name Company at 25Â° C.        Diethylene Glycol Dermol 489 Rovi     Dioctanoate/Diisonanoate   PEG-2 Diethylhexanoate Dermol 488 Rovi    Macadamia Ternifolia  Macadamia nut oil Henry Lamotte   Caprylyl Methicone Silsoft 034 Crampton Corperation   Octyl Palmitate Cegesoft C24 Cognis    Buxus Chinensis  Lipovol J Induchem   Cyclomethicone (=Cyclopentasiloxane/ DC Fluid 345 Dow Corning   cyclohexasiloxane)   Isodecyl Neopentanoate DUB VCI 10   Decyl Olivate Lipodermalol OL Induchem 15.8   Cetyl Dimethicone Abil Wax 9840 Goldschmidt 21.0   Dibutyl Adipate Cetiol B Cognis 22.7   Tridecyl Trimellitate Liponate TDTM Induchem 25.2   Isopropyl Stearate Isopropyl Stearate Cognis 26.3   C12-13 Alykyl Lactate Cosmacol ELI Nordmann & Rassman 26.4   Butyl Octanol Isofol 12 Condea Chemie 26.9   Ethyl Butylacetylaminopropionate Insect repellent 3535 Merck KGaA 27.0   Dicaprylyl Ether Cetiol OE Cognis 27.0   Dicaprylyl Carbonate Cetiol CC Cognis 27.5   Stearyl Heptanoate Tegosoft SH Goldschmidt AG 28.7   Octyldodecanol Eutanol G Cognis 28.9   Propylene Glycol Miglyol 840 Condea Chemie 29.0   Dicaprylate/Dicaprate   Cetearyl Isononanoate Cetiol SN Cognis 29.2   Caprylic/Capric Triglyceride Miglyol 812 Condea Chemie 29.2   Butylene Glycol Dermofeel BGC Dr. Straethmans 29.3   Caprylate/Caprate   Di C12-13 Alkyl Tartrate Cosmacol ETI Nordmann & Rassman 29.4   Caprylic/Capric/Succinic Miglyol 829 Condea Chemie 29.5   Triglyceride   Octyldodecyl Myristate M.O.D. WL 2949/B GattefossÃ© 29.8   Cocoglycerides Myritol 331 Cognis 30.0   Tridecyl Stearate(+) Lipovol MOS-130 Induchem 30.2   Tridecyl Trimellitate(+)   Dipentaerythrityl   Hexacaprylate/Hexacaprate   Hexadecyl Benzoate + Hallstar AB C. P. Hall Company 30.5   Butyloctyl Benzoate   Propylene Glycol Isostearate Emerest 2384 Cognis 30.6   Glycerol triisostearic acid Prisorine 2041 GTIS Uniquema 30.7   Pentaerythrityl Tetraisostearate Crodamol PTIS 3797   30.8   Butyloctyl Salicylate Hallbrite BHB C. P. Hall Company 31.6   C12-15 Alkyl Benzoate Tegesoft TN Goldschmidt AG 31.8    Persea Gratissima  Avocado oil refined DAC 86 Henry Lamotte 32.0   Ethylhexyl Salicylate Neo Heliopan Typ OS Haarmann & Reimer 32.2   Ethylhexyl Methoxycinnamate Neo Heliopan Typ AV Haarmann & Reimer 32.4   Diethylhexyl 2,6-Naphthalate Corapan TQ Haarmann & Reimer 32.6   Homosalate Eusolex HMS Merck KGaA 33.2   Isoamyl-p-Methoxycinnamate Neo Heliopan E-1000 Haarmann & Reimer 34.2    Ricinus Communis  Castor Oil Ph, Europa Gustav Heess Oleochem. 34.6       Erzeugnisse GmbH   Octocrylene Uvinul N-539 T BASF AG 35.7   Dimethyl Isosorbide Arlasolve DMI Uniquema        

     Particularly advantageous oil components according to the invention are UV filter substances liquid at room temperature, such as, for example, homomenthyl salicylate (INCI: Homosalate), 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (INCI: Octocrylene), 2-ethylhexyl 2-hydroxybenzoate (2-ethylhexyl salicylate, octyl salicylate, INCI: Octyl Salicylate) and esters of cinnamic acid, preferably 2-ethylhexyl 4-methoxycinnamate (INCI: Octyl Methoxycinnamate), isopentyl 4-methoxycinnamate (INCI: Isoamyl p-Methoxycinnamate), and 3-(4-(2,2-bisethoxycarbonylvinyl)phenoxy)propenyl)methoxy-silane/dimethylsiloxane copolymer, which is available, for example, under the trade name ParsolÂ® SLX from Hoffmann La Roche. 
     Also particularly advantageous for the purposes of the present invention are [trade names in brackets]: Diethylhexyl 2,6-naphthalate [Hallbrite (Corapan) TQ], C12-15-alkyl benzoate [Tegesoft TN], butylene glycol dicaprylate/dicaprate [Dermofeel BGC], butyloctyl salicylate [Hallbrite BHB], tridecyl trimellitate [Liponate TDTM], cocoglyceride [Myritol 331]. 
     The content of the lipid phase (without UV filter substances, but with any emulsifiers present) is at least 5.0% by weight, preferably between 5.0 and 95% by weight, particularly preferably between 5 and 80% by weight, in each case based on the total weight of the preparation. It is in some instances also advantageous, but not obligatory, when the lipid phase comprises up to 50% by weightâbased on the total weight of the lipid phaseâof lipids with a surface tension of >37 mN/m. 
     The lipids with a surface tension >37 mN/m are advantageously chosen from one of the following groups: 
      natural oils, such as, for example, olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, wheatgerm oil, grapeseed oil, thistle oil, evening primrose oil, macadamia nut oil, jojoba oil   synthetic or semisynthetic lipids, such as, for example, octyl palmitate, octyl cocoate, octyidodecyl myristate, octyldodecanol, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, stearyl heptanoate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, tridecyl stearate, dicaprylyl ether, dicaprylyl carbonate, isoeicosane, neopentyl glycol diheptanoate, dimethyl isosorbide, isohexanedecane, mineral oils, vaseline (petrolatum), squalane and squalene, polyolefins, hydrogenated polyisobutenes.    
    Further advantageous lipids or lipid phase components with a surface tension >37 mN/m are cyclic or linear silicone oils. 
     Silicone oils are high molecular weight synthetic polymeric compounds in which silicon atoms are joined in a chain-like or reticular manner via oxygen atoms and the remaining valences of the silicon are saturated by hydrocarbon radicals (in most cases methyl, less often ethyl, propyl, phenyl groups etc.). Systematically, the silicone oils are referred to as polyorganosiloxanes. The methyl-substituted polyorganosiloxanes, which are the most important compounds of this group in terms of amount and are characterized by the following structural formula  
        

 are also referred to as polydimethylsiloxane or Dimethicone (INCI). Dimethicones have various chain lengths and various molecular weights. 

     Particularly advantageous polyorganosiloxanes for the purposes of the present invention are, for example, dimethylpolysiloxanes [poly(dimethylsiloxane)], which are available, for example, under the trade names Abil 10 to 10 000 from Th. Goldschmidt. Also advantageous are phenylmethylpolysiloxanes (INCI: Phenyl Dimethicone, Phenyl Trimethicone), cyclic silicones (octamethylcyclotetrasiloxane and decamethylcyclopentasiloxane), which are also referred to in accordance with INCI as Cyclomethicone, amino-modified silicones (INCI: Amodimethicone) and silicone waxes, e.g. polysiloxane-polyalkylene copolymers (INCI: Stearyl Dimethicone) and dialkoxydimethylpolysiloxanes (Stearoxy Dimethicone and Behenoxy Stearyl Dimethicone), which are available as various Abil wax grades from Th. Goldschmidt. However, other silicone oils can also be used advantageously for the purposes of the present invention, for example hexamethylcyclotrisiloxane, polydimethylsiloxane, poly(methylphenylsiloxane). 
     Besides comprising one or more oil phases, the preparations for the purposes of the present invention may preferably additionally comprise one or more water phases and be present, for example, in the form of W/O, O/W W/O/W or O/W/O emulsions. Such formulations can preferably also be microemulsions, sticks, mousses, solids emulsions (i.e. emulsions which are stabilized by solids, e.g. Pickering emulsions), sprayable emulsions or hydrodispersions. Furthermore, the preparations may advantageously also be oil-free or aqueous/alcoholic solutions. 
   Sprayable Emulsions, in Particular Microemulsions 
     For the purposes of the present invention, sprayable O/W emulsions, in particular O/W microemulsions, are particularly advantageous. 
     The droplet diameters of the customary âsimpleâ, i.e. non-multiple, emulsions are in the range from about 1 Î¼m to about 50 Î¼m. Such âmacroemulsionsâ are, without further coloring additives, multi-white in color and opaque. Finer âmacroemulsionsâ, the droplet diameters of which are in the range from about 0.5 Î¼m to about 1 Î¼m, are, again without coloring additives, bluish-white in color and opaque. Such âmacroemulsionsâ usually have a high viscosity. 
     The droplet diameter of microemulsions for the purposes of the present invention, by contrast, is in the range from about 50 to about 500 nm. Such microemulsions are bluish-white in color to translucent and in most cases of low viscosity. The viscosity of many microemulsions of the O/W type is comparable with that of water. 
     An advantage of microemulsions is that active ingredients can be present in an essentially more finely disperse form in the disperse phase than in the disperse phase of âmacroemulsionsâ. A further advantage is that, due to their low viscosity, they are sprayable. If microemulsions are used as cosmetics, corresponding products are characterized by high cosmetic elegance. 
     Advantageous according to the invention are, in particular, O/W microemulsions which are obtainable using the so-called phase-inversion temperature technology and comprise at least one emulsifier (emulsifier A), which is chosen from the group of emulsifiers with the following properties: 
      their lipophilicity is dependent on the temperature, such that by increasing the temperature the lipophilicity increases, and by reducing the temperature the lipophilicity of the emulsifier decreases.    
    Advantageous emulsifiers A are, for example, polyethoxylated fatty acids (PEG-100 stearate, PEG-20 stearate, PEG-150 laurath, PEG-8 distearate and the like), polyethoxylated fatty alcohols (cetearath-12, cetearath-20, isoceteth-20, beheneth-20, laureth-9 etc.) and alkyl polyglycosides (cetearyl glycoside, stearyl glycoside, palmityl glycoside etc.). 
     If the phase inversion is triggered essentially by varying the temperature, O/W emulsions, in particular O/W microemulsions, are obtainable where the size of the oil droplets is determined essentially by the concentration of the emulsifier or the emulsifiers used, in such a way that a higher emulsifier concentration results in relatively small droplets, and a lower emulsifier concentration results in relatively large droplets. The droplet sizes are usually between 20 and 500 nm. 
     For the purposes of the present invention, it is in some instances advantageous to use further W/O or O/W emulsifiers which do not fall under the definition of emulsifer A, for example in order to increase the water resistance of the preparations according to the invention. For example, alkylmethicone copolyols or alkyldimethicone copolyols (in particular cetyl dimethicone copolyol, lauryl methicone copolyol), W/O emulsifiers (such as, for example, sorbitan stearate, glyceryl stearate, glycerol stearate, sorbitan oleate, lecithin, glyceryl isostearate, polyglyceryl-3 oleate, polyglyceryl-3 diisostearate, PEG-7 hydrogenated castor oil, polyglyceryl-4 isostearate, acrylate/C10-30-alkyl acrylate crosspolymer, sorbitan isostearate, poloxamer 101, polyglyceryl-2 dipolyhydroxy-stearate, polyglyceryl-3 diisostearate, polyglyceryl-4 dipolyhydroxystearate, PEG-30 dipolyhydroxystearate, diisostearoyl polyglyceryl-3 diisostearate, glycol distearate, polyglyceryl-3 dipolyhydroxystearate) or fatty acid esters of sulfuric acid or phosphoric acid (cetyl phosphate, trilaureth-4 phosphate, trioleth-8 phosphate, stearyl phosphate, cetearyl sulfate etc.) can be used. 
     Further advantageous sprayable O/W emulsions for the purposes of the present invention are low-viscosity cosmetic or dermatological hydrodispersions which comprise at least one oil phase and at least one water phase, where the preparation is stabilized by at least one gel former and does not necessarily have to comprise emulsifiers, but may comprise one or more emulsifiers. 
     Advantageous gel formers for such preparations are, for example, copolymers of C10-30-alkyl acrylates and one or more monomers of acrylic acid, of methacrylic acid or esters thereof. The INCI name for such compounds is âAcrylates/C10-30 Alkyl Acrylate Crosspolymerâ. The PemulenÂ® grades TR1, TR2 and TRZ from Goodrich (Noveon) are particularly advantageous. 
     Carbopols are also advantageous gel formers for such preparations. Carbopols are polymers of acrylic acid, in particular also acrylate-alkyl acrylate copolymers. Advantageous carbopols are, for example, the grades 907, 910, 934, 940, 941, 951, 954, 980, 981, 1342, 1382, 2984 and 5984, likewise the ETD grades 2020, 2050 and Carbopol Ultrez 10. Further advantageous gel formers for such preparations are xanthan gum, cellulose derivatives and carob seed flour. 
     Possible (optional) emulsifiers which may be used are ethoxylated fatty alcohols or ethoxylated fatty acids (in particular PEG-100 stearate, ceteareth-20) and other nonionic surface-active substances. 
     The very low-viscosity to sprayable emulsions may also advantageously be W/O emulsions or water-in-silicone oil (W/S) emulsions. W/O or W/S emulsions which comprise 
      at least one silicone emulsifier (W/S) with a HLB value of â¦8 or at least one W/O emulsifier with a HLB value of <7 and   at least one O/w emulsifier with a HLB value of >10 

 are particularly advantageous. 
   
    Such preparations further comprise at least 20% by weight of lipids, where the lipid phase can also advantageously comprise silicone oils, or even consist entirely of such oils. 
     The silicone emulsifier or emulsifiers can advantageously be chosen from the group of alkyl methicone copolyols or alkyldimethicone copolyols (e.g. dimethicone copolyols which are sold by Goldschmidt AG under the trade names AbilÂ® B 8842, AbilÂ® B 8843, AbilÂ® B8847, AbilÂ® B 8851, AbilÂ® B 8852, AbilÂ® B 8863, AbilÂ® B 8873 and AbilÂ® B 88183, cetyl dimethicone copolyol [Goldschmidt AG/AbilÂ® EM 90], cyclomethicone dimethicone copolyol [Goldschmidt AG/AbilÂ® EM 97], lauryl methicone copolyol [Dow Corning Ltd./Dow CorningÂ® 5200 Formulation Aid], octyl dimethicone ethoxyglucoside [Wacker]). 
     The W/O emulsifier or emulsifiers with a HLB value of <7 can advantageously be chosen from the following group: sorbitan stearate, sorbitan oleate, lecithin, glyceryl lanolate, lanolin, hydrogenated castor oil, glyceryl isostearate, polyglyceryl-3 oleate, pentaerythrityl isostearate, methylglucose dioleate, methylglucose dioleate in a mixture with hydroxystearate and beeswax, PEG-7 hydrogenated castor oil, polyglyceryl-4 isostearate, hexyl laurate, acrylate/C10-30-alkyl acrylate crosspolymer, sorbitan isostearate, poloxamer 101, polyglyceryl-2 dipolyhydroxystearate, polyglyceryl-3 diisostearate, PEG-30 dipolyhydroxystearate, diisostearoyl polyglyceryl-3 diisostearate, polyglyceryl-3 dipolyhydroxystearate, polyglyceryl-4 dipolyhydroxystearate, polyglyceryl-3 dioleate. 
     The O/W emulsifier or emulsifiers with a HLB value of >10 can advantageously be chosen from the following group: glyceryl stearate in a mixture with ceteareth-20, ceteareth-25, ceteareth-6 in a mixture with stearyl alcohol, cetylstearyl alcohol in a mixture with PEG-40 castor oil and sodium cetylstearyl sulfate, triceteareth-4 phosphate, glyceryl stearate, sodium cetylstearyl sulfate, lecithin trilaureth-4 phosphate, laureth-4 phosphate, stearic acid, propylene glycol stearate SE, PEG-9 stearate, PEG-20 stearate, PEG-30 stearate, PEG-40 stearate, PEG-100 stearate, ceteth-2, ceteth-20, polysorbate-20, polysorbate-60, polysorbate-65, polysorbate-100, glyceryl stearate in a mixture with PEG-100 stearate, ceteareth-3, isostearyl glyceryl ether, cetylstearyl alcohol in a mixture with sodium cetylstearyl sulfate, PEG-40 stearate, glycol distearate, PEG-22 dodecyl glycol copolymer, polyglyceryl-2 PEG-4 stearate, ceteareth-12, ceteareth-20, ceteareth-30, methylglucose sesquistearate, steareth-10, PEG-20 stearate, steareth-21, steareth-20, isosteareth-20, PEG-45/dodecyl glycol copolymer, methoxy-PEG-22/dodecyl glycol copolymer, glyceryl stearate SE, ceteth-20, PEG-20 methylglucose sesquistearate, glyceryl stearate citrate, cetyl phosphate, cetearyl sulfate, sorbitan sesquioleate, triceteareth-4 phosphate, trilaureth-4 phosphate, polyglyceryl methylglucose distearate, potassium cetyl phosphate, isosteareth-10, polyglyceryl-2 sesquiisostearate, ceteth-10, isoceteth-20, glyceryl stearate in a mixture with ceteareth-20, ceteareth-12, cetylstearyl alcohol and cetyl palmitate, PEG-30 stearate, PEG-40 stearate, PEG-100 stearate. 
     Aqueous-alcoholic solutions are also advantageous. They can comprise from 0% by weight to 90% by weight of ethanol. Aqueous-alcoholic solutions for the purposes of the present invention may advantageously also comprise solubility promoters, such as, for example, PEG-40 or PEG-60 hydrogenated castor oil. 
     The preparations according to the invention can advantageously also be used as cosmetic or dermatological impregnation solutions with which water-insoluble substrates in particularâsuch as, for example, woven or nonwoven wipesâare moistened. Impregnation solutions of this type are preferably of low viscosity, in particular sprayable (such as, for example, PIT emulsions, hydrodispersions, W/O emulsions, oils (see below), aqueous solutions etc.) and preferably have a viscosity of less than 2000 mPaÂ·s, in particular less than 1500 mPaÂ·s (measuring device: Haake Viskotester VT-02 at 25Â° C.). They can be used to obtain, for example, cosmetic sunscreen wipes, care wipes and the like, which represent the combination of a soft, water-insoluble material with the low viscosity cosmetic and dermatological impregnation solution. 
   Oils 
     The preparations according to the invention can advantageously also be in the form of water-free oils or oil gels or pastes. Oil gel formers which may be used are diverse waxes with a melting point >25Â° C. Also advantageous are gel formers from the group of Aerosils, of alkyl galactomannans (e.g. N-Hance AG 200 and N-Hance AG 50 from Hercules) and polyethylene derivatives. 
   Mousses 
     Also particularly advantageous for the purposes of the present invention are self-foaming, foam-like, after-foaming or foamable cosmetic and dermatological preparations. 
     âSelf-foamingâ, âfoam-likeâ, âafter-foamingâ and âfoamableâ preparations are understood as meaning preparations from which foams can in principle be produced by introducing one or more gasesâwhether during the preparation process, whether upon use by the consumer or in another way. In such foams, the gas bubbles are (randomly) distributed in one (or more) liquid phase(s), where the (foamed) preparations do not necessarily have to have the appearance of a foam in macroscopic terms. Cosmetic or dermatological preparations (foamed) according to the invention (referred to below for the sake of simplicity also as foams) may, for example, be macroscopically visibly dispersed systems of gases dispersed in liquids. The foam character may, however, for example also only be visible under a (light) microscope. Moreover, foams according to the inventionâparticularly when the gas bubbles are too small to be seen under a light microscopeâare also evident from the considerable volume increase of the system. 
     For the purposes of the present invention, such preparations advantageously comprise an emulsifier system which consists of 
    A. at least one emulsifier chosen from the group of completely neutralized, partially neutralized or unneutralized, branched or unbranched, saturated or unsaturated fatty acids with a chain length of from 10 to 40 carbon atoms,   B. at least one emulsifier chosen from the group of polyethoxylated fatty acid esters with a chain length of from 10 to 40 carbon atoms and with a degree of ethoxylation of from 5 to 100 and   C. at least one coemulsifier C chosen from the group of saturated or unsaturated, branched or unbranched fatty alcohols with a chain length of from 10 to 40 carbon atoms.  
    The emulsifier or emulsifiers A are preferably chosen from the group of fatty acids, which are completely or partially neutralized with customary alkalis (such as, for example, sodium hydroxide or potassium hydroxide, sodium carbonate or potassium carbonate, and mono- or triethanolamine). Stearic acid and stearates, isostearic acid and isostearates, palmitic acid and palmitates, and myristic acid and myristates, for example, are particularly advantageous. 
     The emulsifier or emulsifiers B are preferably chosen from the following group: PEG-9 stearate, PEG-8 distearate, PEG-20 stearate, PEG-8 stearate, PEG-8 oleate, PEG-25 glyceryl trioleate, PEG-40 sorbitan lanolate, PEG-15 glyceryl ricinoleate, PEG-20 glyceryl stearate, PEG-20 glyceryl isostearate, PEG-20 glyceryl oleate, PEG-20 stearate, PEG-20 methylglucose sesquistearate, PEG-30 glyceryl isostearate, PEG-20 glyceryl laurate, PEG-30 stearate, PEG-30 glyceryl stearate, PEG-40 stearate, PEG-30 glyceryl laurate, PEG-50 stearate, PEG-100 stearate, PEG-150 laurate. Polyethoxylated stearic esters, for example, are particularly advantageous. 
     According to the invention, the coemulsifier or the coemulsifiers C are preferably chosen from the following group: behenyl alcohol (C22H45OH), cetearyl alcohol [a mixture of cetyl alcohol (C16H33OH) and stearyl alcohol (C18H37OH)], lanolin alcohols (wool wax alcohols which are the unsaponifiable alcohol fraction of wool wax which is obtained following saponification of wool wax). Cetyl and cetylstearyl alcohol are particularly preferred. 
     It is advantageous according to the invention to choose the weight ratios of emulsifier A to emulsifier B to emulsifier C (A:B:C) as a:b:c, where a, b and c, independently of one another, may be rational numbers from 1 to 5, preferably from 1 to 3. A weight ratio of, for example, 1:1:1 is particularly preferred. 
     For the purposes of the present invention, it is advantageous to choose the total amount of the emulsifiers A and B and of coemulsifier C from the range from 2 to 20% by weight, advantageously from 5 to 15% by weight, in particular from 7 to 13% by weight, in each case based on the total weight of the formulation. 
   Pickering/Solids-Stabilized Emulsions 
     Also particularly advantageous for the purposes of the present invention are cosmetic or dermatological preparations which have been stabilized only by very finely divided solids particles. Such âemulsifier-freeâ emulsions are also referred to as Pickering emulsions. 
     In Pickering emulsions, the solid material accumulates at the oil/water interface in the form of a layer, as a result of which coalescence of the disperse phases is prevented. Of essential importance here are, in particular, the surface properties of the solids particles, which should exhibit both hydrophilic and also lipophilic properties. 
     The stabilizing solids particles can also advantageously be treated (âcoatedâ) to repel water, the intention being to form or retain an amphiphilic character of these solids particles. The surface treatment can consist in providing the solids particles with a thin hydrophobic or hydrophilic coat by processes known per se. 
     The average particle diameter of the microfine solids particles used as stabilizer is preferably chosen to be less than 100 Î¼m, particularly advantageously less than 50 Î¼m. In this connection, it is essentially unimportant in what form (platelets, rods, spheres, etc.) or modifications the solids particles used are present. 
     The microfine solids particles are preferably chosen from the group of amphiphilic metal oxide pigments. In particular, 
      titanium dioxides (coated and uncoated): e.g. Eusolex T-2000 from Merck, titanium dioxide MT-100 Z from Tayca Corporation   zinc oxides, e.g. Z-Cote and Z-Cote HP1 from BASF AG, MZ-300, MZ-500 and MZ-505M from Tayca Corporation   iron oxides 

 are advantageous. 
   
    Furthermore, it is advantageous when the microfine solids particles are chosen from the following group: boron nitrides, starch derivatives (tapioca starch, sodium corn starch octynyl succinate etc.), talc, latex particles. 
     It is advantageous according to the invention when the solids-stabilized emulsions comprise significantly less than 0.5% by weight of one or more emulsifiers or are even entirely emulsifier-free. 
   Sticks 
     Also advantageous for the purposes of the invention are preparations in the form of sticks. Viewed technically, most stick formulations are anhydrous fatty mixtures of solid or semisolid waxes and liquid oils, where highly purified paraffin oils and paraffin waxes are the stick base. 
     Customary bases for stick preparations are, for example, liquid oils (such as, for example, paraffin oils, castor oil, isopropyl myristate, C12-15 alkyl benzoate), semisolid constituents (e.g. vaseline, lanolin), solid constituents (e.g. beeswax, ceresin and microcrystalline waxes and ozokerite) or high-melting waxes (e.g. carnauba wax, candelilla wax). Water-containing stick preparations are also known per se, it being possible for these also to be present in the form of W/O emulsions. 
     The cosmetic or dermatological light protection formulations according to the invention can have the customary composition and be used for cosmetic or dermatological light protection, and also for the treatment, care and cleansing of the skin or of the hair and as a make-up product in decorative cosmetics. 
     Depending on their formulation, cosmetic or topical dermatological compositions for the purposes of the present invention can, for example, be used as skin protection cream, cleansing milk, day or night cream etc. It is optionally possible and advantageous to use the compositions according to the invention as a base for pharmaceutical formulations. 
     For use, the cosmetic and dermatological preparations are applied to the skin or the hair in an adequate amount in the manner customary for cosmetics. 
     The cosmetic and dermatological preparations according to the invention can comprise cosmetic auxiliaries as are customarily used in such preparations, e.g. preservatives, preservative aids, complexing agents, bactericides, perfumes, substances for preventing or increasing foaming, dyes, pigments which have a coloring action, thickeners, moisturizing or humectant substances, fillers which improve the feel on the skin, fats, oils, waxes or other customary constituents of a cosmetic or dermatological formulation, such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives. 
     Advantageous preservatives for the purposes of the present invention are, for example, formaldehyde donors (such as, for example, DMDM hydantoin, which is available, for example, under the trade name Glydanâ¢ from Lonza), iodopropyl butylcarbamates (e.g. those available under the trade names Glycacil-L, Glycacil-S from Lonza, or Dekaben LMB from Jan Dekker), parabens (i.e. alkyl p-hydroxybenzoates, such as methyl-, ethyl-, propyl- or butylparaben), phenoxyethanol, ethanol, benzoic acid and the like. In addition, the preservative system according to the invention also usually advantageously comprises preservative aids, such as, for example, octoxyglycerol, glycine soya etc. 
     Advantageous complexing agents for the purposes of the present invention are, for example, EDTA, [S,S]-ethylenediamine disuccinate (EDDS), which is available, for example, under the trade name Octaquest from Octel, pentasodium ethylenediamine tetramethylenephosphonate, which is available, for example, under the trade name Dequest 2046 from Monsanto and iminodisuccinic acid, which is available, inter alia, from Bayer AG under the trade names Iminodisuccinate VP OC 370 (about 30% strength solution) and Baypure CX 100 solid. 
     Particularly advantageous preparations are also obtained when antioxidants are used as additives or active ingredients. According to the invention, the preparations advantageously comprise one or more antioxidants. Favorable, but nevertheless optional, antioxidants which may be used are all antioxidants customary or suitable for cosmetic or dermatological applications. 
     For the purposes of the present invention, water-soluble antioxidants may be used particularly advantageously, such as, for example, vitamins, e.g. ascorbic acid and derivatives thereof. 
     Preferred antioxidants are also vitamin E and derivatives thereof, and vitamin A and derivatives thereof. 
     The amount of antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 0.1 to 10% by weight, based on the total weight of the preparation. 
     If vitamin E or derivatives thereof are the antioxidant or the antioxidants, it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation. 
     If vitamin A or vitamin A derivatives, or carotenes or derivatives thereof are the antioxidant or the antioxidants, it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation. 
     It is particularly advantageous when the cosmetic preparations according to the present invention comprise cosmetic or dermatological active ingredients, preferred active ingredients being antioxidants which can protect the skin against oxidative stress. 
     Further advantageous active ingredients for the purposes of the present invention are natural active ingredients or derivatives thereof, such as, for example, Î±-lipoic acid, phytoene, D-biotin, coenzyme Q10, Î±-glucosylrutin, carnitine, carnosine, natural or synthetic isoflavonoids, creatine, taurine or Î²-alanine, and 8-hexadecene-1,16-dicarboxylic acid (dioic acid, CAS number 20701-68-2; provisional INCI name Octadecenedioic acid). 
     Formulations according to the invention which comprise, for example, known antiwrinkle active ingredients, such as flavone glycosides (in particular Î±-glycosylrutin), coenzyme Q10, vitamin E and derivatives and the like are particularly advantageously suitable for the prophylaxis and treatment of cosmetic or dermatological changes in the skin, as arise, for example, during the skin aging (such as, for example, dryness, roughness and formation of dryness wrinkles, itching, reduced refatting (e.g. after washing), visible vascular dilations (telangiectases, cuperosis), flaccidity and formation of wrinkles and lines, local hyperpigmentation, hypopigmentation and incorrect pigmentation (e.g. age spots), increased susceptibility to mechanical stress (e.g. cracking) and the like). In addition, they are advantageously suitable to counter the appearance of dry or rough skin. 
     The water phase of the preparations according to the invention can advantageously comprise customary cosmetic auxiliaries, such as, for example, alcohols, in particular those of low carbon number, preferably ethanol and/or isopropanol, diols or polyols of low carbon number, and ethers thereof, preferably propylene glycol, glycerol, butylene glycol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products, polymers, foam stabilizers, electrolytes, and in particular one or more thickeners, which may advantageously be chosen from the group consisting of silicon dioxide, aluminum silicates or polysaccharides or derivatives thereof, e.g. hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose, particularly advantageously from the group of polyacrylates, preferably a polyacrylate from the group of so-called Carbopols [from Bf. Goodrich], for example carbopol grades 980, 981, 1382, 2984, 5984, ETD 2020, ETD 2050, Ultrez 10, in each case individually or in combination. 
     In addition, the preparations according to the invention can advantageously also comprise self-tanning substances, such as, for example, dihydroxyacetone or melanin derivatives in concentrations of from 1% by weight to 8% by weight, based on the total weight of the preparation. 
     In addition, the preparations according to the invention can advantageously also comprise repellents for protection against flies, ticks and spiders and the like. For example, N,N-diethyl-3-methylbenzamide (trade name: Meta-delphene, âDEETâ), dimethyl phthalate (trade name: Palatinol M, DMP) and in particular ethyl 3-(N-n-butyl-N-acetylamino)propionate (available under the trade name Insekt RepellentÂ® 3535 from Merck). The repellents can either be used individually or in combination. 
     Moisturizers is the term used to refer to substances or mixtures of substances which impart to cosmetic or dermatological preparations the property, following application or distribution on the surface of the skin, of reducing moisture release by the horny layer (also called trans-epidermal water loss (TEWL)) or of positively influencing hydration of the horny layer. 
     Advantageous moisturizers for the purposes of the present invention are, for example, glycerol, lactic acid, and lactates, in particular sodium lactate, butylene glycol, propylene glycol, biosaccharide gum-1, glycine soya, ethylhexyloxyglycerol, pyrrolidone-carboxylic acid and urea. In addition, it is particularly advantageous to use polymeric moisturizers from the group of water-soluble or water-swellable or water-gelable polysaccharides. Hyaluronic acid, chitosan, and a fucose-rich polysaccharide, which is filed in the Chemical Abstracts under the registry number 178463-23-5 and which is available, for example, under the name FucogelÂ® 1000 by SOLABIA S.A., for example, are particularly advantageous. Moisturizers can advantageously also be used as anti-wrinkle active ingredients for the prophylaxis and treatment of cosmetic or dermatological changes in the skin, as arise, for example, during skin aging. 
     The cosmetic or dermatological preparations according to the invention can also advantageously, but not necessarily, comprise fillers, which, for example, further improve the sensory and cosmetic properties of the formulations and, for example, bring about or enhance a velvety or silky feel on the skin. Advantageous fillers for the purposes of the present invention are starch and starch derivatives (such as, for example, tapioca starch, distarch phosphate, aluminum or sodium starch octenylsuccinate and the like), pigments which have neither a primarily UV filter effect nor a coloring effect (such as, for example, boron nitride etc.), and AerosilsÂ® (CAS No. 7631-86-9). 
     The preparations according to the invention can also advantageously comprise one or more substances from the following group of siloxane elastomers, for example in order to increase the water resistance or the light protection factor of the products: 
    (a) siloxane elastomers which contain the units R2SiO and RSiO1.5 or R3SiO0.5 or SiO2, 
      where the individual radicals R, in each case independently of one another, are hydrogen, C1-24-alkyl (such as, for example, methyl, ethyl, propyl) or aryl (such as, for example, phenyl or tolyl), alkenyl (such as, for example, vinyl), and the weight ratio of the units R2SiO to RSiO1.5 is chosen from the range from 1:1 to 30:1;  
  (b) siloxane elastomers which are insoluble and swellable in silicone oil and which are obtainable by the addition reaction of an organopolysiloxane (1) which contains silicon-bonded hydrogen with an organopolysiloxane (2) which contains unsaturated aliphatic groups, 
      where the quantitative amounts used are chosen such that the amount of hydrogen in the organopolysiloxane (1) or in the unsaturated aliphatic groups of the organopolysiloxane (2) 
          is in the range from 1 to 20 mol % when the organopolysiloxane is noncyclic and   is in the range from 1 to 50 mol % when the organopolysiloxane is cyclic.  
 
 
    For the purposes of the present invention, the siloxane elastomer or elastomers are advantageously present in the form of spherical powders or in the form of gels. 
     Siloxane elastomers present in the form of spherical powders which are advantageous according to the invention are those with the INCI name Dimethicone/Vinyl Dimethicone Crosspolymer, for example that available from DOW CORNING under the trade names DOW CORNING 9506 Powder. 
     It is particularly preferred when the siloxane elastomer is used in combination with oils from hydrocarbons of animal or vegetable origin, synthetic oils, synthetic esters, synthetic ethers or mixtures thereof. 
     It is very particularly preferred when the siloxane elastomer is used in combination with unbranched silicone oils which are liquid or pasty at room temperature or cyclic silicone oils or mixtures thereof. Organopolysiloxane elastomers with the INCI name Dimethicone/Polysilicone-11, very particularly the Gransil grades obtainable from Grant Industries Inc. GCM, GCM-5, DMG-6, CSE gel, PM-gel, LTX, ININ gel, AM-18 gel and DMCM-5 are particularly advantageous. 
     It is very extremely preferred when the siloxane elastomer is used in the form of a gel of siloxane elastomer and a lipid phase where the content of the siloxane elastomer in the gel is 1 to 80% by weight, preferably 0.1 to 60% by weight, in each case based on the total weight of the gel. 
     It is advantageous for the purposes of the present invention to choose the total amount of the siloxane elastomers (active content) from the range from 0.01 to 10% by weight, advantageously from 0.1 to 5% by weight, in each case based on the total weight of the formulation. 
     The cosmetic and dermatological preparations according to the invention can comprise dyes or color pigments, particularly when they are in the form of decorative cosmetics. The dyes and color pigments can be chosen from the corresponding positive list in the Cosmetics Directive or the EC list of cosmetic colorants. In most cases, they are identical to dyes approved for foods. Advantageous color pigments are, for example, titanium dioxide, mica, iron oxides (e.g. Fe2O3, Fe3O4, FeO(OH)) and tin oxide. Advantageous dyes are, for example, carmine, Prussian blue, chromium oxide green, ultramarine blue and manganese violet. It is particularly advantageous to choose the dyes or the color pigments from the Rowe Colour Index, 3 Edition, Society of Dyers and Colourists, Bradford, England, 1971. 
     If the formulations according to the invention are in the form of products which are used on the face, it is favorable to choose one or more substances from the following group as the dye: 2,4-dihydroxyazobenzene, 1-(2â²-chloro-4â²-nitro-1â²-phenylazo)-2-hydroxynaphthalene, Ceres red, 2-(sulfo-1-naphthylazo)-1-naphthol-4-sulfonic acid, calcium salt of 2-hydroxy-1,2â²-azonaphthalene-1â²-sulfonic acid, calcium and barium salts of 1-(2-sulfo-4-methyl-1-phenylazo)-2-naphthylcarboxylic acid, calcium salt of 1-(2-sulfo-1-naphthylazo)-2-hydroxynaphthalene-3-carboxylic acid, aluminum salt of 1-(4-sulfo-1-phenylazo)-2-naphthyl-6-sulfonic acid, aluminum salt of 1-(4-sulfo-1-naphthylazo)-2-naphthyl-3,6-disulfonic acid, 1-(4-sulfo-1-naphthylazo)-2-naphthol-6,8-disulfonic acid, aluminum salt of 4-(4-sulfo-1-phenylazo)-1-(4-sulfophenyl)-5-hydroxypyrazolone-3-carboxylic acid, aluminum and zirconium salts of 4,5-dibromofluorescein, aluminum and zirconium salts of 2,4,5,7-tetrabromofluorescein, 3â²,4â²,5â²,6â²-tetrachloro-2,4,5,7-tetrabromofluorescein and its aluminum salt, aluminum salt of 2,4,5,7-tetraiodofluorescein, aluminum salt of quinophthalonedisulfonic acid, aluminum salt of indigodisulfonic acid, red and black iron oxide (CIN: 77 491 (red) and 77 499 (black)), iron oxide hydrate (CIN: 77 492), manganese ammonium diphosphate and titanium dioxide. 
     Also advantageous are oil-soluble natural dyes, such as, for example, paprika extracts, Î²-carotene or cochineal. 
     Also advantageous for the purposes of the present invention are formulations with a content of pearlescent pigments. Preference is given in particular to the types of pearlescent pigments listed below: 
    1. Natural pearlescent pigments, such as, for example, 
      âpearlessenceâ (guanine/hypoxanthin mixed crystals from fish scales) and   âmother-of-pearlâ (ground mussel shells)  
  2. Monocrystalline pearlescent pigments, such as, for example, bismuth oxychloride (BiOCl)   3. Layer-substrate pigments: e.g. mica/metal oxide  
    Bases for pearlescent pigments are, for example, pulverulent pigments or castor oil dispersions of bismuth oxychloride or titanium dioxide, and bismuth oxychloride or titanium dioxide on mica. The luster pigment listed under CIN 77163, for example, is particularly advantageous. 
     Also advantageous are, for example, the following types of pearlescent pigments based on mica/metal oxide:  
             Group Coating/layer thickness Color        Silver-white pearlescent TiO2: 40-60 nm Silver   pigments   Interference pigments TiO2: 60-80 nm Yellow     TiO2: 80-100 nm Red     TiO2: 100-140 nm Blue     TiO2: 120-160 nm Green   Color luster pigments Fe2O3  Bronze     Fe2O3  Copper     Fe2O3  Red     Fe2O3  Red-violet     Fe2O3  Red-green     Fe2O3  Black   Combination pigments TiO2/Fe2O3  Gold shades     TiO2/Cr2O3  Green     TiO2/Prussian blue Deep blue     TiO2/carmine Red        

     Particular preference is given, for example, to the pearlescent pigments obtainable from Merck under the trade names Timiron, Colorona or Dichrona. 
     The list of given pearlescent pigments is not of course intended to be limiting. Pearlescent pigments which are advantageous for the purposes of the present invention are obtainable by numerous methods known per se. For example, other substrates apart from mica can be coated with further metal oxides, such as, for example, silica and the like. SiO2 particles coated with, for example, TiO2 and Fe2O3 (âronaspheresâ), which are sold by Merck and are particularly suitable for the optical reduction of fine lines, are suitable. 
     It can, moreover, be advantageous to dispense completely with a substrate such as mica. Particular preference is given to iron pearlescent pigments prepared without the use of mica. Such pigments are obtainable, for example, under the trade name Sicopearl Kupfer 1000 from BASF. 
     In addition, also particularly advantageous are effect pigments which are obtainable under the trade name Metasomes Standard/Glitter in various colors (yellow, red, green, blue) from Flora Tech. The glitter particles are present here in mixtures with various auxiliaries and dyes (such as, for example, the dyes with the Colour Index (CI) numbers 19140, 77007, 77289, 77491). 
     The dyes and pigments may be present either individually or in a mixture, and can be mutually coated with one another, different coating thicknesses generally giving rise to different color effects. The total amount of dyes and color-imparting pigments is advantageously chosen from the range from, for example, 0.1% by weight to 30% by weight, preferably from 0.5 to 15% by weight, in particular from 1.0 to 10% by weight, in each case based on the total weight of the preparations. 
     For the purposes of the present invention, it is also advantageous to provide cosmetic and dermatological preparations whose main purpose is not protection against sunlight, but which nevertheless have a content of further UV protection substances. Thus, for example, UV-A and/or UV-B filter substances are usually incorporated into daycreams or make-up products. UV protection substances, like antioxidants and, if desired, preservatives, also constitute effective protection of the preparations themselves against spoilage. Also favorable are cosmetic and dermatological preparations in the form of a sunscreen. 
     Accordingly, for the purposes of the present invention, the preparations preferably additionally comprise at least one further UV-A, UV-B, or broadband filter substance. The formulations can, but do not necessarily, optionally comprise one or more organic or inorganic pigments as UV filter substances, which may be present in the water phase and/or the oil phase. 
     In addition, the preparations according to the invention can also advantageously be in the form of so-called oil-free cosmetic or dermatological emulsions, which comprise a water phase and at least one UV filter substance which is liquid at room temperature as a further phase. 
     Preferred inorganic pigments are metal oxides or other metal compounds which are insoluble or sparingly soluble in water, in particular oxides of titanium (TiO2), zinc (ZnO), iron (e.g. Fe2O3), zirconium (ZrO2), silicon (SiO2), manganese (e.g. MnO), aluminum (Al2O3), cerium (e.g. Ce2O3), mixed oxides of the corresponding metals, and mixtures of such oxides, and also the sulfate of barium (BaSO4). 
     For the purposes of the present invention, the pigments may advantageously also be used in the form of commercially available oily or aqueous predispersions. Dispersion auxiliaries and/or solubility promoters may advantageously be added to these predispersions. 
     According to the invention, the pigments may advantageously be surface-treated (âcoatedâ), the intention being to form or retain, for example, a hydrophilic, amphiphilic or hydrophobic character. This surface treatment can consist in providing the pigments with a thin hydrophilic or hydrophobic inorganic or organic coat by methods known per se. For the purposes of the present invention, the various surface coatings may also comprise water. 
     Inorganic surface coatings for the purposes of the present invention may consist of aluminum oxide (Al2O3), aluminum hydroxide Al(OH)3, or aluminum oxide hydrate (also: alumina, CAS No.: 1333-84-2), sodium hexametaphosphate (NaPO3)6, sodium metaphosphate (NaPO3)n, silicon dioxide (SiO2) (also: silica, CAS No.: 7631-86-9), or iron oxide (Fe2O3). These inorganic surface coatings may be present on their own, in combination or in combination with organic coating materials. 
     Organic surface coatings for the purposes of the present invention may consist of vegetable or animal aluminum stearate, vegetable or animal stearic acid, lauric acid, dimethylpolysiloxane (also: Dimethicone), methylpolysiloxane (Methicone), simethicone (a mixture of dimethylpolysiloxane with an average chain length of from 200 to 350 dimethylsiloxane units and silica gel) or alginic acid. These organic surface coatings may be present on their own, in combination or in combination with inorganic coating materials. 
     Zinc oxide particles and predispersions of zinc oxide particles which are suitable according to the invention are obtainable under the following trade names from the companies listed:  
                   Trade name Coating Manufacturer            Z-Cote HP1 2% Dimethicone BASF     Z-Cote / BASF     ZnO NDM 5% Dimethicone H&R     MZ-303S 3% Methicone Tayca Corporation     MZ-505S 5% Methicone Tayca Corporation          

     Suitable titanium dioxide particles and predispersions of titanium dioxide particles are available under the following trade names from the companies listed:  
             Trade name Coating Manufacturer        MT-100TV Aluminum hydroxide/ Tayca Corporation     stearic acid   MT-100Z Aluminum hydroxide/ Tayca Corporation     stearic acid   Eusolex T-2000 Alumina/Simethicone Merck KgaA   Titanium dioxide Octyltrimethylsilane Degussa   T805 (Uvinul TiO2)   Tioveil AQ 10PG Alumina/Silica Solaveil/Uniquema   Eusolex T-aqua Water/alumina/sodium Merck     metaphosphate        

     Further advantageous pigments are latex particles. Latex particles advantageous according to the invention are those described in the following specifications: U.S. Pat. No. 5,663,213 and EP0 761 201. Particularly advantageous latex particles are those which are formed from water and styrene/acrylate copolymers and are available, for example, under the trade name âAlliance SunSphereâ from Rohm & Haas. 
     Advantageous UV-A filter substances for the purposes of the present invention are dibenzoylmethane derivatives, in particular 4-(tert-butyl)-4â²-methoxydibenzoyl-methane (CAS No. 70356-09-1), which is sold by Givaudan under the name ParsolÂ® 1789 and by Merck under the trade name EusolexÂ® 9020. 
     Further advantageous UV-A filter substances for the purposes of the present invention are hydroxybenzophenones which are characterized by the following structural formula:  
        

 in which 
      R1 and R2, independently of one another, are hydrogen, C1-C20-alkyl, C3-C10-cycloalkyl or C3-C10-cycloalkenyl, where the substituents R1 and R2, together with the nitrogen atom to which they are bonded, can form a 5-membered or 6-membered ring and   R3 is a C1-C20-alkyl radical.    
    A particularly advantageous hydroxybenzophenone for the purposes of the present invention is hexyl 2-(4â²-diethylamino-2â²-hydroxybenzoyl)benzoate (also: Aminobenzophenone), which is characterized by the following structure:  
        

 and is available under Uvinul A Plus from BASF. 

     Advantageous further UV filter substances for the purposes of the present invention are sulfonated, water-soluble UV filters, such as, for example: 
      Phenylene-1,4-bis(2-benzimidazyl)-3,3â²-5,5â²-tetrasulfonic acid and its salts, particularly the corresponding sodium, potassium or triethanolammonium salts, in particular the phenylene-1,4-bis(2-benzimidazyl)-3,3â²-5,5â²-tetrasulfonic acid bis-sodium salt with the INCI name Disodium Phenyl Dibenzimidazole Tetrasulfonate (CAS No.: 180898-37-7), which is available, for example, under the trade name Neo Heliopan AP from Haarmann & Reimer;   Salts of 2-phenylbenzimidazole-5-sulfonic acid, such as its sodium, potassium or its triethanolammonium salt, and the sulfonic acid itself with the INCI name Phenylbenzimidazole Sulfonic Acid (CAS No. 27503-81-7), which is available under the trade name Eusolex 232 from Merck, or under Neo Heliopan Hydro from Haarmann & Reimer;   1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)benzene (also: 3,3â²-(1,4-phenylene-dimethylene)bis(7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-ylmethanesulfonic acid) and salts thereof (particularly the corresponding 10-sulfato compounds, in particular the corresponding sodium, potassium or triethanolammonium salt), which is also referred to as benzene-1,4-di(2-oxo-3-bornylidenemethyl-10-sulfonic acid). Benzene-1,4-di(2-oxo-3-bornylidenemethyl-10-sulfonic acid) has the INCI name Terephthalidene Dicamphor Sulfonic Acid (CAS No.: 90457-82-2) and is available, for example, under the trade name Mexoryl SX from Chimex;   sulfonic acid derivatives of 3-benzylidenecamphor, such as, for example, 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid, 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid and salts thereof.    
    Advantageous UV filter substances for the purposes of the present invention are also so-called broadband filters, i.e. filter substances which absorb both UV-A and also UV-B radiation. 
     Advantageous broadband filters or UV-B filter substances are, for example, triazine derivatives, such as, for example, 
      2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxylphenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (INCI: BisEthylhexyloxyphenol Methoxyphenyl Triazine), which is available under the trade name TinosorbÂ® S from CIBA-Chemikalien GmbH;   dioctylbutylamidotriazone (INCI: Dioctylbutamidotriazone), which is available under the trade name UVASORB HEB from Sigma 3V;   Tris(2-ethylhexyl) 4,4â²,4â³-(1,3,5-triazine-2,4,6-triyltriimino)trisbenzoate, also: 2,4,6-tris[anilino(p-carbo-2â²-ethyl-1â²-hexyloxy)]-1,3,5-triazine (INCI: Octyl Triazone), which is sold by BASF Aktiengesellschaft under the trade name UVINULÂ® T 150;   2-[4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(octyloxy)phenol (CAS No.: 2725-22-6).    
    An advantageous broadband filter for the purposes of the present invention is also 2,2â²-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol), which is available under the trade name TinosorbÂ® M from CIBA-Chemikalien GmbH. 
     For the purposes of the present invention, an advantageous broadband filter is also 2-(2H-benzotriazol-2-yl]-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethyl-silyl)oxy]disiloxanyl]propyl]phenol (CAS No.: 155633-54-8) with the INCI name Drometrizole Trisiloxane. 
     The further UV filter substances may be oil-soluble or water-soluble. Advantageous oil-soluble filter substances are, for example: 
      3-benzylidenecamphor derivatives, preferably 3-(4-methylbenzylidene)camphor, 3-benzylidenecamphor;   4-aminobenzoic acid derivatives, preferably 2-ethylhexyl 4-(dimethyl-amino)benzoate, amyl 4-(dimethylamino)benzoate;   2,4,6-trianilino(p-carbo-2â²-ethyl-1â²-hexyloxy)-1,3,5-triazine;   esters of benzalmalonic acid, preferably di(2-ethylhexyl) 4-methoxybenzalmalonate;   esters of cinnamic acid, preferably 2-ethylhexyl 4-methoxycinnamate, isopentyl 4-methoxycinnamate;   derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4â²-methylbenzophenone, 2,2â²-dihydroxy-4-methoxy-benzophenone and   UV filters bonded to polymers.    
    Advantageous water-soluble filter substances are, for example: 
    Sulfonic acid derivatives of 3-benzylidenecamphor, such as, for example, 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid, 2-methyl-5-(2-oxo-3-bornylidene-methyl)sulfonic acid and salts thereof.  
    A further light protection filter substance to be used advantageously according to the invention is ethylhexyl 2-cyano-3,3-diphenylacrylate (octocrylene), which is available from BASF under the name UvinulÂ® N 539 T. 
     Besides the filter substance(s) according to the invention, particularly advantageous preparations for the purposes of the present invention which are characterized by high or very high UV-A protection preferably also comprise further UV-A or broadband filters, in particular dibenzoylmethane derivatives [for example 4-(tert-butyl)-4â²-methoxydibenzoylmethane] or 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine or phenylene-1,4-bis(2-benzimidazyl)-3,3â²-5,5â²-tetrasulfonic acid bis-sodium salt, in each case individually or in any combinations with one another. 
     The list of given UV filters which can be used for the purposes of the present invention is not of course intended to be limiting. 
     The preparations according to the invention advantageously comprise the substances which absorb UV radiation in the UV-A and/or UV-B region in a total amount of, for example, from 0.1% by weight to 30% by weight, preferably from 0.5 to 20% by weight, in particular 1.0 to 15.0% by weight, in each case based on the total weight of the preparations, in order to provide cosmetic preparations which protect the hair or the skin from the entire range of ultraviolet radiation. 
     In addition, it may in some instances be advantageous to incorporate film formers into the cosmetic or dermatological preparations according to the invention, for example in order to improve the water resistance of the preparations, or to increase the UV protection performance (UV-A and/or UV-B boosting). Both water-soluble or dispersible and also fat-soluble film formers are suitable, in each case individually or in combination with one another. 
     Advantageous water-soluble or dispersible film formers are, for example, polyurethanes (e.g. the AvalureÂ® grades from Goodrich), Dimethicone Copolyol Polyacrylate (Silsoft SurfaceÂ® from the Witco Organa Silicones Group), PVP/VA (VA=vinyl acetate) copolymer (Luviscol VA 64 Powder from BASF), C20-40 carboxylic acid with polyethylene (Performacid 350 from New Phase Technologies) etc. 
     Advantageous fat-soluble film formers are, for example, the film formers from the group of polymers based on polyvinylpyrrolidone (PVP)  
        

     Particular preference is given to copolymers of polyvinylpyrrolidone, for example the PVP hexadecene copolymer and the PVP eicosene copolymer, which are available under the trade names Antaron V216 and Antaron V220 from GAF Chemicals Cooperation, and also Tricontayl PVP and the like. 
     The examples below are intended to illustrate the present invention without limiting it. The numerical values in the examples are percentages by weight, based on the total weight of the respective preparations. 
 EXAMPLES 
    In the following examples:  
             1. O/W sunscreen emulsions              UVASorbâÂ® K2A = 2,4-bis[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-ethylhexyl)imino-1,3,5-triazine   [CAS No. 288254-16-0]   UvinulâÂ® A Plus = hexyl 2-(4â²-diethylamino-2â²-hydroxybenzoyl)benzoate (also: aminobenzophenone)           1 2 3 4 5 6 7           Glycerol monostearate SE 0.50 1.00 3.00     1.50     Glyceryl stearate citrate 2.00     1.00 2.00   2.50   Stearic acid   3.00 0.75 2.00   PEG-40 Stearate 0.50         2.00   PEG-100 Stearate     1.50   Cetyl dimethicone copolyol       0.75   0.50   Cetyl phosphate     0.75   1.00   Stearyl alcohol     3.00     2.00 0.50   Cetyl alcohol 2.50 1.00     0.50   2.00   UVASorbâÂ® K2A 1.00 2.50 3.00 4.00 1.50 5.00 1.00   Phenylbenzimidazolesulfonic acid   0.50     1.00   0.50   Disodium phenyl dibenzimidazole- 2.50 1.00         1.00   tetrasulfonate   Terephthalidenedicamphorsulfonic acid       0.50     0.50   Butylmethoxydibenzoylmethane         2.00   1.00   UvinulâÂ® A Plus   1.00   Bisethylhexyloxyphenol   1.50         2.50   methoxyphenyltriazine   Ethylhexyltriazone 2.00     2.00 4.00 2.00   Diethylhexylbutamidotriazone   2.00   Ethylhexyl methoxycinnamate   3.50   10.00   Octocrylene   5.00 9.00 7.50     2.50   Methylenebisbenztriazolyl 2.00   0.50   tetramethylbutylphenol   Homosalate   2.00   Ethylhexyl salicylate     3.00       5.00   Drometrizoltrisiloxane     0.5     1.00   Titanium dioxide T 805   1.50     1.00 0.50   Titanium dioxide MT-100Z 1.00     3.00 1.00   Zinc oxide NDM     1.50       3.00   C12-15 alkyl benzoate   2.50       7.00 5.00   Dicaprylyl ether     3.50   2.00   Butylene glycol dicaprylate/dicaprate 5.00   Tridecyl trimellitate     6.00     2.00 2.00   Butyloctyl salicylate   0.50     5.00   Cyclomethicone 2.00     4.50     0.50   Shea butter   2.00         0.50   PVP hexadecene copolymer 0.50     0.50 1.00   1.00   PerformacidâÂ® 350     0.75   Glycerol 3.00 7.50   7.50 5.00   2.50   Xanthan gum 0.15   0.05       0.30   Sodium carbomer   0.20 0.10 0.20   Vitamin E Acetate 0.5   0.25 0.50 0.75   1.00   Alpha-glucosylrutin 0.25     0.20   0.25   DMDM hydantoin   0.60 0.40 0.20   Konkaben LMBâÂ®       0.18 0.20   0.15   Methylparaben 0.15   0.25   0.50   Phenoxyethanol 1.00 0.40   0.40 0.50   0.60   EDTA   0.20 0.35 0.50 0.02   0.03   Ethanol   2.00 1.50   3.00 5.00 1.00   Perfume 0.20 0.20       0.30 0.40   Water ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100        

    




 


 


2. Foam-like O/W emulsions:




 
Emulsion 1
Emulsion 2




 
% by
% by
% by
% by


 
wt.
vol.
wt.
vol.


 
 




Stearic acid
5.00
 
1.00
 


Cetyl alcohol
5.50


Cetylstearyl alcohol
 
 
2.00


PEG-40 stearate
8.50


PEG-20 stearate
 
 
1.00


Caprylic/capric triglycerides
4.00
 
2.00


Cocoglycerides
2.50


C12-15 alkylbenzoate
10.00


C12-13 alkyllactate
 
 
7.50


Cyclomethicone
4.00


Dimethicone
 
 
0.50


Octyl isostearate
 
 
5.00


Diethylhexyl 2,6-naphthalate
3.00


Myristyl myristate
 
 
2.00


Ceresine
1.50


Glycerol
 
 
3.00


UVASorbâÂ® K2A
2.00
 
4.00


Phenylbenzimidazolesulfonic
 
 
0.50


acid


Disodium
2.00
 
1.50


phenyldibenzimidazoletetra-


sulfonate


Terephthalidenedicamphor-
0.50


sulfonic acid


Ethylhexyl methoxycinnamate
5.00
 
4.00


Butylmethoxydibenzoylmethane
 
 
3.00


Ethylhexyltriazone
 
 
3.00


Octocrylene
5.00


Titanium dioxide MT-100 TV
1.00


BHT
 
 
0.02


Na2H2EDTA
0.50
 
0.10


Perfume, preservative,
q.s.
 
q.s.


Dyes, etc.
q.s.
 
q.s.


Potassium hydroxide
q.s.
 
q.s.


Water
ad
 
ad


 
100.00
 
100.00




 
pH adjusted
pH adjusted


 
to 6.5-7.5
to 5.0-6.0




Emulsion 1
 
70
 
 


Emulsion 2
 
 
 
35


Gas (nitrogen)
 
30


Gas (helium)
 
 
 
65


 





     Combining of the fatty/light protection filter phase heated to 78Â° C. with the water/light protection filter phase heated to 75Â° C. Homogenization using a toothed-wheel dispersing machine (rotor-stator principle) at 65Â° C. Stirring for 45 min in the Becomix with gassing with helium at 1 bar with cooling to 30Â° C. Addition of the additives at 30Â° C. (perfume). Homogenization by means of a toothed-wheel dispersing machine (rotor-stator principle) at 23Â° C.  
            3. PIT emulsions (for use as impregnation solution, spray or aerosol)       1 2 3 4 5 6 7 8           Glycerol monostearate SE 0.50 2.00 3.00 5.00     0.50 4.00   Glyceryl isostearate         3.50 4.00 2.00   Isoceteth-20   0.50     2.00   Ceteareth-12   5.00   1.00       3.50   Ceteareth-20       2.00   2.50 3.00   PEG-100 Stearate 5.00   1.00   1.00     0.50   Cetyl alcohol 2.50 1.00   1.50   0.50 1.50   Cetyl palmitate       0.50   1.00   Cetyldimethicone copolyol 0.50       0.50   1.00   Polyglyceryl-2 dipolyhydroxystearate       0.75 0.25   UVASorbâÂ® K2A 1.50 2.00 2.00 3.00 2.50 3.00 1.00 3.50   Disodium phenyldibenzimidazole-   2.00   1.00       2.00   tetrasulfonate   Terephthalidenedicamphorsulfonic acid             1.00   Phenylbenzimidazolesulfonic acid 1.00 2.00       2.00   UvinulâÂ® A Plus 2.00   Bisethylhexyloxyphenol       2.00 1.00   0.75   methoxyphenyltriazine   Butylmethoxydibenzoylmethane 1.50   1.00       0.75   Drometrizoletrisiloxane     2.00     3.00   1.00   Ethylhexyl methoxycinnamate 8.00     4.50 5.00 10.00   Diethylhexylbutamidotriazone         2.00 2.00   1.50   Ethylhexyltriazone     2.00 4.00   2.00 1.50 3.00   Octocrylene     5.00   10.00     7.50   C12-15 alkylbenzoate 3.50   Cocoglycerides   3.00   3.00       3.50   Dicaprylyl ether 4.00   2.00   Di-C12-13-alkyl lactate       1.50     1.00   Butylene glycol dicaprylate/dicaprate   4.00       3.00   Dicaprylyl carbonate     5.00         6.00    Persea gratissima        3.00     2.00   Phenyltrimethicone 2.00       2.00   PVP hexadecene copolymer       1.00 1.50   Glycerol 10.0 5.00   7.50   10.00   FucogelâÂ® 1000     2.50 6.00   Tocopherol 1.00     0.75 0.50   1.00   Shea butter   2.00 3.50         0.50   Iodopropyl butylcarbamate 0.12       0.20   DMDM hydantoin       0.10   Methylparaben   0.50 0.25   0.45   Phenoxyethanol 0.50 0.40   1.00       1.00   Ethylhexyloxyglycerol   0.30     1.00 0.35   Ethanol       2.00   6.00 7.50 4.00   Trisodium EDTA   0.40   0.15   0.20   0.50   Perfume 0.20   0.20 0.20 0.45     0.20   Water ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100        

    




 


 


4. Low viscosity to sprayable W/O emulsions (for


use as impregnation solution, spray or aerosol)




 
1
2
3
4
5


 
 




Cetyl dimethicone copolyol
4.00
 
 
2.50
3.00


Polyglyceryl-2 dipolyhydroxystearate
 
 
3.00
 
1.00


Isostearyl diglyceryl succinate
 
 
0.75
 
0.30


Lauryl methicone copolyol
 
 
 
2.00


Polysorbate-65
 
 
2.00
 
1.50


PEG-100 Stearate
 
 
 
1.20
0.70


Cetearyl sulfate
 
 
0.25
 
1.00


Dimethicone
 
4.00
 
 
2.00


Cyclomethicone
12.00
20.00
 
30.00
15.00


UVASorbâÂ® K2A
2.00
1.50
3.00
0.50
5.00


Disodium
1.00
0.75


phenyldibenzimidazoletetrasulfonate


Terephthalidenedicamphorsulfonic acid
 
 
 
 
1.00


Phenylbenzimidazolesulfonic acid
 
1.50
 
 
2.00


UvinulâÂ® A Plus
 
1.00
 
0.75


Bisethylhexyloxyphenol
1.50
2.00
0.50


methoxyphenyltriazine


Drometrizol trisiloxane
 
 
 
1.00


Ethylhexyl methoxycinnamate
3.00
4.00
 
 
10.00


Diethylhexylbutamidotriazone
 
1.00
 
 
6.50


Ethylhexyltriazone
3.00
 
 
 
4.00


Titanium dioxide MT-100 TV
 
0.50
1.00
1.50
0.50


Zinc oxide Z-Cote HP1
2.00
 
 
 
4.00


Dicaprylyl carbonate
5.00
 
15.00
 
4.00


Dihexyl carbonate
 
10.00


C12-15 alkyl benzoate
7.00
 
10.00


Ethyl butylacetylaminopropionate
 
 
 
7.50


Propylene glycol dicaprylate/dicaprate
 
2.50
 
8.00


Mineral oil
10.00
 
 
 
6.00


PVP hexadecene copolymer
 
0.75
 
 
0.40


Glycerol
 
 
 
5.00
7.00


Î±-glucosylrutin
 
 
 
 
0.15


EDTA
 
0.15
0.03
 
0.15


Glycine soya
0.75
 
 
1.50


Magnesium sulfate
0.75
1.00
 
0.45
1.00


Sodium chloride
 
 
1.00


DMDM hydantoin
 
0.05
 
 
0.10


Phenoxyethanol
1.00
0.75
0.50
 
1.00


Ethanol
2.00
 
 
5.00
1.00


Dye
0.02
 
 
0.01


Perfume
0.30
0.45
0.35
 
0.15


Water
ad 100
ad 100
ad 100
ad 100
ad 100


 





    




 


 


5. W/O sunscreen emulsions (creams and lotions)




 
1
2
3
4
5


 
 




Cetyldimethicone copolyol
 
 
 
4.00
 


Polyglyceryl-2 dipolyhydroxystearate
5.00
4.50
 
 
4.50


PEG-30 dipolyhydroxystearate
 
 
5.00
2.00


UVASorbâÂ® K2A
3.50
2.00
1.50
4.00
0.50


Disodiumphenyldibenzimidazoletetrasulfonate
1.00
 
1.00
1.00
2.00


Terephthalidenedicamphorsulfonic acid
 
 
0.75


Phenylbenzimidazolsulfonic acid
 
4.00
 
2.00
0.50


UvinulâÂ® A Plus
2.00
 
 
 
1.00


Methylenebisbenzotriazolyltetramethyl-
 
 
2.00
 
0.50


butylphenol


Bisethylhexyloxyphenol methoxyphenyltriazine
2.00
 
 
2.00
2.50


Butylmethoxydibenzoylmethane
 
 
2.00
1.00


Ethylhexyl methoxycinnamate
 
8.00
 
5.00
4.00


Diethylhexylbutamidotriazone
3.00
1.00
 
 
3.00


Ethylhexyltriazone
 
 
3.00
4.00


ParsolâÂ® SLX
5.00


Octocrylene
7.00
 
8.00
 
2.50


Titanium dioxide UvinulâÂ® T 805
2.00
1.00


Titanium dioxide MT-100 Z
 
 
3.00
 
2.00


Zinc oxide Z-CoteâÂ® HP1
2.50
 
6.00


Mineral oil
 
 
10.0
 
8.00


Cocoglycerides
4.00
6.50


C12-15 alkylbenzoates
 
 
 
9.00


Cetyl dimethicone
6.00
 
 
 
7.00


Isodecyl neopentanoate
 
5.00
 
4.00


Butylene glycol dicaprylate/dicaprate
 
 
2.00
8.00
4.00


Cyclomethicone
2.00
 
 
 
2.00


PVP hexadecene copolymer
0.50
 
 
1.50
1.00


Baypure CX 100âÂ®
0.45
 
0.75
 
0.25


Trisodium EDTA
1.00
 
 
0.35


Ethylhexyloxyglycerol
 
0.30
1.00
 
0.50


Glycerol
3.00
7.50
 
7.50
2.50


Butylene glycol
 
 
10.00
 
6.50


Glycine soya
 
1.00
1.50


MgSO4 
1.00
0.50
 
0.50


MgCl2 
 
 
1.00
 
0.70


Vitamin E
0.50
 
0.25
 
1.00


DMDM hydantoin
 
0.60
 
0.20


Methylparaben
0.50
 
 
0.15


Phenoxyethanol
0.50
0.40
 
1.00
0.60


Ethanol
3.00
 
4.50
 
1.00


Perfume
0.20
 
0.20
 
0.20


Water
ad 100
ad 100
ad 100
ad 100
ad 100


 





    




 


 


6. Hydrodispersions (for use as lotion, impregnation solution or spray)




 
1
2
3
4
5


 
 




Ceteareth-20
1.00
 
 
0.5
 


Cetyl alcohol
 
 
 
1.00


Sodium carbomer
 
0.20
 
0.30


Acrylates/C10-30 alkyl acrylate
 
 
0.40
0.10
0.10


crosspolymer


Xanthan gum
0.50
0.30
0.15
 
0.50


Dimethicone/vinyldimethicone crosspolymer
 
 
5.00
 
3.00


UVASorbâÂ® K2A
2.00
1.50
4.00
3.50
0.50


Disodium phenyldibenzimidazoletetrasulfonate
4.00
1.00


Phenylbenzimidazolsulfonic acid
 
 
 
2.00


UvinulâÂ® A Plus
3.00
 
 
 
0.50


Ethylhexyl methoxycinnamate
 
 
 
5.00
8.00


Bisethylhexyloxyphenol methoxy-
 
1.50
2.00
 
1.00


phenyltriazine


Butylmethoxydibenzoylmethane
1.00
 
 
0.50
0.50


Diethylhexylbutamidotriazone
 
2.00
1.00
 
1.00


Methylenebis-benzotriazolyltetramethyl-
3.00


butylphenol


Ethylhexyltriazone
4.00
 
3.00
4.00


Drometrizol trisiloxane
3.00


Titanium dioxide T805âÂ®
0.50
 
2.00
3.00
1.00


Zinc oxide Z-CoteâÂ®
2.00
4.00


C12-15 alkylbenzoates
2.00
2.50


Butylene glycol dicaprylate/dicaprate
4.00
 
 
6.00


Dicaprylyl carbonate
 
2.00


Hexadecyl benzoate + butyloctyl benzoate
 
 
5.00


Diethylhexyl 2,6-naphthalate
 
 
 
10.00


Dimethicone
 
0.50
12.50
4.50
7.00


Cyclomethicone
10.00
2.00
 
2.50
10.00


Shea butter
 
2.00


PVP hexadecene copolymer
0.50
 
 
0.50
1.00


Ethylhexyloxyglycerol
 
0.50
1.00
 
0.50


Glycerol
3.00
7.50
 
7.50
2.50


Butylene glycol
 
 
10.00


Glycine soya
 
1.50
1.00


Vitamin E acetate
0.50
0.20
0.25
0.75
1.00


Î±-Glycosylrutin
 
0.30
 
0.25


Butyloctyl salicylate
 
1.50


2,6-diethylhexyl naphthalate
 
 
 
 
3.50


Trisodium EDTA
 
0.30
0.10
0.20


Konkaben LMBâÂ®
0.20
 
 
 
0.15


Methylparaben
0.50
 
 
0.15


Phenoxyethanol
0.50
 
 
1.00
0.60


Ethanol
3.00
7.00
3.50
 
1.00


Insect repellent 3535
 
 
 
7.50


Perfume
0.20
 
0.20
0.40
0.20


Dyes, water-soluble
 
 
0.02


Water
ad 100
ad 100
ad 100
ad 100
ad 100


 





    




 


 


7. Solids-stabilized emulsions




 
1
2
3
4
5


 
 




Mineral oil
 
 
16.00
16.00
 


Octyldodecanol
9.00
9.00
5.00


Polyglyceryl-2 dipolyhydroxystearate
 
 
 
 
0.45


Caprylic/capric triglyceride
9.00
9.00
6.00


C12-15-alkyl benzoates
 
 
 
5.00
8.00


Butylene glycol dicaprylate/dicaprate
 
 
 
 
8.00


Dicaprylyl ether
9.00
 
 
4.00


Dicaprylyl carbonate
 
9.00


Hydroxyoctacosanyl hydroxystearate
2.00
2.00
2.00
2.00
1.50


Disteardimonium hectorite
1.00
0.750
0.50
0.50
0.25


 Cera Microcristallina +
 
 
2.50
 
5.00


Paraffinum Liquidum


Hydroxypropylmethylcellulose
0.15
 
 
 
0.05


Dimethicone
 
 
4.50


UVASorbâÂ® K2A
2.00
5.00
3.00
1.50
1.00


Disodiumphenyldibenzimidazoletetrasulfonate
3.00
 
 
 
2.00


Terephthalidenedicamphorsulfonic acid
 
2.00


Phenylbenzimidazolsulfonic acid
2.00


UvinulâÂ® A Plus
 
 
2.75
 
0.50


Ethylhexyl methoxycinnamate
6.00
 
 
 
3.0


Octocrylene
3.50
 
7.50


Ethylhexyl salicylate
 
3.50
 
 
4.00


Diethylhexylbutamidotriazone
 
 
 
 
4.0


Parsol SLXâÂ®
10.00


Benzophenone-3
 
2.50
 
 
0.50


Methylenebis-benzotriazolyl
 
 
 
 
4.00


tetramethylbutylphenol


Titanium dioxide EusolexâÂ® T-2000
 
2.00
4.00
2.00
4.00


Titanium dioxide T 805âÂ®
 
 
 
 
3.00


Zinc oxide NDMâÂ®
 
 
 
6.00


Silica dimethyl silylate
 
 
1.00


Boron nitride
2.00
 
 
3.00


Starch/sodium metaphosphate polymer
 
0.5


Tapioca starch
 
 
 
1.00


Sodium chloride
1.00
1.00
1.00
1.00


Glycerol
5.0
10.0
 
6.00
10.0


Iminosuccinate VP OC 370âÂ®
 
 
1.50
0.75


Trisodium EDTA
 
1.00
 
1.00


Methylparaben
0.21
 
 
 
0.20


Propylparaben
0.07


Phenoxyethanol
0.50
 
0.40
0.40
0.50


Hexamidine diisethionate
 
 
 
 
0.08


Diazolidinylurea
 
 
0.28
0.28


Alcohol
 
5.00
 
2.50


Perfume
0.45
0.20
 
 
0.45


Water
ad 100
ad 100
ad 100
ad 100
ad 100


 





    




 


 


8. Oils and oil gels




 
1
2
3
4
5


 
 




Octyldodecanol
9.00
9.00
 
 
 


Caprylic/capric triglyceride
9.00
 
6.00


C12-15-alkyl benzoates
 
 
 
5.00
8.00


Butylene glycol dicaprylate/dicaprate
 
9.00
 
 
8.00


Cocoglycerides
 
 
9.00
 
3.00


Dicaprylyl ether
9.00
 
 
4.00


Dicaprylyl carbonate
 
7.00


Ethyl galactomannan (N-HanceâÂ® AG 200)
3.50
 
 
 
4.00


C20-40 fatty acids + polyethylenes
 
 
 
3.60


(PerformacidâÂ®â350)


Hydroxyoctacosanyl hydroxystearate
2.00


Disteardimonium hectorite
1.00
 
 
 
1.00


Cetyl dimethicone
0.50
 
4.50


Cyclomethicones
 
 
15.00
 
5.00


UVASorbâÂ® K2A
2.00
5.00
3.00
1.50
1.00


Drometrizol trisiloxane
0.75
2.00
1.85
3.00
0.50


Butylmethoxydibenzoylmethane
1.00
 
 
2.00


Ethylhexyl methoxycinnamate
6.00
 
 
10.00
3.0


Octocrylene
3.50
 
7.50
10.00


Ethylhexyl salicylate
 
3.50
 
 
4.00


Ethylhexyltriazone
 
 
2.00


Diethylhexylbutamidotriazone
 
0.50
 
3.00
4.0


Phenoxyethanol
0.50


Diethylhexyl 2,6-naphthalate
5.00
 
 
 
5.00


Perfume
0.45
0.20
 
0.45
0.45


Dyes, oil-soluble
 
 
 
0.015
0.025


Mineral oil
ad 100
ad 100
ad 100


Rice oil
 
 
 
ad 100
ad 100


 





    




 


 


9. Sunscreen sticks (for lips and/or face)




 
1
2
3
4


 
 




Caprylic/capric triglyceride
12.00
10.00
6.00
 


Octyldodecanol
7.00
14.00
8.00
3.00


Butylene glycol dicaprylate/
 
 
 
12.00


dicaprate


Pentaerythrityl tetraisostearate
10.00
 
8.00
7.00


Cocogycerides
 
10.00


Polyglyceryl-3 diisostearate
2.50


Bisdiglyceryl polyacyl adipate-2
9.00
8.00
10.00
8.00


Cetearyl alcohol
8.00
11.00
9.00
7.00


Myristyl myristate
3.50
3.00
4.00
3.00


Beeswax
5.00
5.00
6.00
6.00



Cera carnauba

1.50
2.00
2.00
1.50



Cera Alba

0.50
0.50
 
0.50


C16-40-alkyl stearates
 
2.50
1.50
1.50


UVASorbâÂ® K2A
2.00
4.50
3.00
0.50


Drometrizol trisiloxane
1.00
2.00
4.00


Ethylhexyltriazone
2.00


Diethylhexylbutamidotriazone
 
 
 
3.00


Z-CoteâÂ® HP1
 
 
 
4.50


MT-100 TV
 
4.00
2.50


Titanium dioxide T 805
 
3.60
 
5.00


Ethylhexyl methoxycinnamate
3.00
3.60
 
2.50


Octocrylene
 
 
7.50


Benzophenone-3
 
 
3.50


Tocopheryl acetate
0.50
1.00


Ascorbyl palmitate
0.05
 
0.05



Buxus Chinensis

2.00
1.00
 
1.00


Perfume, BHT
0.10
0.25
 
0.35



Ricinus Communis

ad 100
ad 100
ad 100
ad 100


 





    




 


 


10. W/O sunscreen sticks (for lips and/or face)




 
1
2
3
4
5
6
7


 
 




PEG-45 dodecyl glycol copolymer
1.5
2
1
1.5
2
 
 


Polyglyceryl 3 diisostearate
1.5
1.75
3
 
 
2
1


Cetyldimethicone copolyol
 
 
 
 
1
2
1.5


PEG-30 dipolyhydroxystearate
0.25
 
 
2
1.5
 
2


Stearyl alcohol
1
 
 
 
2
 
1


Cetyl alcohol
1
 
1.5
 
 
2


Hydrogenated cocoglycerides
1
2
 
 
3
1
2


Shea butter
1
 
 
1
 
 
5


C18-36 acid triglycerides
6
 
10
 
5
1
3


C20-40-alkyl Stearate
 
5
2
12
5
 
2


C12-15 alkyl benzoates
2
 
 
2
2


Butylene glycol dicaprylate/dicaprate
5
2
 
 
6
 
5


Dicapryl ether
 
2
 
 
 
3


Dicaprylyl carbonate
2
 
 
3
 
2


Caprylic/capric triglycerides
 
1
 
1.5
 
 
1.5


Diethylhexyl 2,6-naphthalate
5


Dibutyl adipate
 
 
7


Octyldodecanol
 
 
 
2


Mineral oil
2
 
 
 
 
2


Cyclomethicones
 
 
2


Dimethicones
2
 
 
 
 
2
1


Cyclomethicone
 
 
 
2
 
 
1


UVASorbâÂ® K2A
3
1
0.5
4.2
2
3
1


UvinulâÂ® A Plus
3
 
 
 
1
 
0.75


Bisethylhexyloxyphenol
1.7
 
2
 
1.5
2


methoxyphenyltriazines


Butylmethoxydibenzoylmethane
 
 
 
1.5
 
 
2


Disodium
0.5
2
 
 
 
0.5


phenyldibenzimidazoletetrasulfonate


Octocrylene
 
 
 
 
5
10


Ethylhexyl salicylate
 
 
 
 
1


Ethylhexyl methoxycinnamate
 
 
5
7.5
5


Homosalate
 
 
1


Diethylhexylbutamidotriazone
2
1
1
 
1
3
2


Ethylhexyltriazone
1
2
2
3
2
1
2


Phenylbenzimidazolsulfonic acid
 
1


Titanium dioxide MT 100-Z
 
2
 
 
 
5


Titanium dioxide T 805
2
 
1
 
 
2
1


Zinc oxide neutral
 
1
 
0.5


Trisodium EDTA
1
1
 
1
1
1
1


PVP/hexadecene copolymer
1
 
 
0.5
 
0.5


Tricontayl PVP
 
0.5
0.5
 
1
 
1


Polyurethane-4 (Avalure UR-445âÂ®)
1
 
 
1
1


Tocopheryl acetate
0.5
0.5
 
0.5
 
1
0.5


Glucosylrutin + isoquercitrin
 
0.5
0.2
 
 
0.5


Phenoxyethanol
0.1
0.5
0.5
 
0.5
 
0.5


Parabens
0.6


Xanthan gum
0.2
 
 
0.5
0.2
0.15


Carbomer
 
0.2
 
 
0.1
0.3
0.3


Alkyl acrylates crosspolymer
 
 
0.1


Cellulose ether
 
 
0.2
0.5


Iodopropynyl butylcarbamate
0.05
0.15
 
0.2
 
 
0.1


(Glycasil gradesâÂ®, Konkaben LMBâÂ®)


Sodium hydroxide solution 45%
 
0.5
 
 
 
 
0.25


Glycerol
5
7.5
2.5
 
5
 
2


Butylene glycol
 
 
5
7.5
 
3
3


Octoxyglycerol
0.5
0.4


DMDM hydantoin
 
 
0.5
 
0.6
0.4
0.05


Alcohol denat.
 
1
 
2.5
2
 
3


Dye pigments
0.2
 
 
 
0.05


Dye oil-soluble
 
0.3


Distarch phosphate
 
0.5
 
 
 
 
5


Perfume
0.5
0.15
 
 
 
0.45
0.5


Water
ad 100
ad 100
ad 100
ad 100
ad 100
ad 100
ad 100


 





 



Claims (38)

 
 1. A light protection cosmetic or dermatological preparation, comprising 
(a) at least one benzoxazole derivative and  (b) at least one oil component with a surface tension (Ï) of less than 37 mN/m (at 25Â° C.).  

  
 2. The preparation as claimed in claim 1, wherein the at least one benzoxazole derivative includes 2,4-bis[5-1(dimethylpropyl)benzoxazole-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine. 

  
 3. The preparation as claimed in claim 1, wherein the at least one oil component includes at least one compound selected from the group consisting of UV filter substances that are liquid at room temperature. 

  
 4. The preparation as claimed in claim 1, wherein the at least one oil component includes at least one compound selected from the group consisting of diethylhexyl 2,6-naphthalate, C12-15-alkyl benzoate, butylene glycol dicaprylate/dicaprate, butyloctyl salicylate, tridecyl trimellitate, and cocoglycerides. 

  
 5. The preparation as claimed in claim 1, further comprising at least one UV filter substance selected from the group consisting of triazines, camphor derivatives, water-soluble UV filter substances, organic pigments, and inorganic pigments. 

  
 6. The preparation as claimed in claim 1, further comprising at least one further UV filter substance selected from the group consisting of dibenzoylmethane derivatives, phenylene-1,4-bis(2-benzimidazyl)-3,3â²-5,5â²-tetrasulfonic acid bis-sodium salt, hexyl 2-(4â²-diethylamino-2â²-hydroxybenzayl)benzoate and 2,4-bis{(4-(2-ethylhexyloxy)-2-hydroxylphenyl}-6-(4-methoxyphenyl)-1,3,5-triazine. 

  
 7. The preparation as claimed in claim 6, wherein the at least one further UV filter substance includes 4-(tert-butyl)-4â²-methoxydibenzoylmethane. 

  
 8. The preparation as claimed in claim 1, wherein the lipid phase consists of UV filter substances that are liquid at room temperature. 

  
 9. The preparation as claimed in claim 1, further comprising at least one flavone glycoside. 

  
 10. The preparation as claimed in claim 9, wherein the at least one flavone glycoside includes at least one compound selected from the group consisting of Î±-glycosylrutin, vitamin E, and vitamin E derivatives. 

  
 11. The preparation as claimed in claim 1, further comprising at least one active ingredient selected from the group consisting of 8-hexadecene-1,16-dicarboxylic acid and Î±-lipoic acid. 

  
 12. The preparation as claimed in claim 1, further comprising at least one self-tanning substance. 

  
 13. The preparation as claimed in claim 12, wherein the at least one self-tanning substance includes dihydroxyacetone. 

  
 14. The preparation as claimed in claim 1, further comprising at least one repellent. 

  
 15. The preparation as claimed in claim 14, wherein the at least one repellent includes ethyl-3-(N-n-butyl-N-acetlylamino)propionate. 

  
 16. A method of treating or preventing cosmetic or dermatological changes in the skin, comprising applying a cosmetic or dermatological preparation to the skin comprising 
(a) at least one benzoxazole derivative and  (b) at least one oil component with a surface tension (Ï) of less than 37 mN/m (at 25Â° C.).  

  
 17. The method as claimed in claim 16, wherein the at least one benzoxazole derivative includes 2,4-bis[5-1(dimethylpropyl)benzoxazole-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine. 

  
 18. The method as claimed in claim 16, wherein the at least one oil component includes at least one compound selected from the group consisting of UV filter substances that are liquid at room temperature. 

  
 19. The method as claimed in claim 16, wherein the at least one oil component includes at least one compound selected from the group consisting of diethylhexyl 2,6-naphthalate, C12-15-alkyl benzoate, butylene glycol dicaprylate/dicaprate, butyloctyl salicylate, tridecyl trimellitate, and cocoglycerides. 

  
 20. A method of tanning or accelerating tanning of the skin, comprising applying a cosmetic or dermatological preparation to the skin comprising 
(a) at least one benzoxazole derivative and  (b) at least one oil component with a surface tension (Ï) of less than 37 mN/m (at 25Â° C.).  

  
 21. The method as claimed in claim 20, wherein the at least one benzoxazole derivative includes 2,4-bis[5-1(dimethylpropyl)benzoxazole-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine. 

  
 22. The method as claimed in claim 20, wherein the at least one oil component includes at least one compound selected from the group consisting of UV filter substances that are liquid at room temperature. 

  
 23. The method as claimed in claim 20, wherein the at least one oil component includes at least one compound selected from the group consisting of diethylhexyl 2,6-naphthalate, C12-15-alkyl benzoate, butylene glycol dicaprylate/dicaprate, butyloctyl salicylate, tridecyl trimellitate, and cocoglycerides. 

  
 24. A method of protecting the skin against light-induced aging, comprising applying a cosmetic or dermatological preparation to the skin comprising 
(a) at least one benzoxazole derivative and  (b) at least one oil component with a surface tension (a) of less than 37 mN/m (at 25Â° C.).  

  
 25. The method as claimed in claim 24, wherein the at least one benzoxazole derivative includes 2,4-bis[5-1(dimethylpropyl)benzoxazole-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine. 

  
 26. The method as claimed in claim 24, wherein the at least one oil component includes at least one compound selected from the group consisting of UV filter substances that are liquid at room temperature. 

  
 27. The method as claimed in claim 24, wherein the at least one oil component includes at least one compound selected from the group consisting of diethylhexyl 2,6-naphthalate, C12-15-alkyl benzoate, butylene glycol dicaprylate/dicaprate, butyloctyl salicylate, tridecyl trimellitate, and cocoglycerides. 

  
 28. The method as claimed in claim 24, wherein the preparation further comprises at least one UV filter substance selected from the group consisting of triazines, camphor derivatives, water-soluble UV filter substances, organic pigments, and inorganic pigments. 

  
 29. The method as claimed in claim 24, wherein the preparation further comprises at least one UV filter substance selected from the group consisting of dibenzoylmethane derivatives, phenylene-1,4-bis(2-benzimidazyl)-3,3â²-5,5â²-tetrasulfonic acid bis-sodium salt, hexyl 2-(4â²-diethylamino-2â²-hydroxybenzayl)benzoate and 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine. 

  
 30. The method as claimed in claim 24, wherein the preparation further includes 4-(tert-butyl)-4â²-methoxydibenzoylmethane. 

  
 31. The method as claimed in claim 24, wherein the preparation further comprises at least one flavone glycoside. 

  
 32. The method as claimed in claim 31, wherein the at least one flavone glycoside includes at least one compound selected from the group consisting of Î±-glycosylrutin, vitamin E, and vitamin E derivatives. 

  
 33. The method as claimed in claim 24, wherein the preparation further comprises at least one active ingredient selected from the group consisting of 8-hexadecene-1,16-dicarboxylic acid and Î±-lipoic acid. 

  
 34. A method of increasing the solubility of a benzoxazole derivative in a cosmetic or dermatological preparation comprising adding to said preparation at least one oil component that has a surface tension (a) of less than 37 mN/m. 

  
 35. A cosmetic or dermatological wipe comprising a water-insoluble substrate impregnated with a preparation comprising 
(a) at least one benzoxazole derivative and  (b) at least one oil component with a surface tension (a) of less than 37 mN/m (at 25Â° C.).  

  
 36. The wipe as claimed in claim 35, wherein the at least one benzoxazole derivative includes 2,4-bis[5-1(dimethylpropyl)benzoxazole-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine. 

  
 37. The wipe as claimed in claim 35, wherein the at least one oil component includes at least one compound selected from the group consisting of UV filter substances that are liquid at room temperature. 

  
 38. The wipe as claimed in claim 35, wherein the at least one oil component includes at least one compound selected from the group consisting of diethylhexyl 2,6-naphthalate, C12-15-alkyl benzoate, butylene glycol dicaprylate/dicaprate, butyloctyl salicylate, tridecyl trimellitate, and cocoglycerides.

 




US10/871,819
2001-12-20
2004-06-18
Cosmetic or dermatological light protection formulation with a benzoxazole derivative 
       
Abandoned

US20050142080A1
            (en)
        

Priority Applications (1)



Application Number
Priority Date
Filing Date
Title





US10/871,819

US20050142080A1
                          (en)
                      
2001-12-20
2004-06-18
Cosmetic or dermatological light protection formulation with a benzoxazole derivative 
       



Applications Claiming Priority (4)



Application Number
Priority Date
Filing Date
Title





DE10162841.2

2001-12-20



DE2001162841

DE10162841A1
                          (en)
                      
2001-12-20
2001-12-20

  Cosmetic and dermatological light protection formulations containing benzoxazole derivatives
 
       


PCT/EP2002/014298

WO2003053390A1
                          (en)
                      
2001-12-20
2002-12-16
Cosmetic and dermatological light protection formulations having a content of benzoxazol derivatives 
       


US10/871,819

US20050142080A1
                          (en)
                      
2001-12-20
2004-06-18
Cosmetic or dermatological light protection formulation with a benzoxazole derivative 
       



Related Parent Applications (1)



Application Number
Title
Priority Date
Filing Date





PCT/EP2002/014298
Continuation

WO2003053390A1
                          (en)
                      

2001-12-20
2002-12-16
Cosmetic and dermatological light protection formulations having a content of benzoxazol derivatives 
       



Publications (1)



Publication Number
Publication Date





US20050142080A1
true
US20050142080A1
                       (en)
                   

2005-06-30





Family
ID=34701908
Family Applications (1)



Application Number
Title
Priority Date
Filing Date





US10/871,819
Abandoned

US20050142080A1
                          (en)
                      

2001-12-20
2004-06-18
Cosmetic or dermatological light protection formulation with a benzoxazole derivative 
       



Country Status (1)



Country
Link





US
                (1)
              



US20050142080A1
                  (en)
              




Cited By (10)

* Cited by examiner, â  Cited by third party


Publication number
Priority date
Publication date
Assignee
Title






US20040265346A1
              (en)
            
*

2003-04-28
2004-12-30
Aurore Verloo
Water-in-oil emulsions for use in cosmetics 
       



US20060013793A1
              (en)
            
*

2004-07-16
2006-01-19
Agnes Themens
Solid water-in-oil cosmetic emulsion 
       



US20090092688A1
              (en)
            
*

2007-10-08
2009-04-09
Anson Williams
Ointment for topical treatment of hot flashes and method of use 
       



EP2351801A1
              (en)
            
*

2010-01-28
2011-08-03
Clariant International Ltd.
Aqueous dispersion paints containing lactic acid esters used as film binders 
       



FR2976479A1
              (en)
            
*

2011-06-16
2012-12-21
Oreal
Composition, useful for e.g. treating skin, lips and hair including scalp, comprises e.g. particles A of hydrophobic titanium oxide treated with fatty acids or their salts, and particles B of titanium oxide doped with transition metals 
       



US20130089588A1
              (en)
            
*

2011-10-11
2013-04-11
Fallien Cosmeceuticals, Ltd.
Foamable sunscreen formulation 
       



WO2013102248A3
              (en)
            
*

2012-01-06
2014-08-07
. Johnson & Johnson Do Brasil Industria E Comercio De Produtos Para Saude Ltda.
"aqueous cosmetic sunscreen composition and use thereof, cosmetic method for application of said composition, cosmetic method to prevent and control skin oiliness, cosmetic method to protect the skin from the damages caused by ultraviolet radiation, and cosmetic product." 
       



CN104994834A
              (en)
            
*

2013-02-20
2015-10-21
æ ªå¼ä¼ç¤¾é«ä¸
Aerosol-type sunscreen cosmetic 
       



US9931294B2
              (en)
            
*

2015-12-29
2018-04-03
L'oreal
Stable skin care composition having cosmetically acceptable oils 
       



US20180235864A1
              (en)
            
*

2015-08-06
2018-08-23
Laboratori Derivati Organici Spa
Compositions comprising dermatan sulfate and chondroitin sulfate and use thereof in cosmetological  compositions 
       



Citations (14)

* Cited by examiner, â  Cited by third party


Publication number
Priority date
Publication date
Assignee
Title






US4076687A
              (en)
            
*

1976-08-16
1978-02-28
Eastman Kodak Company
Bichromophoric benzotriazole-benzoxazole ultraviolet stabilizers and their use in organic compositions 
       



US4250315A
              (en)
            
*

1978-10-31
1981-02-10
Hoffmann-La Roche Inc.
Light-screening benzoxazole derivatives 
       



US5154850A
              (en)
            
*

1989-07-18
1992-10-13
Kao Corporation
Neutral liquid detergent composition 
       



US5302376A
              (en)
            
*

1990-05-18
1994-04-12
L'oreal
Cosmetic screening emulsion comprising a UV-A screening agent and a UV-B screening agent and its use for skin protection against ultraviolet radiation 
       



US5961960A
              (en)
            
*

1996-11-20
1999-10-05
Haarmann & Reimer Gmbh
Use of substituted benzazoles as UV absorbers, new benzazoles and processes for their preparation 
       



US6248311B1
              (en)
            
*

1999-02-12
2001-06-19
Societe L'oreal S.A.
Photoprotective/cosmetic compositions comprising bisresorcinyltriazine and benzoazolyl/benzodiazolyl 
       



US6251373B1
              (en)
            
*

1999-02-12
2001-06-26
Societe L'oreal S.A.
Photoprotective/cosmetic compositions comprising benzotriazole, bisresorcinyltriazine and benzoazolyl/benzodiazolyl sunscreens 
       



US6254898B1
              (en)
            
*

2000-05-25
2001-07-03
Protective Factors, Inc.
Nutraceutical composition for protection against solar radiation 
       



US6296835B1
              (en)
            
*

1999-06-08
2001-10-02
Societe L'oreal S.A.
Photoprotective/cosmetic compositions comprising bis-hydroxyphenylbenzotriazole and benzazolyl/benzodiazolyl sunscreens 
       



US20020001570A1
              (en)
            
*

2000-03-15
2002-01-03
Thomas Heidenfelder
Use of sunscreen combinations comprising, as essential constituent, amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations 
       



US6409995B1
              (en)
            
*

1999-04-20
2002-06-25
Basf Aktiengesellschaft
Use of amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations 
       



US20020085981A1
              (en)
            
*

2000-02-11
2002-07-04
Giuseppe Raspanti
Benzoxazole derivatives for use in cosmetic compositions and for stabilizing synthetic polymers 
       



US6514485B1
              (en)
            
*

1999-01-11
2003-02-04
3V Sigma S.P.A.
Combinations of sunscreens 
       



US6646011B2
              (en)
            
*

1998-06-03
2003-11-11
Johnson & Johnson Consumer Companies, Inc.
Insect repellant compositions 
       





2004


2004-06-18
US
US10/871,819
patent/US20050142080A1/en
not_active
Abandoned







Patent Citations (14)

* Cited by examiner, â  Cited by third party


Publication number
Priority date
Publication date
Assignee
Title






US4076687A
              (en)
            
*

1976-08-16
1978-02-28
Eastman Kodak Company
Bichromophoric benzotriazole-benzoxazole ultraviolet stabilizers and their use in organic compositions 
       



US4250315A
              (en)
            
*

1978-10-31
1981-02-10
Hoffmann-La Roche Inc.
Light-screening benzoxazole derivatives 
       



US5154850A
              (en)
            
*

1989-07-18
1992-10-13
Kao Corporation
Neutral liquid detergent composition 
       



US5302376A
              (en)
            
*

1990-05-18
1994-04-12
L'oreal
Cosmetic screening emulsion comprising a UV-A screening agent and a UV-B screening agent and its use for skin protection against ultraviolet radiation 
       



US5961960A
              (en)
            
*

1996-11-20
1999-10-05
Haarmann & Reimer Gmbh
Use of substituted benzazoles as UV absorbers, new benzazoles and processes for their preparation 
       



US6646011B2
              (en)
            
*

1998-06-03
2003-11-11
Johnson & Johnson Consumer Companies, Inc.
Insect repellant compositions 
       



US6514485B1
              (en)
            
*

1999-01-11
2003-02-04
3V Sigma S.P.A.
Combinations of sunscreens 
       



US6251373B1
              (en)
            
*

1999-02-12
2001-06-26
Societe L'oreal S.A.
Photoprotective/cosmetic compositions comprising benzotriazole, bisresorcinyltriazine and benzoazolyl/benzodiazolyl sunscreens 
       



US6248311B1
              (en)
            
*

1999-02-12
2001-06-19
Societe L'oreal S.A.
Photoprotective/cosmetic compositions comprising bisresorcinyltriazine and benzoazolyl/benzodiazolyl 
       



US6409995B1
              (en)
            
*

1999-04-20
2002-06-25
Basf Aktiengesellschaft
Use of amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations 
       



US6296835B1
              (en)
            
*

1999-06-08
2001-10-02
Societe L'oreal S.A.
Photoprotective/cosmetic compositions comprising bis-hydroxyphenylbenzotriazole and benzazolyl/benzodiazolyl sunscreens 
       



US20020085981A1
              (en)
            
*

2000-02-11
2002-07-04
Giuseppe Raspanti
Benzoxazole derivatives for use in cosmetic compositions and for stabilizing synthetic polymers 
       



US20020001570A1
              (en)
            
*

2000-03-15
2002-01-03
Thomas Heidenfelder
Use of sunscreen combinations comprising, as essential constituent, amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations 
       



US6254898B1
              (en)
            
*

2000-05-25
2001-07-03
Protective Factors, Inc.
Nutraceutical composition for protection against solar radiation 
       




Cited By (21)

* Cited by examiner, â  Cited by third party


Publication number
Priority date
Publication date
Assignee
Title






US20040265346A1
            (en)
          
*

2003-04-28
2004-12-30
Aurore Verloo
Water-in-oil emulsions for use in cosmetics 
       



US20060013793A1
            (en)
          
*

2004-07-16
2006-01-19
Agnes Themens
Solid water-in-oil cosmetic emulsion 
       



US20090092688A1
            (en)
          
*

2007-10-08
2009-04-09
Anson Williams
Ointment for topical treatment of hot flashes and method of use 
       



US8053004B2
            (en)
          
*

2007-10-08
2011-11-08
Starmaker Products, Llc
Ointment for topical treatment of hot flashes and method of use 
       



EP2351801A1
            (en)
          
*

2010-01-28
2011-08-03
Clariant International Ltd.
Aqueous dispersion paints containing lactic acid esters used as film binders 
       



FR2976479A1
            (en)
          
*

2011-06-16
2012-12-21
Oreal
Composition, useful for e.g. treating skin, lips and hair including scalp, comprises e.g. particles A of hydrophobic titanium oxide treated with fatty acids or their salts, and particles B of titanium oxide doped with transition metals 
       



US8911754B2
            (en)
          
*

2011-10-11
2014-12-16
Fallien Cosmeceuticals, Ltd.
Foamable sunscreen formulation 
       



US10154946B2
            (en)
          

2011-10-11
2018-12-18
Fallien Cosmeceuticals, Ltd.
Foamable sunscreen formulation 
       



US8795696B2
            (en)
          

2011-10-11
2014-08-05
Fallien Cosmeceuticals, Ltd.
Foamable sunscreen formulation comprising pigments 
       



US11077030B2
            (en)
          

2011-10-11
2021-08-03
Fallien Cosmeceuticals, Ltd.
Sunscreen formulation 
       



US20130089588A1
            (en)
          
*

2011-10-11
2013-04-11
Fallien Cosmeceuticals, Ltd.
Foamable sunscreen formulation 
       



US10588832B2
            (en)
          

2011-10-11
2020-03-17
Fallien Cosmeceuticals, Ltd.
Foamable sunscreen formulation 
       



US9561159B2
            (en)
          

2011-10-11
2017-02-07
Fallien Cosmeceuticals, Ltd.
Foamable sunscreen formulation 
       



US10576026B2
            (en)
          

2011-10-11
2020-03-03
Fallien Cosmeceuticals, Ltd.
Sunscreen formulation 
       



WO2013055774A1
            (en)
          
*

2011-10-11
2013-04-18
Fallien Cosmeceuticals, Ltd.
Foamable sunscreen formulation 
       



WO2013102248A3
            (en)
          
*

2012-01-06
2014-08-07
. Johnson & Johnson Do Brasil Industria E Comercio De Produtos Para Saude Ltda.
"aqueous cosmetic sunscreen composition and use thereof, cosmetic method for application of said composition, cosmetic method to prevent and control skin oiliness, cosmetic method to protect the skin from the damages caused by ultraviolet radiation, and cosmetic product." 
       



CN104994834B
            (en)
          
*

2013-02-20
2018-04-06
æ ªå¼ä¼ç¤¾é«ä¸
The sun-proof cosmetic preparation of aerosol type 
       



CN104994834A
            (en)
          
*

2013-02-20
2015-10-21
æ ªå¼ä¼ç¤¾é«ä¸
Aerosol-type sunscreen cosmetic 
       



US20180235864A1
            (en)
          
*

2015-08-06
2018-08-23
Laboratori Derivati Organici Spa
Compositions comprising dermatan sulfate and chondroitin sulfate and use thereof in cosmetological  compositions 
       



AU2016304201B2
            (en)
          
*

2015-08-06
2022-03-31
Laboratori Derivati Organici Spa
Compositions comprising dermatan sulfate and chondroitin sulfate and use thereof in cosmetological compositions 
       



US9931294B2
            (en)
          
*

2015-12-29
2018-04-03
L'oreal
Stable skin care composition having cosmetically acceptable oils 
       




Similar Documents



Publication
Publication Date
Title







US7060257B2
                (en)
              


2006-06-13

Cosmetic or dermatological light-protective formulation comprising a water-soluble UV filter substance and a benzoxazole derivative 
       




US7029660B2
                (en)
              


2006-04-18

Cosmetic or dermatological light-protective formulation comprising a benzotriazole and a benzoxazole derivative 
       




US20050013782A1
                (en)
              


2005-01-20

Cosmetic or dermatological light-protective formulation comprising a bisresorcinyl triazine derivative and a benzoxazole derivative 
       




US7341712B2
                (en)
              


2008-03-11

Cosmetic or dermatological light-protective formulation comprising a hydroxybenzophenone and a benzoxazole derivative 
       




US20050142080A1
                (en)
              


2005-06-30

Cosmetic or dermatological light protection formulation with a benzoxazole derivative 
       




EP1380288B1
                (en)
              


2010-11-17

Cosmetic and dermatological photoprotective compositions containing hydrophobic acrylamidomethylpropanesulphonic acid (AMPS) polymer 
       




DE10216508A1
                (en)
              


2003-10-23


  Cosmetic and dermatological formulations containing hydroxybenzophenones and one or more pre-gelatinized, cross-linked starch derivatives
 
       




JP2005513090A
                (en)
              


2005-05-12


  Cosmetic and dermatological photoprotective formulations with a certain content of benzoxazole derivatives
 
     




US20050169855A1
                (en)
              


2005-08-04

Cosmetic and dermatological light protection formulations 
       




US7413730B2
                (en)
              


2008-08-19

Cosmetic and dermatological light protection formulations 
       




EP1492489B1
                (en)
              


2016-09-14

Waterproof cosmetic and dermatological sun protecting formulations containing polyoxyethylene-polydodecylglycol-block polymers 
       




DE10214054A1
                (en)
              


2003-10-09

Oil-soluble or -dispersible alpha-olefin/maleic anhydride copolymers are used to increase the water-resistance and foaming of sunscreen compositions and O/W emulsions 
       




AU2003229572A1
                (en)
              


2003-10-13

Water proof cosmetic and dermatological sun protecting formulations containing acetylated stearic acid esters 
     




EP1555014A1
                (en)
              


2005-07-20

Photoprotectant compositions 
       




DE102004002602A1
                (en)
              


2005-08-04

Cosmetic or dermatological preparation, useful as photo protection formulation, comprises flavin compounds and/or their derivatives e.g. 7,8-dimethyl alloxazine 
       




DE10214059A1
                (en)
              


2003-10-09

Water-soluble or -dispersible polyoxyethylene-polyoxypropylene block copolymers are used to increase the water-resistance of sunscreen compositions and O/W emulsions 
       




DE10249367A1
                (en)
              


2003-07-17


  Cosmetic and dermatological light protection formulations containing hydroxybenzophenones and benzoxazole derivatives
 
       




DE102004002607A1
                (en)
              


2005-08-04


  Visualization of sunscreen on the skin
 
       




DE102004002608A1
                (en)
              


2005-08-04

Use of rhodamine derivatives for visualizing the effect of cosmetic and dermatological photo protection formulation on the skin 
       





Legal Events



Date
Code
Title
Description




2005-03-07
AS
Assignment


Owner name:
              BEIERSDORF AG, GERMAN DEMOCRATIC REPUBLIC


Free format text:
              ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GOPPEL ANJA;SCHULZ, JENS;LERG, HEIKE;REEL/FRAME:015849/0429


Effective date:
              20050223




2008-09-08
STCB
Information on status: application discontinuation


Free format text:
              ABANDONED  --  FAILURE TO RESPOND TO AN OFFICE ACTION














